Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,A1BG,Alpha-1B-glycoprotein,2278,252,0.92 [0.46-1.88],0.8287859961414468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AAMDC,Mth938 domain-containing protein,2230,249,0.99 [0.78-1.25],0.9155692433832068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,2639,307,1.02 [0.85-1.22],0.818949573483591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABCA2,ATP-binding cassette sub-family A member 2,2202,248,1.70 [1.24-2.32],0.0008667419604501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABHD14B,Protein ABHD14B,2628,310,0.99 [0.83-1.19],0.9207722484353268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABL1,Tyrosine-protein kinase ABL1,2639,307,1.10 [0.94-1.27],0.2288058412437777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABO,Histo-blood group ABO system transferase,2287,256,1.01 [0.93-1.10],0.785400128174135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABRAXAS2,BRISC complex subunit Abraxas 2,2202,248,1.10 [0.91-1.32],0.3415718317701139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",2583,300,1.00 [0.89-1.13],0.961625438493294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",2251,250,1.14 [0.98-1.34],0.0999006209987944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",2273,252,0.94 [0.81-1.07],0.3417720243002176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACAN,Aggrecan core protein,2618,305,0.95 [0.67-1.34],0.7825200611925538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACE,Angiotensin-converting enzyme,2287,256,1.31 [0.86-1.98],0.204246517595975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACE2,Angiotensin-converting enzyme 2,2603,303,1.03 [0.88-1.19],0.7452903456949957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACHE,Acetylcholinesterase,2242,246,0.96 [0.68-1.35],0.8146317610231357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACOT13,Acyl-coenzyme A thioesterase 13,2268,253,0.96 [0.86-1.07],0.4188550202464643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,2648,308,0.92 [0.75-1.13],0.4239922679983953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,2214,250,0.96 [0.74-1.25],0.7698766787546842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP5,Tartrate-resistant acid phosphatase type 5,2659,312,1.55 [1.14-2.09],0.0046750539548166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP6,Lysophosphatidic acid phosphatase type 6,2663,312,0.92 [0.80-1.06],0.2600429311857118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACRBP,Acrosin-binding protein,2267,249,0.94 [0.69-1.29],0.7071983342750674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACRV1,Acrosomal protein SP-10,2214,250,1.12 [0.98-1.27],0.0897114039997628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,2202,248,1.33 [0.99-1.78],0.0555011544604554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTA2,"Actin, aortic smooth muscle",2603,303,1.53 [1.31-1.79],7.899582006033697e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTN2,Alpha-actinin-2,2202,248,1.14 [0.95-1.39],0.1673023512763832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTN4,Alpha-actinin-4,2585,303,1.32 [1.06-1.64],0.0143353980862257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACVRL1,Serine/threonine-protein kinase receptor R3,2633,311,2.71 [2.02-3.64],2.935032206091891e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACY1,Aminoacylase-1,2648,308,0.95 [0.82-1.09],0.4551467244473368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,2202,248,1.07 [0.88-1.31],0.4955171041359894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACYP1,Acylphosphatase-1,2239,246,1.00 [0.83-1.20],0.993363605189263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA,Adenosine deaminase,2674,311,1.17 [0.89-1.53],0.2593348967538014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA2,Adenosine deaminase 2,2626,305,1.69 [1.39-2.06],1.7308437082245796e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,2214,250,1.50 [1.10-2.06],0.0113721392367074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,2603,303,1.28 [0.92-1.76],0.1383397053324741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,2634,311,1.45 [1.12-1.90],0.0056454046090962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,2674,311,1.45 [1.07-1.96],0.016121910566472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,2670,312,1.29 [0.92-1.81],0.1462116593494105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,2268,253,2.21 [1.58-3.08],2.9625914735425124e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,2214,250,1.20 [0.78-1.84],0.4127129090242938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,2679,313,0.79 [0.53-1.16],0.2294478367217699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,2639,307,1.06 [0.85-1.32],0.6244434191261754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,2603,303,1.05 [0.77-1.43],0.7652406443671617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,2214,250,1.14 [0.81-1.60],0.4551584380190635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,2658,311,0.95 [0.77-1.18],0.6713504454359098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTSL2,ADAMTS-like protein 2,2286,255,1.25 [0.94-1.66],0.122401725687826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTSL4,ADAMTS-like protein 4,2230,249,0.75 [0.45-1.24],0.2564783206825104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTSL5,ADAMTS-like protein 5,2273,252,1.16 [0.86-1.56],0.3355295725932015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,2583,300,1.00 [0.75-1.34],0.9973647765200504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADD1,Alpha-adducin,2242,246,1.02 [0.86-1.21],0.8246565858808942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRB3,Adhesion G protein-coupled receptor B3,2633,311,1.99 [1.57-2.52],1.5728509553847177e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRD1,Adhesion G-protein coupled receptor D1,2242,246,1.10 [0.82-1.47],0.5189297764828891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE1,Adhesion G protein-coupled receptor E1,2268,253,1.16 [0.95-1.43],0.1532323307540589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE2,Adhesion G protein-coupled receptor E2,2665,309,1.91 [1.39-2.61],5.313569955445373e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE5,Adhesion G protein-coupled receptor E5,2666,313,2.01 [1.54-2.62],2.465384896006869e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRF5,Adhesion G protein-coupled receptor F5,2273,252,1.04 [0.66-1.64],0.8559916181507872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG1,Adhesion G-protein coupled receptor G1,2639,307,1.22 [1.13-1.33],1.681752123238047e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG2,Adhesion G-protein coupled receptor G2,2648,308,0.54 [0.38-0.77],0.0005493894054825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRV1,Adhesion G-protein coupled receptor V1,2206,248,0.94 [0.78-1.14],0.5217276484358413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH1B,All-trans-retinol dehydrogenase,2242,246,0.84 [0.73-0.98],0.0229401474074678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,2603,303,0.87 [0.78-0.98],0.0211278055277623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADIPOQ,Adiponectin,2278,252,1.06 [0.91-1.24],0.4639487818953864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADM,Pro-adrenomedullin,2668,312,2.21 [1.52-3.21],3.412201284602759e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADRA2A,Alpha-2A adrenergic receptor,2202,248,1.09 [0.92-1.29],0.3225320478545392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFAP1,Actin filament-associated protein 1,2242,246,0.98 [0.84-1.15],0.8334238397457435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFM,Afamin,2278,252,0.31 [0.18-0.51],5.971395406935761e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFP,Alpha-fetoprotein,2626,310,0.68 [0.58-0.80],2.050524640656464e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGBL2,Cytosolic carboxypeptidase 2,2206,248,1.03 [0.90-1.17],0.6977736792075964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGER,Advanced glycosylation end product-specific receptor,2646,307,1.17 [0.93-1.48],0.1721506022709398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR2,Anterior gradient protein 2 homolog,2564,298,1.22 [1.11-1.34],3.063938297798612e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR3,Anterior gradient protein 3,2578,300,1.29 [1.09-1.53],0.0029629709288766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRN,Agrin,2665,309,1.65 [1.30-2.09],3.3728826197368766e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRP,Agouti-related protein,2674,311,1.28 [1.06-1.56],0.0107235180286421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGT,Angiotensinogen,2287,256,1.18 [0.72-1.92],0.5054666743945136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGXT,Serine--pyruvate aminotransferase,2648,308,1.03 [0.91-1.16],0.6383163282186791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHCY,Adenosylhomocysteinase,2648,308,0.92 [0.78-1.07],0.2669753778610502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,2230,249,1.04 [0.71-1.55],0.8267362481865637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHNAK2,Protein AHNAK2,2230,249,1.53 [1.11-2.09],0.0085257062815115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,2267,249,0.97 [0.80-1.18],0.7577871620578842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHSG,Alpha-2-HS-glycoprotein,2287,256,0.99 [0.64-1.54],0.9706886949302852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHSP,Alpha-hemoglobin-stabilizing protein,2656,313,0.93 [0.83-1.04],0.209809746517728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIDA,"Axin interactor, dorsalization-associated protein",2234,253,1.09 [0.95-1.25],0.2259954701222061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIF1,Allograft inflammatory factor 1,2583,300,0.98 [0.81-1.20],0.8660084985916612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIF1L,Allograft inflammatory factor 1-like,2230,249,1.06 [0.86-1.31],0.5707239190748785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",2638,307,0.99 [0.90-1.09],0.9129364293824184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AK1,Adenylate kinase isoenzyme 1,2648,308,0.88 [0.75-1.03],0.1192469780645472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AK2,"Adenylate kinase 2, mitochondrial",2278,254,1.06 [0.94-1.19],0.3509010172323995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKAP12,A-kinase anchor protein 12,2242,246,1.23 [0.69-2.19],0.4909735029226102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR1B1,Aldo-keto reductase family 1 member B1,2583,300,0.92 [0.80-1.06],0.2426776224256893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR1B10,Aldo-keto reductase family 1 member B10,2234,253,1.05 [0.90-1.21],0.549128372447141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR1C4,Aldo-keto reductase family 1 member C4,2603,303,1.07 [0.89-1.28],0.4819198948089535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,2214,250,0.93 [0.78-1.10],0.3812166901175451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKT1S1,Proline-rich AKT1 substrate 1,2581,302,1.00 [0.86-1.18],0.954774255529932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKT2,RAC-beta serine/threonine-protein kinase,2274,254,1.00 [0.91-1.11],0.921389563362552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKT3,RAC-gamma serine/threonine-protein kinase,2572,299,1.00 [0.83-1.20],0.9799319177098328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALCAM,CD166 antigen,2679,313,1.82 [1.16-2.86],0.0092748580319202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH1A1,Retinal dehydrogenase 1,2661,313,0.86 [0.73-1.01],0.0635694019448882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",2267,249,0.92 [0.71-1.18],0.4874779554569365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",2641,310,0.97 [0.86-1.10],0.6491465715762522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",2274,254,1.03 [0.80-1.35],0.7996964254783925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALMS1,Alstrom syndrome protein 1,2251,250,0.93 [0.69-1.25],0.6328481691785468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALPI,Intestinal-type alkaline phosphatase,2214,250,1.13 [1.03-1.24],0.013150242381203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALPP,"Alkaline phosphatase, placental type",2639,307,1.12 [1.02-1.24],0.0148012966580168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMBN,Ameloblastin,2585,303,1.14 [0.87-1.50],0.347481173862702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMBP,Protein AMBP,2667,312,3.20 [2.05-4.99],2.859778931590025e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,2286,255,0.71 [0.45-1.11],0.1337223540514554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMFR,E3 ubiquitin-protein ligase AMFR,2581,302,1.14 [0.97-1.33],0.1111261268050029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMIGO1,Amphoterin-induced protein 1,2234,253,0.95 [0.74-1.21],0.6706252534406387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMIGO2,Amphoterin-induced protein 2,2639,307,1.57 [1.05-2.34],0.0270420068400383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMN,Protein amnionless,2585,303,1.00 [0.82-1.23],0.9791718744657288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMOT,Angiomotin,2242,246,0.68 [0.50-0.93],0.0162366543340835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMOTL2,Angiomotin-like protein 2,2254,245,1.04 [0.80-1.37],0.7560222069114816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMPD3,AMP deaminase 3,2278,254,1.01 [0.86-1.19],0.9177636254030204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,2160,249,0.86 [0.67-1.09],0.2115364457832605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMY2A,Pancreatic alpha-amylase,2548,294,0.87 [0.72-1.06],0.1655040943309219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMY2B,Alpha-amylase 2B,2473,288,0.83 [0.68-1.01],0.0605344849965316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANG,Angiogenin,2643,307,1.72 [1.31-2.26],0.0001073049246165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPT1,Angiopoietin-1,2642,307,0.94 [0.83-1.06],0.2873319433551529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPT2,Angiopoietin-2,2668,312,1.31 [1.01-1.70],0.0392927535703445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL1,Angiopoietin-related protein 1,2604,304,1.49 [1.06-2.08],0.0218890506379461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL2,Angiopoietin-related protein 2,2657,308,0.95 [0.74-1.20],0.6539672707955375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL3,Angiopoietin-related protein 3,2651,307,0.75 [0.58-0.97],0.0276799569984154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL4,Angiopoietin-related protein 4,2660,308,1.60 [1.28-1.99],3.649414963247824e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL7,Angiopoietin-related protein 7,2668,312,1.35 [1.06-1.72],0.0156232245932901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANK2,Ankyrin-2,2202,248,0.90 [0.75-1.09],0.2795306465488104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,2214,250,0.97 [0.83-1.13],0.7214560454624499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANKRA2,Ankyrin repeat family A protein 2,2199,248,1.03 [0.82-1.30],0.7962636099757215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANKRD54,Ankyrin repeat domain-containing protein 54,2583,300,0.89 [0.75-1.07],0.2238330336103534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,2230,249,0.84 [0.60-1.19],0.3310271486291096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANPEP,Aminopeptidase N,2649,308,1.17 [0.84-1.65],0.3539975584154472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA1,Annexin A1,2234,245,0.83 [0.61-1.14],0.2499701115414588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA10,Annexin A10,2581,302,1.11 [1.00-1.23],0.0576985046731259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA11,Annexin A11,2642,310,0.91 [0.78-1.06],0.2191021134501259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA2,Annexin A2,2201,247,1.02 [0.86-1.22],0.8139408893653841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA3,Annexin A3,2670,312,0.95 [0.82-1.10],0.5147126208425413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA4,Annexin A4,2637,306,0.96 [0.82-1.11],0.555004105575003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA5,Annexin A5,2576,301,1.69 [1.32-2.16],2.984420077616944e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],2585,303,1.03 [0.87-1.23],0.703777852274716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AOC3,Membrane primary amine oxidase,2655,309,3.03 [2.22-4.13],3.345243428274192e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP1G2,AP-1 complex subunit gamma-like 2,2267,249,1.07 [0.92-1.24],0.3712916574727437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP2B1,AP-2 complex subunit beta,2234,253,1.21 [0.96-1.53],0.1044899808471224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP3B1,AP-3 complex subunit beta-1,2268,253,1.06 [0.90-1.25],0.4949518043823062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP3S2,AP-3 complex subunit sigma-2,2278,254,1.11 [0.87-1.43],0.4002357282800088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,2639,307,1.06 [0.85-1.32],0.6039655312590979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APCS,Serum amyloid P-component,2252,251,0.66 [0.46-0.93],0.0163949546056062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,2659,312,0.87 [0.73-1.04],0.1228248055237198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APLP1,Amyloid-like protein 1,2648,308,0.79 [0.65-0.96],0.0167814667690895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA1,Apolipoprotein A-I,2278,252,0.43 [0.27-0.70],0.0006168193729024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA2,Apolipoprotein A-II,2287,256,1.49 [1.20-1.85],0.0003277796428849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA4,Apolipoprotein A-IV,2278,252,2.55 [1.93-3.36],3.868634639889207e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOB,Apolipoprotein B-100,2287,256,0.88 [0.53-1.48],0.6373030883500967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOBR,Apolipoprotein B receptor,2230,249,0.74 [0.56-0.99],0.0397920228049681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOC1,Apolipoprotein C-I,2274,252,0.55 [0.39-0.76],0.0003511022806276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOD,Apolipoprotein D,2173,241,0.68 [0.48-0.96],0.0270117025758501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOE,Apolipoprotein E,2278,252,0.71 [0.56-0.90],0.004202721464015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOF,Apolipoprotein F,2287,256,1.02 [0.71-1.46],0.9144512327082032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOH,Beta-2-glycoprotein 1,2661,313,1.16 [0.90-1.48],0.2451312944746084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOL1,Apolipoprotein L1,2287,256,0.76 [0.60-0.95],0.0180297723651446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOM,Apolipoprotein M,2653,308,0.63 [0.46-0.86],0.004429027505691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APP,Amyloid-beta precursor protein,2657,313,0.98 [0.85-1.14],0.8248877755050419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APPL2,DCC-interacting protein 13-beta,2242,246,0.95 [0.85-1.06],0.3480732745876073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APRT,Adenine phosphoribosyltransferase,2632,311,1.21 [0.96-1.51],0.1005230291650255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARAF,Serine/threonine-protein kinase A-Raf,2251,250,1.06 [0.88-1.26],0.5446256214468257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AREG,Amphiregulin,2639,307,1.92 [1.60-2.30],1.7534652594833437e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARF6,ADP-ribosylation factor 6,2268,253,1.01 [0.90-1.14],0.8090003380463704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARFIP1,Arfaptin-1,2274,254,1.00 [0.84-1.20],0.9948495262944154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARG1,Arginase-1,2617,309,0.93 [0.77-1.12],0.4438845591830705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARG2,"Arginase-2, mitochondrial",2267,249,1.14 [0.86-1.50],0.3512404072443923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP1,Rho GTPase-activating protein 1,2583,300,0.96 [0.76-1.21],0.7029917699271024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP25,Rho GTPase-activating protein 25,2583,300,1.05 [0.88-1.26],0.5808586419163374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP30,Rho GTPase-activating protein 30,2251,250,1.24 [0.92-1.68],0.1555653471170222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP45,Rho GTPase-activating protein 45,2242,246,0.93 [0.80-1.09],0.3898572829300571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP5,Rho GTPase-activating protein 5,2199,248,1.07 [0.92-1.24],0.3604574307341091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,2278,254,0.97 [0.84-1.11],0.6387385366397547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,2274,254,0.92 [0.81-1.05],0.237004630578372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,2646,311,0.95 [0.86-1.05],0.31114701274737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,2206,248,1.22 [1.05-1.43],0.0111254101626132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARID3A,AT-rich interactive domain-containing protein 3A,2206,248,1.03 [0.73-1.43],0.8806938053861058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARID4B,AT-rich interactive domain-containing protein 4B,2581,302,1.03 [0.81-1.30],0.8095098929261686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARL13B,ADP-ribosylation factor-like protein 13B,2202,248,1.01 [0.85-1.20],0.9150899096491596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,2202,248,0.87 [0.63-1.19],0.3829149783921761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,2206,248,0.96 [0.77-1.21],0.7301655941582994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,2585,303,1.08 [0.82-1.41],0.5812453094594332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,2202,248,0.88 [0.68-1.12],0.2956661357737576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARSA,Arylsulfatase A,2661,313,0.91 [0.73-1.13],0.3886057717632687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARSB,Arylsulfatase B,2639,307,0.98 [0.82-1.17],0.8064645619597629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ART3,Ecto-ADP-ribosyltransferase 3,2655,309,1.69 [1.32-2.17],3.2395567626571584e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ART5,Ecto-ADP-ribosyltransferase 5,2206,248,1.05 [0.87-1.27],0.596183801724554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARTN,Artemin,2585,303,0.96 [0.75-1.21],0.7166082310301183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASAH1,Acid ceramidase,2272,255,1.00 [0.78-1.29],0.9917147041181652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASAH2,Neutral ceramidase,2634,311,0.96 [0.80-1.15],0.6607898536225605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR1,Asialoglycoprotein receptor 1,2634,311,1.74 [1.29-2.35],0.0003107269254809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR2,Asialoglycoprotein receptor 2,2287,256,1.90 [1.28-2.82],0.0014405931415768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASPN,Asporin,2273,252,1.31 [0.87-1.98],0.200627959366187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASPSCR1,Tether containing UBX domain for GLUT4,2274,254,0.96 [0.80-1.17],0.6987747793111587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,2230,249,0.97 [0.85-1.10],0.6403990013291283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASS1,Argininosuccinate synthase,2202,248,0.92 [0.80-1.07],0.2975371829097057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,2581,302,1.06 [0.91-1.22],0.4580524906500163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,2199,248,0.77 [0.54-1.12],0.1703335830799216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATG16L1,Autophagy-related protein 16-1,2268,253,0.99 [0.86-1.15],0.9371260217826178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATG4A,Cysteine protease ATG4A,2583,300,0.96 [0.81-1.14],0.6224618028022794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATOX1,Copper transport protein ATOX1,2658,311,1.11 [0.95-1.29],0.1745119417057523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,2202,248,1.24 [0.98-1.56],0.0695177491964369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,2202,248,1.16 [0.85-1.58],0.3423111292526553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,2202,248,1.47 [1.12-1.91],0.0050210667330974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B4,Protein ATP1B4,2199,248,1.23 [0.95-1.59],0.1084856629415282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,2202,248,1.08 [0.89-1.31],0.4610722365567652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",2202,248,1.21 [0.96-1.53],0.1052503707474028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP5IF1,"ATPase inhibitor, mitochondrial",2665,309,0.99 [0.91-1.09],0.9129578552074432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP5PO,"ATP synthase subunit O, mitochondrial",2581,302,1.19 [1.01-1.40],0.0370083695753605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6AP2,Renin receptor,2583,300,1.07 [0.82-1.39],0.6083798414354251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1D,V-type proton ATPase subunit D,2639,307,1.00 [0.71-1.42],0.9920128039258108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1F,V-type proton ATPase subunit F,2578,301,1.00 [0.85-1.17],0.9916493411715864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1G1,V-type proton ATPase subunit G 1,2230,249,1.08 [0.91-1.28],0.3992886262727784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1G2,V-type proton ATPase subunit G 2,2202,248,0.96 [0.84-1.10],0.5223753297878465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATRAID,All-trans retinoic acid-induced differentiation factor,2268,253,2.09 [1.52-2.88],5.599647695986705e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATRN,"Attractin, Isoform 2",2278,252,0.59 [0.29-1.19],0.1406332960507604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN10,Ataxin-10,2581,302,0.98 [0.85-1.14],0.8175414048435636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN2,Ataxin-2,2206,248,1.01 [0.91-1.12],0.8994069186263037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN2L,Ataxin-2-like protein,2274,254,0.94 [0.73-1.22],0.6539682130009477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN3,Ataxin-3,2278,254,1.01 [0.84-1.23],0.8929303744926274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AXIN1,Axin-1,2646,311,0.95 [0.85-1.06],0.3486642032016214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AXL,Tyrosine-protein kinase receptor UFO,2655,309,1.63 [1.16-2.29],0.004654789114207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AZI2,5-azacytidine-induced protein 2,2274,254,0.88 [0.70-1.11],0.280503133461834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AZU1,Azurocidin,2571,299,0.95 [0.83-1.09],0.4741125820650669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B2M,Beta-2-microglobulin,2278,252,2.07 [1.48-2.88],1.7275628553137344e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,2202,248,0.84 [0.45-1.56],0.5782574994991647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",2230,249,2.25 [1.63-3.11],7.809608908154479e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",2665,309,1.93 [1.36-2.73],0.0002213461828712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",2661,313,1.23 [0.81-1.86],0.338857738980771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BABAM1,BRISC and BRCA1-A complex member 1,2214,250,1.10 [0.70-1.72],0.6848427255079295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BACH1,Transcription regulator protein BACH1,2646,311,0.85 [0.74-0.99],0.0339406889813346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAG3,BAG family molecular chaperone regulator 3,2633,311,0.99 [0.78-1.25],0.9169327222792174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAG4,BAG family molecular chaperone regulator 4,2214,250,1.02 [0.79-1.32],0.8702953975125913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAG6,Large proline-rich protein BAG6,2603,303,1.08 [0.81-1.43],0.6131975894429669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,2583,300,1.12 [0.97-1.28],0.1204599079683069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,2583,300,1.85 [1.39-2.45],2.011045111750713e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BANK1,B-cell scaffold protein with ankyrin repeats,2646,311,0.91 [0.83-1.00],0.0575625771174225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAP18,Chromatin complexes subunit BAP18,2278,254,0.90 [0.75-1.08],0.2682884143692892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BATF,Basic leucine zipper transcriptional factor ATF-like,2234,253,1.00 [0.86-1.15],0.9701834949080236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAX,Apoptosis regulator BAX,2577,302,1.08 [0.96-1.21],0.2059884265790211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAM,Basal cell adhesion molecule,2661,313,1.56 [1.05-2.31],0.026445625078125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAN,Brevican core protein,2634,311,0.46 [0.35-0.60],1.0380322977411904e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",2273,252,1.05 [0.71-1.54],0.816250805819601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",2206,248,0.90 [0.69-1.18],0.4486898389614667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCHE,Cholinesterase,2248,255,0.84 [0.54-1.31],0.4368828366913811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2,Apoptosis regulator Bcl-2,2268,253,1.03 [0.82-1.30],0.7873721755138569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L1,Bcl-2-like protein 1,2278,254,1.01 [0.89-1.15],0.8186494086391286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",2646,311,1.52 [1.17-1.99],0.002032881934465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L15,Bcl-2-like protein 15,2214,250,1.18 [0.98-1.43],0.0767809814201522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,2199,248,0.94 [0.77-1.16],0.5594269768339449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,2267,249,1.06 [0.80-1.42],0.6743955645315782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCR,Breakpoint cluster region protein,2646,311,0.98 [0.87-1.09],0.6819653837975517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BDNF,Brain-derived neurotrophic factor,2286,255,0.94 [0.82-1.08],0.3990949421304317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BECN1,Beclin-1,2230,249,0.93 [0.75-1.16],0.5249022422274943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BEX3,Protein BEX3,2199,248,1.19 [0.99-1.44],0.0681082746691475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BGLAP,Osteocalcin,2286,255,0.73 [0.65-0.82],1.582973217159697e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BGN,Biglycan,2582,300,1.03 [0.95-1.12],0.4594546751811821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BHLHE40,Class E basic helix-loop-helix protein 40,2206,248,1.04 [0.88-1.22],0.657584372239793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,2202,248,0.98 [0.60-1.59],0.925751951329702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BID,BH3-interacting domain death agonist,2646,311,0.93 [0.80-1.08],0.3540954969747454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BIN2,Bridging integrator 2,2661,313,0.94 [0.83-1.05],0.2583367633067803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BIRC2,Baculoviral IAP repeat-containing protein 2,2583,300,1.08 [0.91-1.28],0.3919870008703454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLMH,Bleomycin hydrolase,2679,313,0.88 [0.64-1.21],0.4446302987673237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLNK,B-cell linker protein,2214,250,0.84 [0.60-1.17],0.2974572166140731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,2206,248,1.03 [0.89-1.20],0.6930886801617893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,2278,254,0.90 [0.66-1.25],0.5380468147677075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLVRB,Flavin reductase,2661,313,0.96 [0.83-1.11],0.5464677793787944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP10,Bone morphogenetic protein 10,2242,246,2.07 [1.48-2.89],2.041675547676987e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP4,Bone morphogenetic protein 4,2633,311,1.19 [0.98-1.45],0.0828871574313054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP6,Bone morphogenetic protein 6,2600,303,1.05 [0.81-1.35],0.7292722586067912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMPER,BMP-binding endothelial regulator protein,2242,246,2.23 [1.39-3.58],0.0009343855027846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,2273,252,1.09 [0.75-1.59],0.6415351584738209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,2214,250,1.28 [0.98-1.69],0.0746982400109329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOC,Brother of CDO,2603,303,2.70 [1.81-4.03],1.0480133718009978e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOLA1,BolA-like protein 1,2206,248,1.03 [0.84-1.28],0.7683359774444133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOLA2_BOLA2B,BolA-like protein 2,2230,249,0.93 [0.74-1.17],0.5308653750150424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BPIFA2,BPI fold-containing family A member 2,2155,240,1.06 [0.96-1.18],0.2606543739177621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BPIFB1,BPI fold-containing family B member 1,2634,307,1.03 [0.88-1.20],0.7024919217506509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BPIFB2,BPI fold-containing family B member 2,2269,252,0.90 [0.76-1.06],0.1929455759215372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRAP,BRCA1-associated protein,2244,251,0.99 [0.88-1.11],0.8274536194051219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRD1,Bromodomain-containing protein 1,2251,250,0.99 [0.65-1.51],0.9686172248157884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRD2,Bromodomain-containing protein 2,2206,248,1.05 [0.74-1.50],0.7670573753977316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRD3,Bromodomain-containing protein 3,2202,248,0.99 [0.76-1.29],0.9374223953387204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRDT,Bromodomain testis-specific protein,2202,248,1.03 [0.74-1.45],0.8517733418346318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRK1,Protein BRICK1,2581,302,1.44 [1.16-1.79],0.0011372296584866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRME1,Break repair meiotic recombinase recruitment factor 1,2206,248,0.99 [0.71-1.36],0.9355289125412238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRSK2,Serine/threonine-protein kinase BRSK2,2274,254,0.95 [0.68-1.34],0.7892277536614681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BSG,Basigin,2669,311,2.15 [1.41-3.29],0.0003936675629445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BSND,Barttin,2199,248,1.13 [0.81-1.58],0.4712925282500542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,2673,312,1.19 [0.93-1.52],0.1691503792927166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BST2,Bone marrow stromal antigen 2,2673,312,1.03 [0.86-1.24],0.735637321241392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTC,Probetacellulin,2583,300,0.98 [0.84-1.13],0.7658305507916984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTD,Biotinidase,2278,252,0.83 [0.47-1.46],0.5151475378922086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTLA,B- and T-lymphocyte attenuator,2199,248,0.90 [0.78-1.05],0.1895410330783288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN1A1,Butyrophilin subfamily 1 member A1,2264,249,1.08 [0.79-1.48],0.6336532442709311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN2A1,Butyrophilin subfamily 2 member A1,2665,309,2.41 [1.82-3.21],1.1249035740296855e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN3A2,Butyrophilin subfamily 3 member A2,2646,311,1.21 [0.93-1.57],0.1523744767283175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTNL10,Butyrophilin-like protein 10,2199,248,1.01 [0.73-1.40],0.9513156480746868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C19orf12,Protein C19orf12,2581,302,0.94 [0.82-1.07],0.3314046103726055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1GALT1C1,C1GALT1-specific chaperone 1,2202,248,1.07 [0.76-1.52],0.6967034849032916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QA,Complement C1q subcomponent subunit A,2661,309,1.81 [1.21-2.72],0.0042287196086603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",2274,254,1.03 [0.88-1.21],0.7280930668371826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QL2,Complement C1q-like protein 2,2214,250,0.72 [0.53-0.96],0.0252307605720409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,2655,309,1.22 [1.00-1.48],0.0493943741467623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,2242,246,0.78 [0.56-1.10],0.153372384390107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,2274,254,1.26 [0.91-1.77],0.1688529212443558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,2239,245,0.77 [0.61-0.98],0.0306482342423072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1R,Complement C1r subcomponent,2278,252,0.43 [0.20-0.94],0.0337839452029284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1RL,Complement C1r subcomponent-like protein,2273,252,1.27 [0.70-2.31],0.4300165459388072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1S,Complement C1s subcomponent,2278,252,0.66 [0.39-1.12],0.1215986441950778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2,Complement C2,2653,308,1.92 [1.17-3.14],0.0098004203353579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2CD2L,Phospholipid transfer protein C2CD2L,2578,301,1.13 [0.88-1.43],0.334564381336889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2orf69,UPF0565 protein C2orf69,2234,253,1.10 [0.90-1.36],0.3397394771543643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C3,Complement C3,2156,234,0.90 [0.67-1.22],0.5011291091429041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C4BPB,C4b-binding protein beta chain,2658,311,0.90 [0.71-1.15],0.4219680978560766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C5,Complement C5,2278,252,0.92 [0.42-2.05],0.8464815646537907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7,Complement component C7,2219,248,2.29 [1.66-3.15],4.2023662855283364e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7orf50,Uncharacterized protein C7orf50,2278,254,0.82 [0.43-1.56],0.5493010075495584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C8B,Complement component C8 beta chain,2278,252,0.55 [0.37-0.82],0.0032254056239243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C9,Complement component C9,2287,256,1.04 [0.85-1.28],0.6746623293672571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C9orf40,Uncharacterized protein C9orf40,2268,253,0.99 [0.85-1.14],0.8392411560885803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA1,Carbonic anhydrase 1,2603,302,0.97 [0.82-1.15],0.7378029647125597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA11,Carbonic anhydrase-related protein 11,2583,300,1.22 [0.97-1.52],0.0838715673146419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA12,Carbonic anhydrase 12,2639,307,2.73 [2.12-3.52],6.919618184165904e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA13,Carbonic anhydrase 13,2622,301,0.97 [0.87-1.07],0.5106124431326515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA14,Carbonic anhydrase 14,2668,312,1.61 [1.26-2.06],0.0001608430332107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA2,Carbonic anhydrase 2,2654,313,0.97 [0.84-1.11],0.62715325380975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA3,Carbonic anhydrase 3,2677,312,1.19 [1.02-1.40],0.0282804185757422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA4,Carbonic anhydrase 4,2679,313,1.56 [1.08-2.25],0.0185590901650586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",2603,303,0.93 [0.84-1.03],0.1833880862759401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA6,Carbonic anhydrase 6,2650,309,0.94 [0.80-1.11],0.4805640857090709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA7,Carbonic anhydrase 7,2251,250,0.96 [0.67-1.37],0.8169808783782736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA8,Carbonic anhydrase-related protein,2214,250,1.23 [0.79-1.93],0.3539172873024362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA9,Carbonic anhydrase 9,2668,312,1.50 [1.27-1.77],1.7961476135219632e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CABP2,Calcium-binding protein 2,2234,253,1.19 [0.99-1.43],0.0623139023828369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,2206,248,0.90 [0.61-1.33],0.5911639217726502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,2202,248,1.06 [0.87-1.29],0.5663443588426398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,2206,248,1.25 [1.04-1.50],0.0155348149106696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,2274,254,1.02 [0.88-1.18],0.7857148502144776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACYBP,Calcyclin-binding protein,2241,246,0.97 [0.86-1.10],0.6128424712451044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CADPS,Calcium-dependent secretion activator 1,2234,253,0.98 [0.74-1.30],0.8849678188494957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALB1,Calbindin,2639,307,1.22 [0.99-1.52],0.0681931428185115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALB2,Calretinin,2581,302,1.80 [1.36-2.37],3.724127086942637e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCA,Calcitonin,2631,310,1.33 [1.16-1.53],4.600454421204067e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCB,Calcitonin gene-related peptide 2,2278,254,1.44 [1.17-1.77],0.0006628555661015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,2659,312,0.98 [0.89-1.09],0.7190910401524153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,2230,249,0.97 [0.82-1.15],0.7042699311217834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALY,Neuron-specific vesicular protein calcyon,2202,248,0.88 [0.61-1.27],0.5059817748169726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,2583,300,1.15 [0.92-1.46],0.2248014932012364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,2234,253,1.09 [0.87-1.36],0.4699891430484922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,2274,254,0.99 [0.88-1.12],0.912465246612976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CANT1,Soluble calcium-activated nucleotidase 1,2640,306,1.38 [0.87-2.21],0.1745257400768198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAPG,Macrophage-capping protein,2629,308,1.18 [1.00-1.40],0.0476232184448237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAPN3,Calpain-3,2267,249,1.17 [0.86-1.59],0.3161973870481932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAPS,Calcyphosin,2278,254,1.03 [0.92-1.15],0.5835109482243531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CARHSP1,Calcium-regulated heat-stable protein 1,2581,302,0.99 [0.82-1.20],0.9152417643526188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASC3,Protein CASC3,2234,253,1.12 [0.84-1.50],0.436325885230972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP1,Caspase-1,2581,302,1.00 [0.87-1.15],0.9943658153757708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP10,Caspase-10,2581,302,0.95 [0.82-1.10],0.4847803638935117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP2,Caspase-2,2646,311,0.93 [0.80-1.09],0.3676909329394716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP3,Caspase-3,2679,313,0.99 [0.88-1.11],0.857242146768266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP4,Caspase-4,2251,250,1.01 [0.95-1.09],0.6760492237765985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP7,Caspase-7,2278,254,0.95 [0.81-1.10],0.4920940596660111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP8,Caspase-8,2662,312,1.01 [0.86-1.19],0.89679983420869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP9,Caspase-9,2214,250,0.91 [0.74-1.13],0.4029797278388788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASQ2,Calsequestrin-2,2202,248,0.98 [0.73-1.33],0.9192958058891592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAT,Catalase,2249,254,0.91 [0.73-1.14],0.4131622495282048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLIF,Cobalamin binding intrinsic factor,2647,307,1.11 [1.00-1.24],0.059259122386057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLN1,Cerebellin-1,2206,248,1.03 [0.90-1.17],0.717182832208515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLN4,Cerebellin-4,2668,312,0.71 [0.53-0.95],0.0209609746837447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBS,Cystathionine beta-synthase,2230,249,0.80 [0.63-1.01],0.0641386023963276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBX2,Chromobox protein homolog 2,2202,248,1.06 [0.77-1.46],0.7121428422206446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,2634,311,0.99 [0.86-1.14],0.8397957344527369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCAR2,Cell cycle and apoptosis regulator protein 2,2278,254,1.22 [1.02-1.47],0.0325158378578834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC134,Coiled-coil domain-containing protein 134,2267,249,1.24 [0.97-1.58],0.091912481776734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC28A,Coiled-coil domain-containing protein 28A,2234,253,1.24 [0.83-1.83],0.2936665781856693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC50,Coiled-coil domain-containing protein 50,2274,254,0.96 [0.80-1.14],0.624514161850765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC80,Coiled-coil domain-containing protein 80,2648,308,1.27 [0.99-1.65],0.0642754911750237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,2230,249,0.94 [0.78-1.13],0.4804889296173804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL11,Eotaxin,2674,311,1.89 [1.45-2.48],3.447320599334101e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL13,C-C motif chemokine 13,2670,310,1.00 [0.87-1.16],0.9651966864003116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL14,C-C motif chemokine 14,2643,307,1.44 [1.14-1.83],0.002633216526538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL15,C-C motif chemokine 15,2679,313,1.63 [1.34-1.98],1.0676485976837673e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL16,C-C motif chemokine 16,2679,313,1.10 [0.93-1.32],0.2714752348398278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL17,C-C motif chemokine 17,2648,308,1.03 [0.92-1.15],0.5950009084121417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL18,C-C motif chemokine 18,2617,303,1.02 [0.89-1.18],0.7550507195344317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL19,C-C motif chemokine 19,2673,312,0.97 [0.90-1.05],0.4385408958402107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL2,C-C motif chemokine 2,2633,311,1.09 [0.90-1.32],0.3784101484783876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL20,C-C motif chemokine 20,2674,311,1.08 [0.98-1.19],0.1328363896495109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL21,C-C motif chemokine 21,2665,309,1.26 [1.06-1.51],0.0094953170380686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL22,C-C motif chemokine 22,2628,306,0.98 [0.82-1.19],0.8630302044663245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL23,C-C motif chemokine 23,2665,309,1.02 [0.82-1.27],0.8766929718501798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL24,C-C motif chemokine 24,2660,308,1.04 [0.92-1.18],0.5021072965812687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL25,C-C motif chemokine 25,2674,311,1.81 [1.47-2.24],2.5031818024005764e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL26,C-C motif chemokine 26,2646,311,1.00 [0.90-1.11],0.9955687279195516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL27,C-C motif chemokine 27,2648,308,1.11 [0.94-1.31],0.2077123845720412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL28,C-C motif chemokine 28,2637,309,1.19 [1.01-1.39],0.0346051456324183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL3,C-C motif chemokine 3,2646,311,1.07 [0.92-1.25],0.3572277357833091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL4,C-C motif chemokine 4,2657,309,0.92 [0.79-1.08],0.3146051709364553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL5,C-C motif chemokine 5,2655,309,0.96 [0.87-1.06],0.3913936761240009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL7,C-C motif chemokine 7,2646,311,1.15 [0.97-1.37],0.1153596648301418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL8,C-C motif chemokine 8,2667,312,1.00 [0.85-1.19],0.9557657031929764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN1,CCN family member 1,2638,307,0.97 [0.84-1.11],0.6429344780425517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN2,CCN family member 2,2652,308,0.97 [0.81-1.17],0.7619809258311104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN3,CCN family member 3,2672,313,1.53 [1.20-1.96],0.0006998919329466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN4,CCN family member 4,2668,312,1.57 [1.25-1.99],0.0001423037104536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN5,CCN family member 5,2661,313,1.67 [1.32-2.12],2.5425787088528947e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCND2,G1/S-specific cyclin-D2,2251,250,0.87 [0.64-1.18],0.3678806176558187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCNE1,G1/S-specific cyclin-E1,2214,250,0.92 [0.77-1.10],0.3570793613763268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCS,Copper chaperone for superoxide dismutase,2634,311,0.83 [0.67-1.03],0.0853168223405653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCT5,T-complex protein 1 subunit epsilon,2583,300,1.07 [0.85-1.34],0.5696270584348448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD101,Immunoglobulin superfamily member 2,2268,253,1.36 [1.06-1.75],0.0160141112445662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD109,CD109 antigen,2661,313,1.56 [1.18-2.07],0.001861537426016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD14,Monocyte differentiation antigen CD14,2608,304,1.54 [1.22-1.94],0.0002547180376535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD160,CD160 antigen,2674,311,1.74 [1.45-2.09],2.628719417636218e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,2655,309,1.42 [1.14-1.77],0.0016408356889153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD164,Sialomucin core protein 24,2661,313,1.52 [1.22-1.89],0.0001812024195076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD164L2,CD164 sialomucin-like 2 protein,2234,253,1.25 [0.92-1.70],0.1455240777778092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD177,CD177 antigen,2653,313,0.97 [0.90-1.05],0.4646551260385381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD1C,T-cell surface glycoprotein CD1c,2658,311,0.57 [0.39-0.83],0.0037558439863507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD2,T-cell surface antigen CD2,2202,248,1.21 [0.94-1.56],0.1474761919603483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD200,OX-2 membrane glycoprotein,2646,311,1.45 [1.05-2.01],0.0226059384440762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,2639,310,1.01 [0.76-1.34],0.9584807297678638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD207,C-type lectin domain family 4 member K,2599,307,1.65 [1.30-2.11],4.7621023810107474e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD209,CD209 antigen,2660,311,1.13 [0.86-1.48],0.3821153599702241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD22,B-cell receptor CD22,2674,311,0.97 [0.78-1.21],0.8059528203307659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD226,CD226 antigen,2214,250,0.97 [0.72-1.30],0.8287896682480927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD244,Natural killer cell receptor 2B4,2674,311,1.30 [0.92-1.84],0.1363808097644784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD248,Endosialin,2286,255,0.97 [0.73-1.28],0.8102019198743671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD27,CD27 antigen,2658,311,2.08 [1.72-2.52],9.411664622551153e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD274,Programmed cell death 1 ligand 1,2634,311,1.47 [1.15-1.88],0.0023261193664439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD276,CD276 antigen,2649,308,2.67 [2.09-3.42],3.293925611908431e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD28,T-cell-specific surface glycoprotein CD28,2583,300,1.79 [1.40-2.29],3.7971367228508497e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD2AP,CD2-associated protein,2648,308,1.01 [0.87-1.19],0.8556352023716429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300A,CMRF35-like molecule 8,2242,246,1.47 [1.00-2.15],0.0514793055958424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300C,CMRF35-like molecule 6,2673,312,1.82 [1.40-2.37],6.885187707248966e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300E,CMRF35-like molecule 2,2658,309,1.47 [1.18-1.83],0.0005758960046832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300LF,CMRF35-like molecule 1,2668,312,1.26 [1.07-1.48],0.0052360747724743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300LG,CMRF35-like molecule 9,2661,313,1.23 [0.97-1.57],0.0863692728870671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD302,CD302 antigen,2639,307,2.33 [1.82-2.98],2.4579692420085843e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD33,Myeloid cell surface antigen CD33,2658,311,0.99 [0.87-1.12],0.8648491013213986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD34,Hematopoietic progenitor cell antigen CD34,2667,310,1.04 [0.70-1.55],0.8526207346969306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD36,Platelet glycoprotein 4,2214,250,1.26 [0.97-1.65],0.0834533916663277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,2639,307,1.67 [1.27-2.20],0.0002699230741283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD3D,T-cell surface glycoprotein CD3 delta chain,2206,248,1.04 [0.71-1.54],0.8250129230188822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,2251,250,1.12 [0.79-1.60],0.5172029885780759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,2214,250,0.97 [0.83-1.12],0.6709650442449202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD4,T-cell surface glycoprotein CD4,2642,310,1.61 [1.24-2.10],0.000372952796457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD40,Tumor necrosis factor receptor superfamily member 5,2652,308,1.27 [1.06-1.54],0.0116766980103085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD40LG,CD40 ligand,2674,311,0.92 [0.81-1.05],0.2217514283417408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD46,Membrane cofactor protein,2633,305,1.76 [1.27-2.44],0.0006353062806537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD48,CD48 antigen,2660,308,1.76 [1.28-2.42],0.0004471171479851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD5,T-cell surface glycoprotein CD5,2667,312,1.65 [1.30-2.11],4.86920710933914e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD55,Complement decay-accelerating factor,2551,297,1.78 [1.29-2.46],0.0004012834426317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD58,Lymphocyte function-associated antigen 3,2644,308,1.25 [0.72-2.17],0.430202848508863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD59,CD59 glycoprotein,2533,299,2.22 [1.58-3.12],4.602511925719024e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD5L,CD5 antigen-like,2267,252,1.02 [0.80-1.30],0.8787243457175227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD6,T-cell differentiation antigen CD6,2669,311,0.95 [0.78-1.15],0.586795912521033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD63,CD63 antigen,2633,311,1.06 [0.86-1.30],0.5854407077036785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD69,Early activation antigen CD69,2635,308,1.00 [0.89-1.12],0.9631570687591507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD7,T-cell antigen CD7,2208,249,1.44 [1.13-1.85],0.0034811396281837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD70,CD70 antigen,2646,311,1.24 [0.99-1.56],0.0616034496297685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD72,B-cell differentiation antigen CD72,2242,246,1.09 [0.83-1.44],0.5363836962650617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD74,HLA class II histocompatibility antigen gamma chain,2673,312,2.15 [1.65-2.79],1.2131741820587225e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,2674,311,1.58 [1.30-1.93],4.8816117679142975e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD80,T-lymphocyte activation antigen CD80,2273,252,1.49 [1.09-2.04],0.012291292512311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD82,CD82 antigen,2251,250,0.81 [0.59-1.12],0.2006034125745779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD83,CD83 antigen,2646,311,1.48 [1.14-1.92],0.0035302841166423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD84,SLAM family member 5,2646,311,0.84 [0.61-1.16],0.2955131818234663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD86,T-lymphocyte activation antigen CD86,2268,253,0.97 [0.65-1.44],0.882381655932693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,2673,312,1.21 [1.01-1.44],0.0338664937025459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD93,Complement component C1q receptor,2570,297,1.56 [1.16-2.09],0.0036021326306788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD99,CD99 antigen,2661,313,2.41 [1.54-3.79],0.0001324460863542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD99L2,CD99 antigen-like protein 2,2661,313,1.38 [0.93-2.04],0.1087114779724225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDA,Cytidine deaminase,2271,252,0.75 [0.58-0.97],0.0296512656436179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDAN1,Codanin-1,2278,254,1.23 [0.79-1.91],0.363890484354421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC123,Cell division cycle protein 123 homolog,2199,248,0.87 [0.71-1.06],0.1744687945328468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC25A,M-phase inducer phosphatase 1,2199,248,1.00 [0.70-1.41],0.9819080633376438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC26,Anaphase-promoting complex subunit CDC26,2262,251,1.05 [0.87-1.26],0.6233840201459349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC27,Cell division cycle protein 27 homolog,2583,300,1.06 [0.90-1.25],0.514816865598703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC37,Hsp90 co-chaperone Cdc37,2658,311,0.98 [0.87-1.11],0.8063602833284735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,2268,253,0.95 [0.84-1.07],0.3902357441207938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDCP1,CUB domain-containing protein 1,2634,311,1.16 [0.98-1.37],0.091397107132885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH1,Cadherin-1,2547,296,2.00 [1.69-2.38],1.230062082791701e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH15,Cadherin-15,2670,311,1.26 [1.12-1.42],9.651342085982772e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH17,Cadherin-17,2648,308,1.40 [1.24-1.58],5.4133686907324256e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH2,Cadherin-2,2648,308,0.96 [0.74-1.24],0.7394164175433094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH22,Cadherin-22,2251,250,1.27 [0.84-1.91],0.2529590543887623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH23,Cadherin-23,2278,254,1.31 [0.83-2.07],0.2531923904919028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH3,Cadherin-3,2673,312,1.59 [1.26-2.03],0.0001329303255495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH4,Cadherin-4,2206,248,1.15 [0.91-1.45],0.2531608637604489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH5,Cadherin-5,2679,313,1.27 [0.93-1.75],0.1327712987363529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH6,Cadherin-6,2648,308,1.46 [1.15-1.86],0.0017551682638045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR1,Cadherin-related family member 1,2581,302,1.03 [0.83-1.29],0.7711239130765049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR2,Cadherin-related family member 2,2639,307,0.81 [0.71-0.93],0.0028527049388577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR5,Cadherin-related family member 5,2648,308,0.85 [0.66-1.09],0.1905917637281633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDK1,Cyclin-dependent kinase 1,2199,248,1.26 [0.92-1.73],0.1555032973704788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,2274,254,1.08 [0.88-1.33],0.4606233468475922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDKL5,Cyclin-dependent kinase-like 5,2206,248,1.12 [0.91-1.37],0.2879187620378407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,2639,307,1.03 [0.93-1.13],0.5549509689073252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,2639,307,0.99 [0.88-1.10],0.8037373240236284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDNF,Cerebral dopamine neurotrophic factor,2639,307,1.41 [1.16-1.71],0.000522808212688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,2656,308,1.47 [1.01-2.14],0.0434652935188167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDSN,Corneodesmosin,2663,311,1.39 [1.12-1.72],0.0027876219350529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,2649,310,0.83 [0.59-1.15],0.2633768957491249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,2268,253,0.91 [0.79-1.06],0.2396677598524053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,2251,250,1.00 [0.85-1.18],0.9721385980665744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,2268,253,1.08 [0.81-1.45],0.5985922262510865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,2251,250,1.06 [0.82-1.36],0.6663287057867515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,2646,311,1.18 [1.06-1.32],0.0023373581845297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,2583,300,1.04 [0.84-1.30],0.702072299686364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,2557,299,1.20 [1.04-1.40],0.0157184030006276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,2286,255,1.00 [0.74-1.35],0.9944704262126444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,2603,303,1.10 [0.89-1.35],0.3894131356441394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEBPA,CCAAT/enhancer-binding protein alpha,2214,250,1.15 [0.82-1.60],0.4141242843211751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEBPB,CCAAT/enhancer-binding protein beta,2603,303,0.84 [0.63-1.11],0.2191093376857036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CELA2A,Chymotrypsin-like elastase family member 2A,2286,255,0.93 [0.79-1.09],0.3820848032381719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CELA3A,Chymotrypsin-like elastase family member 3A,2675,313,0.99 [0.86-1.15],0.9384518835078288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,2242,246,0.92 [0.62-1.38],0.689904185133302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEMIP2,Cell surface hyaluronidase,2214,250,0.98 [0.67-1.44],0.9238554215456608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,2206,248,1.01 [0.83-1.23],0.9054898757218022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CENPF,Centromere protein F,2251,250,0.99 [0.79-1.23],0.9273919210755284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CENPJ,Centromere protein J,2251,250,1.18 [1.02-1.37],0.0297022995442431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP112,Centrosomal protein of 112 kDa,2202,248,0.82 [0.59-1.13],0.2206033740533527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP152,Centrosomal protein of 152 kDa,2199,248,1.04 [0.78-1.38],0.8053552853509224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP164,Centrosomal protein of 164 kDa,2585,303,1.01 [0.87-1.17],0.927287535660609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP170,Centrosomal protein of 170 kDa,2230,249,1.00 [0.84-1.19],0.9971388095796864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP20,Centrosomal protein 20,2583,300,1.05 [0.92-1.20],0.4742207755900224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP290,Centrosomal protein of 290 kDa,2251,250,1.04 [0.84-1.29],0.7410708112223318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP350,Centrosome-associated protein 350,2199,248,1.07 [0.76-1.51],0.6932995301627698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP43,Centrosomal protein 43,2587,300,0.97 [0.83-1.13],0.7050873691656028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP85,Centrosomal protein of 85 kDa,2583,300,0.92 [0.78-1.09],0.3384781806949148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CERT,Ceramide transfer protein,2581,302,0.99 [0.83-1.17],0.8956275281634795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES1,Liver carboxylesterase 1,2657,310,0.87 [0.79-0.97],0.0091849665626422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES2,Cocaine esterase,2639,307,1.33 [1.12-1.56],0.0007688215617264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES3,Carboxylesterase 3,2639,307,0.92 [0.79-1.07],0.2648744389303739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CETN2,Centrin-2,2581,302,0.98 [0.84-1.15],0.798262739203228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CETN3,Centrin-3,2268,253,0.95 [0.81-1.12],0.5664990914650916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFB,Complement factor B,2231,245,0.78 [0.54-1.13],0.1939498609250446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFC1,Cryptic protein,2583,300,1.25 [1.04-1.51],0.0190371734532414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFD,Complement factor D,2278,252,1.32 [0.78-2.23],0.2945308547367229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFH,Complement factor H,2131,234,0.82 [0.47-1.45],0.5028395708032446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR2,Complement factor H-related protein 2,2259,249,1.27 [1.02-1.60],0.0360388668010792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR4,Complement factor H-related protein 4,2274,251,1.08 [0.91-1.27],0.3862758264654854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR5,Complement factor H-related protein 5,2255,252,0.80 [0.61-1.04],0.0978589304325719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFI,Complement factor I,2278,252,0.61 [0.33-1.10],0.0990193584492611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFP,Properdin,2278,252,0.44 [0.25-0.78],0.004693733913311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGA,Glycoprotein hormones alpha chain,2661,313,1.34 [1.15-1.55],0.000148379570936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,2287,256,1.64 [1.19-2.27],0.002768603301952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGN,Cingulin,2234,253,0.83 [0.59-1.17],0.2910466586994966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGREF1,Cell growth regulator with EF hand domain protein 1,2648,308,1.58 [1.28-1.93],1.2860242399896666e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,2583,300,1.01 [0.85-1.20],0.8735030005973756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAD,Chondroadherin,2242,246,0.55 [0.44-0.69],9.44258492887281e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",2278,254,2.08 [1.64-2.63],1.3581299588607915e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHCHD6,MICOS complex subunit MIC25,2267,249,1.41 [0.97-2.05],0.0707061768692792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHEK2,Serine/threonine-protein kinase Chk2,2603,303,1.09 [0.81-1.48],0.5579610725184865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGA,Chromogranin-A,2286,255,1.16 [1.06-1.27],0.0020256902880068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGB,Secretogranin-1,2664,310,1.61 [1.31-1.97],4.429865138834328e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHI3L1,Chitinase-3-like protein 1,2592,305,1.21 [1.08-1.35],0.0009082482983112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHIT1,Chitotriosidase-1,2655,311,0.98 [0.92-1.04],0.4864085949126875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHL1,Neural cell adhesion molecule L1-like protein,2650,308,1.43 [1.06-1.93],0.0188730662869715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHM,Rab proteins geranylgeranyltransferase component A 1,2234,253,1.01 [0.83-1.24],0.8898412910442808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHMP1A,Charged multivesicular body protein 1a,2634,311,1.02 [0.90-1.17],0.7340376433069521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHMP6,Charged multivesicular body protein 6,2273,252,0.89 [0.72-1.10],0.2841963903970096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHP1,Calcineurin B homologous protein 1,2206,248,1.02 [0.85-1.23],0.8140062572604043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRDL1,Chordin-like protein 1,2660,308,1.66 [1.25-2.20],0.0005301862429588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRDL2,Chordin-like protein 2,2648,308,0.94 [0.77-1.15],0.572884065822431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRM1,Muscarinic acetylcholine receptor M1,2234,253,1.13 [0.85-1.50],0.4015730534171592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIAPIN1,Anamorsin,2658,311,1.05 [0.88-1.24],0.6025669683775436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CILP,Cartilage intermediate layer protein 1,2286,255,1.50 [1.21-1.86],0.0001924723315267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CINP,Cyclin-dependent kinase 2-interacting protein,2251,250,1.01 [0.77-1.32],0.9485452208416548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIRBP,Cold-inducible RNA-binding protein,2268,253,1.00 [0.88-1.14],0.9872010951181092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIT,Citron Rho-interacting kinase,2234,253,1.07 [0.84-1.37],0.568269196175132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKAP4,Cytoskeleton-associated protein 4,2662,311,2.08 [1.63-2.65],3.657456939597702e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKB,Creatine kinase B-type,2286,255,1.44 [1.21-1.72],5.909469619733815e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",2640,308,1.34 [1.14-1.57],0.0003229292705203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLASP1,CLIP-associating protein 1,2199,248,1.00 [0.84-1.19],0.9931639453763405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLC,Galectin-10,2645,308,1.20 [1.04-1.39],0.0155237489221358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC10A,C-type lectin domain family 10 member A,2634,311,1.36 [1.03-1.79],0.0304776303864109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC11A,C-type lectin domain family 11 member A,2658,312,0.84 [0.69-1.02],0.0831582341032541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC12A,C-type lectin domain family 12 member A,2214,250,0.98 [0.53-1.81],0.9464837614284632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC14A,C-type lectin domain family 14 member A,2661,313,1.84 [1.40-2.40],9.668686932305038e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC1A,C-type lectin domain family 1 member A,2603,303,1.57 [1.21-2.04],0.0007437819699468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC1B,C-type lectin domain family 1 member B,2673,312,0.98 [0.88-1.09],0.6672858848347929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC2L,C-type lectin domain family 2 member L,2234,253,1.29 [1.04-1.60],0.0192526537407442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC3B,Tetranectin,2215,240,0.31 [0.18-0.53],1.8470996098367843e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4A,C-type lectin domain family 4 member A,2646,311,0.76 [0.58-1.00],0.051651759015933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4C,C-type lectin domain family 4 member C,2646,311,0.73 [0.60-0.89],0.001674729731746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4D,C-type lectin domain family 4 member D,2646,311,1.18 [1.02-1.37],0.025591498489838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4G,C-type lectin domain family 4 member G,2646,311,0.90 [0.67-1.22],0.5013254050967293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4M,C-type lectin domain family 4 member M,2283,255,0.83 [0.64-1.08],0.169196077828547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC5A,C-type lectin domain family 5 member A,2641,308,1.64 [1.21-2.24],0.0016081169388802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC6A,C-type lectin domain family 6 member A,2583,300,1.19 [0.96-1.48],0.1026142426322736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC7A,C-type lectin domain family 7 member A,2674,311,1.51 [1.24-1.84],4.6996755324202166e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLGN,Calmegin,2234,253,1.29 [1.00-1.66],0.0500278959322388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLIC5,Chloride intracellular channel protein 5,2234,253,1.27 [0.94-1.72],0.1151690640256106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLINT1,Clathrin interactor 1,2199,248,1.00 [0.75-1.32],0.989040083916226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLIP2,CAP-Gly domain-containing linker protein 2,2646,311,0.97 [0.89-1.06],0.5353610082183164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLMP,CXADR-like membrane protein,2668,312,2.14 [1.43-3.20],0.0001990826771529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLNS1A,Methylosome subunit pICln,2234,253,1.09 [0.77-1.54],0.6312568010389703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",2631,310,1.05 [0.95-1.17],0.3278668145588786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLPS,Colipase,2656,313,1.01 [0.89-1.14],0.9255050847085308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSPN,Claspin,2578,301,1.00 [0.74-1.35],0.9906517803920872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN1,Calsyntenin-1,2581,302,0.99 [0.82-1.20],0.954137965765652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN2,Calsyntenin-2,2674,311,1.17 [0.93-1.46],0.1731181258388213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN3,Calsyntenin-3,2278,254,0.86 [0.58-1.27],0.4502469140273148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLTA,Clathrin light chain A,2603,303,1.06 [0.85-1.31],0.6193554694142795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLU,Clusterin,2278,252,0.80 [0.44-1.46],0.4639356662098639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLUL1,Clusterin-like protein 1,2645,307,0.88 [0.71-1.09],0.240674414849166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CMC1,COX assembly mitochondrial protein homolog,2273,252,0.99 [0.86-1.13],0.8783031719581088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CMIP,C-Maf-inducing protein,2267,249,1.02 [0.88-1.18],0.8267598219233966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNDP1,Beta-Ala-His dipeptidase,2655,309,1.08 [0.88-1.33],0.4474960529726254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,2206,248,1.04 [0.83-1.29],0.7573265929205937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",2223,249,1.00 [0.85-1.18],0.9917852825961736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNPY2,Protein canopy homolog 2,2603,303,0.86 [0.72-1.04],0.1303996735762985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNPY4,Protein canopy homolog 4,2639,307,1.04 [0.90-1.19],0.6164777544522284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNST,Consortin,2648,308,0.99 [0.90-1.09],0.8790927537647041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTF,Ciliary neurotrophic factor,2206,248,0.94 [0.65-1.36],0.7459188614982555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN1,Contactin-1,2679,313,1.49 [1.05-2.11],0.024230117266503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN2,Contactin-2,2668,312,1.33 [1.08-1.64],0.0084662345419503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN3,Contactin-3,2661,313,1.31 [0.95-1.79],0.0949418879704976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN4,Contactin-4,2661,313,1.31 [0.87-1.95],0.1925948059459652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN5,Contactin-5,2658,309,0.81 [0.62-1.04],0.1033957134611407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTNAP2,Contactin-associated protein-like 2,2646,311,0.98 [0.79-1.23],0.8748036965961266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTNAP4,Contactin-associated protein-like 4,2234,253,1.07 [0.95-1.19],0.2547897839372299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COCH,Cochlin,2273,252,0.83 [0.64-1.08],0.1718259848195098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL15A1,Collagen alpha-1(XV) chain,2286,255,0.76 [0.51-1.14],0.1897233116813292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL18A1,Collagen alpha-1(XVIII) chain,2653,313,2.76 [1.91-4.00],6.223738474924215e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL1A1,Collagen alpha-1(I) chain,2679,313,0.62 [0.41-0.93],0.0202598496113004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL24A1,Collagen alpha-1(XXIV) chain,2268,253,1.13 [0.91-1.40],0.2599045925695948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL28A1,Collagen alpha-1(XXVIII) chain,2234,253,1.05 [0.91-1.22],0.4859824526830355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL2A1,Collagen alpha-1(II) chain,2230,249,0.96 [0.82-1.12],0.5808125008198706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL3A1,Collagen alpha-1(III) chain,2286,255,0.91 [0.56-1.50],0.7232062390291112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL4A1,Collagen alpha-1(IV) chain,2648,308,1.73 [1.41-2.11],9.732462074575858e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL4A4,Collagen alpha-4(IV) chain,2248,250,1.08 [0.85-1.37],0.5193373038018985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL5A1,Collagen alpha-1(V) chain,2242,246,1.09 [0.84-1.42],0.531702946700263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL6A3,Collagen alpha-3(VI) chain,2679,313,1.90 [1.52-2.36],1.3216441474466517e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL9A1,Collagen alpha-1(IX) chain,2646,311,0.91 [0.75-1.11],0.3684445388857581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL9A2,Collagen alpha-2(IX) chain,2251,250,1.03 [0.78-1.36],0.8524936814480186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COLEC12,Collectin-12,2649,308,2.28 [1.67-3.10],1.768919424405977e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMMD1,COMM domain-containing protein 1,2230,249,0.99 [0.80-1.23],0.961023003623092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMMD9,COMM domain-containing protein 9,2267,249,1.09 [0.82-1.45],0.5434587440013523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMP,Cartilage oligomeric matrix protein,2609,304,0.84 [0.63-1.12],0.2345764200560673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMT,Catechol O-methyltransferase,2582,300,0.99 [0.87-1.13],0.8949841156266801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COPB2,Coatomer subunit beta',2202,248,1.02 [0.76-1.37],0.8792026390180492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COPE,Coatomer subunit epsilon,2581,302,1.07 [0.90-1.29],0.4395322310700259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",2230,249,0.80 [0.58-1.11],0.1856622566980949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CORO1A,Coronin-1A,2592,299,1.00 [0.88-1.12],0.936100565905483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CORO6,Coronin-6,2206,248,1.23 [0.93-1.62],0.1542916526936575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",2639,307,1.05 [0.91-1.22],0.5073679205734245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COX6B1,Cytochrome c oxidase subunit 6B1,2273,252,1.16 [0.80-1.67],0.4337783225270805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA1,Carboxypeptidase A1,2679,313,0.95 [0.83-1.08],0.4391600567820718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA2,Carboxypeptidase A2,2669,311,1.56 [1.38-1.77],8.29444640198016e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA4,Carboxypeptidase A4,2185,241,0.93 [0.70-1.23],0.6064966430076015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPB1,Carboxypeptidase B,2679,313,1.00 [0.87-1.15],0.9759503199669912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPB2,Carboxypeptidase B2,2274,252,0.73 [0.42-1.24],0.2445216035995355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPE,Carboxypeptidase E,2641,308,0.93 [0.72-1.21],0.5846411890933236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPLX2,Complexin-2,2199,248,0.91 [0.60-1.38],0.653082282596961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPM,Carboxypeptidase M,2657,307,1.40 [1.07-1.83],0.0134377690284208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",2214,250,0.61 [0.38-0.98],0.0415372287115067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,2673,312,1.04 [0.89-1.22],0.5846976728300992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPQ,Carboxypeptidase Q,2284,255,1.19 [0.86-1.64],0.2925308854031461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPTP,Ceramide-1-phosphate transfer protein,2202,248,1.24 [0.93-1.66],0.1505019764393552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPVL,Probable serine carboxypeptidase CPVL,2665,312,1.33 [1.03-1.72],0.0294902378276368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPXM1,Probable carboxypeptidase X1,2658,311,1.03 [0.89-1.18],0.7071787149171129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPXM2,Inactive carboxypeptidase-like protein X2,2273,252,1.54 [1.01-2.35],0.0443442073586651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CR1,Complement receptor type 1,2282,255,1.11 [0.80-1.52],0.5340335923183082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CR2,Complement receptor type 2,2655,309,1.10 [0.90-1.35],0.3286888136676043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,2583,300,0.98 [0.86-1.11],0.727551288601235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRADD,Death domain-containing protein CRADD,2631,310,1.01 [0.88-1.16],0.8954812893927706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREB3,Cyclic AMP-responsive element-binding protein 3,2199,248,0.95 [0.75-1.21],0.6876621324484193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREBZF,CREB/ATF bZIP transcription factor,2199,248,1.28 [0.81-2.02],0.2826705195549454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREG1,Protein CREG1,2625,307,0.64 [0.49-0.82],0.0004831779561999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRELD1,Protein disulfide isomerase CRELD1,2242,246,1.24 [0.91-1.68],0.1804252632054487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRELD2,Protein disulfide isomerase CRELD2,2660,308,1.09 [0.91-1.32],0.3437935393973094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRH,Corticoliberin,2581,299,1.01 [0.90-1.14],0.854379975260563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRHBP,Corticotropin-releasing factor-binding protein,2649,308,1.31 [0.93-1.86],0.1257909393441518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRHR1,Corticotropin-releasing factor receptor 1,2603,303,1.07 [0.92-1.24],0.380862220034032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRIM1,Cysteine-rich motor neuron 1 protein,2665,309,1.88 [1.19-2.98],0.0065145605431911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRIP2,Cysteine-rich protein 2,2634,311,1.44 [1.11-1.88],0.0069301451604845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP2,Cysteine-rich secretory protein 2,2668,312,0.85 [0.73-0.99],0.0371843349080769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP3,Cysteine-rich secretory protein 3,2269,253,0.40 [0.26-0.62],4.8663986400605054e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRKL,Crk-like protein,2655,308,0.97 [0.88-1.08],0.6112308327796279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRLF1,Cytokine receptor-like factor 1,2665,309,1.08 [0.74-1.60],0.683943880468131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRNN,Cornulin,2578,303,1.04 [0.90-1.19],0.6162960336553878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAC1,Cartilage acidic protein 1,2679,313,0.76 [0.56-1.04],0.0846188060629877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAM,Cytotoxic and regulatory T-cell molecule,2634,311,1.27 [1.05-1.54],0.014813633562382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAP,Cartilage-associated protein,2234,253,1.22 [0.96-1.56],0.0991513426847061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRX,Cone-rod homeobox protein,2603,303,0.94 [0.85-1.05],0.3039789900991287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYBB1,Beta-crystallin B1,2273,252,1.07 [0.88-1.29],0.5077448784817258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYBB2,Beta-crystallin B2,2278,254,1.00 [0.88-1.14],0.985878417259709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYGD,Gamma-crystallin D,2278,254,0.95 [0.84-1.07],0.4105937508834291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYM,Ketimine reductase mu-crystallin,2206,248,0.96 [0.80-1.14],0.6288150778623782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYZL1,Quinone oxidoreductase-like protein 1,2230,249,0.98 [0.85-1.13],0.7656244593273033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSDE1,Cold shock domain-containing protein E1,2202,248,1.09 [0.99-1.21],0.0909743131060757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF1,Macrophage colony-stimulating factor 1,2665,309,1.86 [1.33-2.62],0.0003109189570917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,2287,256,1.33 [1.00-1.75],0.0474475270620375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF2,Granulocyte-macrophage colony-stimulating factor,2202,248,1.24 [0.91-1.69],0.1706557789518146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,2634,311,1.13 [0.96-1.34],0.1387225415018432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF2RB,Cytokine receptor common subunit beta,2214,250,0.98 [0.73-1.31],0.8925178397798837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF3,Granulocyte colony-stimulating factor,2585,303,0.88 [0.71-1.09],0.2501811259392192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF3R,Granulocyte colony-stimulating factor receptor,2214,250,0.86 [0.57-1.28],0.4558121689078996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSH1,Chorionic somatomammotropin hormone 1,2287,256,1.12 [0.74-1.71],0.5880971460194315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSNK1D,Casein kinase I isoform delta,2214,250,1.05 [0.86-1.28],0.6153813717188489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSNK2A1,Casein kinase II subunit alpha,2274,254,0.98 [0.75-1.30],0.9116557092392964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSPG4,Chondroitin sulfate proteoglycan 4,2286,255,1.76 [1.25-2.48],0.0011344920995463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSPG5,Chondroitin sulfate proteoglycan 5,2206,248,0.82 [0.62-1.08],0.1618241880533343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSRP3,Cysteine and glycine-rich protein 3,2202,248,1.11 [0.98-1.25],0.0943779799121824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST1,Cystatin-SN,2004,219,1.00 [0.88-1.14],0.9592261050427864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST3,Cystatin-C,2648,309,1.96 [1.48-2.60],3.0457842507219244e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST5,Cystatin-D,2610,309,1.29 [1.08-1.52],0.0037560098265605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST6,Cystatin-M,2575,303,0.97 [0.80-1.18],0.7938778728618473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST7,Cystatin-F,2657,309,1.03 [0.93-1.15],0.5361594928540041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSTB,Cystatin-B,2614,303,1.42 [1.13-1.80],0.0031199532618086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,2249,250,0.96 [0.75-1.24],0.7651703005211898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTBS,Di-N-acetylchitobiase,2252,252,1.00 [0.63-1.58],0.9875606557452168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTF1,Cardiotrophin-1,2603,303,1.02 [0.90-1.16],0.7171849394960238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTHRC1,Collagen triple helix repeat-containing protein 1,2286,255,1.64 [1.15-2.33],0.0058818792069454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTLA4,Cytotoxic T-lymphocyte protein 4,2286,255,0.79 [0.54-1.15],0.2186965159316179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTNNA1,Catenin alpha-1,2206,248,1.32 [0.95-1.85],0.1003521374910865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRB1,Chymotrypsinogen B,2661,313,0.98 [0.85-1.12],0.7234450305596912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRC,Chymotrypsin-C,2655,308,0.84 [0.73-0.95],0.0065742518632083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRL,Chymotrypsin-like protease CTRL-1,2278,254,0.91 [0.79-1.05],0.2138102057279138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSB,Cathepsin B,2645,309,1.10 [0.90-1.33],0.3495689811491118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSC,Dipeptidyl peptidase 1,2651,309,0.87 [0.69-1.09],0.213650171251741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSD,Cathepsin D,2484,289,1.13 [0.90-1.41],0.2890769614794871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSE,Cathepsin E,2242,246,1.48 [1.19-1.83],0.0004485250950203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSF,Cathepsin F,2658,311,1.27 [1.00-1.62],0.0546451864973548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSH,Pro-cathepsin H,2599,303,1.16 [1.01-1.33],0.0374748605061903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSL,Cathepsin L1,2648,308,1.94 [1.34-2.80],0.0004676531937832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSO,Cathepsin O,2674,311,1.70 [1.27-2.28],0.0003799434084483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSS,Cathepsin S,2086,230,2.07 [1.23-3.48],0.0060084974669304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSV,Cathepsin L2,2659,311,0.87 [0.69-1.08],0.2115899938020407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSZ,Cathepsin Z,2647,308,1.66 [1.26-2.20],0.0003470296347742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,2234,253,1.30 [1.10-1.54],0.0020534721368093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CWC15,Spliceosome-associated protein CWC15 homolog,2256,251,1.13 [0.94-1.36],0.1910908287134065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CX3CL1,Fractalkine,2634,311,1.56 [1.20-2.03],0.0008063464121672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXADR,Coxsackievirus and adenovirus receptor,2646,311,1.32 [1.09-1.60],0.004245834723967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL1,Growth-regulated alpha protein,2652,308,1.04 [0.94-1.16],0.4331368813197834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL10,C-X-C motif chemokine 10,2665,309,1.07 [0.92-1.24],0.3929627224670854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL11,C-X-C motif chemokine 11,2673,312,0.98 [0.86-1.11],0.7143695504616421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL12,Stromal cell-derived factor 1,2585,303,0.95 [0.74-1.22],0.680952438931241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL13,C-X-C motif chemokine 13,2673,312,1.13 [0.98-1.30],0.0901508816603832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL14,C-X-C motif chemokine 14,2585,303,0.98 [0.81-1.18],0.8245046479575644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL16,C-X-C motif chemokine 16,2676,313,1.40 [0.94-2.07],0.0970539514448002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL17,C-X-C motif chemokine 17,2674,311,0.91 [0.72-1.15],0.4245664665621715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL3,C-X-C motif chemokine 3,2652,308,0.97 [0.87-1.08],0.5336175213708123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL5,C-X-C motif chemokine 5,2639,307,0.95 [0.87-1.03],0.2069283862685995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL6,C-X-C motif chemokine 6,2674,311,1.05 [0.92-1.19],0.4919226122690268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL8,Interleukin-8,2622,307,1.19 [1.04-1.35],0.0116357614933149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL9,C-X-C motif chemokine 9,2665,309,1.26 [1.09-1.44],0.0011530047649008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYB5A,Cytochrome b5,2199,248,0.94 [0.78-1.13],0.5141103221819185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYB5R2,NADH-cytochrome b5 reductase 2,2250,252,1.03 [0.82-1.29],0.8080255656711242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",2202,248,0.94 [0.81-1.09],0.3901051649539045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYTH3,Cytohesin-3,2199,248,1.15 [0.98-1.35],0.0865113026898668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYTL1,Cytokine-like protein 1,2286,255,0.64 [0.41-1.01],0.0558944913934838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAAM1,Disheveled-associated activator of morphogenesis 1,2242,246,0.96 [0.82-1.11],0.5678213733230628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAB2,Disabled homolog 2,2668,312,0.98 [0.90-1.08],0.6874742665793738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAG1,Dystroglycan,2665,309,1.21 [0.97-1.51],0.096205661932895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAND5,DAN domain family member 5,2214,250,1.08 [0.90-1.30],0.4203129383564751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAPK2,Death-associated protein kinase 2,2214,250,1.12 [0.91-1.37],0.294947651806133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,2646,311,0.96 [0.89-1.04],0.3467450838372456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",2631,310,0.93 [0.81-1.08],0.3502145171836588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBH,Dopamine beta-hydroxylase,2285,256,0.95 [0.86-1.06],0.3678464953633391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBI,Acyl-CoA-binding protein,2645,312,1.10 [0.96-1.27],0.1658313601203074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBN1,Drebrin,2214,250,1.07 [0.83-1.37],0.6138209569049886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBNL,Drebrin-like protein,2665,309,1.00 [0.89-1.12],0.9454604808665406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",2658,311,2.23 [1.73-2.89],9.932840269800755e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCC,Netrin receptor DCC,2234,253,0.99 [0.55-1.79],0.9844591705051736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCDC2C,Doublecortin domain-containing protein 2C,2199,248,1.14 [0.94-1.38],0.192791441349254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCLRE1C,Protein artemis,2199,248,0.57 [0.37-0.88],0.0104268357451904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCN,Decorin,2603,303,2.98 [2.08-4.25],1.989378731842941e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTD,Deoxycytidylate deaminase,2242,246,0.95 [0.83-1.09],0.4799978682808712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTN1,Dynactin subunit 1,2668,312,0.95 [0.81-1.12],0.5575217599715849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTN2,Dynactin subunit 2,2639,307,1.00 [0.90-1.12],0.9799166397985936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTN6,Dynactin subunit 6,2581,302,1.08 [0.95-1.23],0.2542110065042525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTPP1,dCTP pyrophosphatase 1,2648,308,0.98 [0.71-1.34],0.8842871004707844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCUN1D1,DCN1-like protein 1,2206,248,1.03 [0.88-1.21],0.6974757577471007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCUN1D2,DCN1-like protein 2,2199,248,1.11 [0.96-1.28],0.1762944190895908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCXR,L-xylulose reductase,2658,311,0.78 [0.65-0.93],0.0069276087818524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDA1,DET1- and DDB1-associated protein 1,2202,248,0.96 [0.70-1.32],0.7970412222065277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",2639,307,1.18 [0.94-1.48],0.1554034904613536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDC,Aromatic-L-amino-acid decarboxylase,2647,307,0.94 [0.77-1.14],0.5039128848667969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDHD2,Phospholipase DDHD2,2274,254,0.90 [0.75-1.09],0.3012400573637986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDI2,Protein DDI1 homolog 2,2242,246,0.93 [0.80-1.09],0.3783786054107129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDR1,Epithelial discoidin domain-containing receptor 1,2673,312,1.55 [1.06-2.28],0.0247782501917337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDT,D-dopachrome decarboxylase,2286,255,0.94 [0.71-1.25],0.6834417687397606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX1,ATP-dependent RNA helicase DDX1,2268,253,1.26 [1.00-1.58],0.0495385484567923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX25,ATP-dependent RNA helicase DDX25,2234,253,1.51 [1.17-1.94],0.0013355860670317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX39A,ATP-dependent RNA helicase DDX39A,2214,250,0.91 [0.54-1.53],0.7221445164162479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX4,Probable ATP-dependent RNA helicase DDX4,2214,250,0.92 [0.71-1.19],0.5107558595917905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX53,Probable ATP-dependent RNA helicase DDX53,2234,253,0.94 [0.67-1.33],0.7251474055161455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX58,Antiviral innate immune response receptor RIG-I,2583,300,0.76 [0.62-0.93],0.0092540408194285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",2646,311,0.97 [0.87-1.09],0.6289787869345198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFA1_DEFA1B,Neutrophil defensin 1,2587,303,1.13 [0.94-1.35],0.1944943381679984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB103A_DEFB103B,Beta-defensin 103,2201,249,1.34 [1.10-1.64],0.004144576896064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB104A_DEFB104B,Beta-defensin 104,2206,248,0.98 [0.78-1.23],0.8350862868672456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB116,Beta-defensin 116,2206,248,1.00 [0.84-1.18],0.9537538767260808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB118,Beta-defensin 118,2206,248,0.84 [0.66-1.08],0.1860898274069188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB4A_DEFB4B,Beta-defensin 4A,2624,307,1.03 [0.97-1.11],0.3104707802742061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DENND2B,DENN domain-containing protein 2B,2202,248,1.03 [0.81-1.32],0.7977454051074497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DENR,Density-regulated protein,2214,250,1.12 [0.93-1.36],0.2311541699543131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DFFA,DNA fragmentation factor subunit alpha,2674,311,1.02 [0.87-1.20],0.7894290560823709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DGCR6,Protein DGCR6,2206,248,1.02 [0.75-1.39],0.897723507548265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DGKA,Diacylglycerol kinase alpha,2214,250,1.08 [0.86-1.35],0.5284777004105192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DGKZ,Diacylglycerol kinase zeta,2585,303,0.75 [0.56-1.02],0.0654814534280035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DHODH,Dihydroorotate dehydrogenase,2202,248,1.01 [0.78-1.29],0.9675802862395724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DHPS,Deoxyhypusine synthase,2267,249,1.08 [0.81-1.44],0.6003615219508196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,2278,254,1.18 [0.94-1.47],0.1582401774114747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DIABLO,"Diablo homolog, mitochondrial",2641,308,0.96 [0.88-1.06],0.4523438135827563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DIPK1C,Divergent protein kinase domain 1C,2234,253,1.09 [0.82-1.45],0.5488065800930098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DIPK2B,Divergent protein kinase domain 2B,2242,246,1.10 [0.71-1.69],0.6711611680867717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK1,Dickkopf-related protein 1,2673,312,0.94 [0.79-1.11],0.4689028989477998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK3,Dickkopf-related protein 3,2679,313,1.15 [0.83-1.60],0.3880318767713804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK4,Dickkopf-related protein 4,2630,310,1.71 [1.42-2.06],1.488936249842268e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKKL1,Dickkopf-like protein 1,2639,307,0.93 [0.83-1.04],0.1797218140536797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLG4,Disks large homolog 4,2278,254,1.01 [0.85-1.21],0.8901305494469721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLGAP5,Disks large-associated protein 5,2274,254,0.85 [0.64-1.14],0.2702763624656422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLK1,Protein delta homolog 1,2679,313,1.05 [0.88-1.24],0.6155444179867038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL1,Delta-like protein 1,2658,311,2.37 [1.81-3.10],4.3929980094758757e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL4,Delta-like protein 4,2230,249,1.08 [0.95-1.23],0.2381333042712791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DMD,Dystrophin,2230,249,1.22 [0.96-1.55],0.1012405141258691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DMP1,Dentin matrix acidic phosphoprotein 1,2230,249,0.62 [0.52-0.73],4.979138564561346e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJA1,DnaJ homolog subfamily A member 1,2199,248,0.98 [0.72-1.32],0.8789282704574884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJA2,DnaJ homolog subfamily A member 2,2667,311,0.99 [0.87-1.12],0.8701363891219799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJA4,DnaJ homolog subfamily A member 4,2278,254,0.97 [0.83-1.15],0.7458514802631163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB1,DnaJ homolog subfamily B member 1,2639,307,1.00 [0.89-1.13],0.9975690244345772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB14,DnaJ homolog subfamily B member 14,2268,253,1.08 [0.89-1.32],0.4157970570571239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB2,DnaJ homolog subfamily B member 2,2242,246,0.90 [0.72-1.14],0.3853841351531596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB6,DnaJ homolog subfamily B member 6,2224,245,0.99 [0.85-1.16],0.9085672694741592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB8,DnaJ homolog subfamily B member 8,2603,303,0.94 [0.77-1.15],0.5516274747065196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC21,DnaJ homolog subfamily C member 21,2278,254,1.01 [0.73-1.39],0.9539637278433446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,2230,249,1.00 [0.86-1.16],0.9975719627019906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC9,DnaJ homolog subfamily C member 9,2268,253,0.99 [0.84-1.16],0.8954464904963548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,2652,308,0.76 [0.53-1.11],0.157567361315261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNLZ,DNL-type zinc finger protein,2206,248,0.98 [0.84-1.14],0.753521994072573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNM1,Dynamin-1,2268,253,1.02 [0.92-1.14],0.6709492828173009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNM3,Dynamin-3,2274,254,1.12 [0.90-1.39],0.3259050623057035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNMBP,Dynamin-binding protein,2634,311,1.06 [0.89-1.25],0.5209765080150905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNPEP,Aspartyl aminopeptidase,2278,254,1.09 [0.88-1.34],0.4245221693561797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,2660,309,0.88 [0.72-1.07],0.2081666194230826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOC2B,Double C2-like domain-containing protein beta,2234,253,0.82 [0.56-1.19],0.2977466127301559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOCK9,Dedicator of cytokinesis protein 9,2206,248,0.97 [0.86-1.08],0.5540933712855239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOK1,Docking protein 1,2278,254,1.00 [0.91-1.09],0.9951855410796064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOK2,Docking protein 2,2648,308,1.00 [0.92-1.09],0.9796163903525104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPEP1,Dipeptidase 1,2631,310,0.96 [0.79-1.17],0.7099257025504764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPEP2,Dipeptidase 2,2639,307,1.41 [1.02-1.96],0.0397423541419142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP10,Inactive dipeptidyl peptidase 10,2646,311,1.03 [0.81-1.32],0.8027909942111859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP4,Dipeptidyl peptidase 4,2602,297,1.01 [0.73-1.39],0.9726616147187708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,2639,307,1.71 [1.32-2.20],3.704616217605886e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP7,Dipeptidyl peptidase 2,2632,306,1.03 [0.87-1.22],0.7348291033202587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPT,Dermatopontin,2679,313,1.20 [0.81-1.79],0.3586846172715284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPY30,Protein dpy-30 homolog,2659,312,1.26 [1.07-1.48],0.0049772633374472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DRAXIN,Draxin,2634,311,1.06 [0.85-1.33],0.6021288828578998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DRG2,Developmentally-regulated GTP-binding protein 2,2639,307,0.99 [0.83-1.19],0.9405065182050942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSC2,Desmocollin-2,2633,307,2.42 [1.89-3.12],4.8007825116370046e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSCAM,Down syndrome cell adhesion molecule,2274,254,1.14 [0.84-1.54],0.4030017830311524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG2,Desmoglein-2,2661,313,1.93 [1.43-2.59],1.5211208470437194e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG3,Desmoglein-3,2660,312,1.01 [0.76-1.33],0.9436224666214624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG4,Desmoglein-4,2633,307,0.68 [0.55-0.82],0.0001169366576377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTD1,D-aminoacyl-tRNA deacylase 1,2242,246,1.00 [0.87-1.16],0.95742306621937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTNB,Dystrobrevin beta,2261,247,1.40 [1.08-1.82],0.0108411235511757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,2234,253,0.84 [0.66-1.07],0.1500172758309433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,2639,307,2.03 [1.39-2.97],0.0002808405331693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTYMK,Thymidylate kinase,2273,252,1.00 [0.83-1.20],0.980146115765618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUOX2,Dual oxidase 2,2603,303,1.02 [0.89-1.18],0.7690615188393264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,2267,249,1.00 [0.76-1.31],0.9875981414841096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP29,Dual specificity phosphatase 29,2234,253,0.98 [0.81-1.18],0.7928317348117746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP3,Dual specificity protein phosphatase 3,2581,302,1.04 [0.93-1.17],0.4941051063235946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",2268,253,0.99 [0.88-1.12],0.8889837539536702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DXO,Decapping and exoribonuclease protein,2278,254,1.14 [0.87-1.50],0.3407722221478095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,2267,249,0.95 [0.69-1.29],0.7234994801536621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DYNLT1,Dynein light chain Tctex-type 1,2234,253,1.02 [0.87-1.19],0.8259329121027554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DYNLT3,Dynein light chain Tctex-type 3,2267,249,0.96 [0.73-1.27],0.7750041180785352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,2634,311,0.98 [0.88-1.10],0.7777210527163332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EBI3_IL27,Interleukin-27,2663,312,1.78 [1.30-2.44],0.0003406019114779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECE1,Endothelin-converting enzyme 1,2581,302,0.87 [0.65-1.15],0.3166268134697032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",2273,252,0.92 [0.79-1.07],0.2630484306403132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",2230,249,0.96 [0.85-1.10],0.5740515599252691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECI2,Enoyl-CoA delta isomerase 2,2202,248,0.92 [0.76-1.12],0.4287782257988748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECM1,Extracellular matrix protein 1,2212,244,0.90 [0.63-1.28],0.5470853098630062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECSCR,Endothelial cell-specific chemotaxis regulator,2206,248,1.18 [0.93-1.50],0.1677543362275582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,2668,312,2.18 [1.81-2.63],2.3915008093196943e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,2646,311,1.04 [0.93-1.17],0.4975016623615712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDDM3B,Epididymal secretory protein E3-beta,2267,249,0.89 [0.70-1.13],0.3314422925512934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,2202,248,1.10 [0.78-1.56],0.5847215223480932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDF1,Endothelial differentiation-related factor 1,2274,254,1.07 [0.89-1.28],0.4671375545435091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,2603,303,1.60 [1.23-2.09],0.0004699273275567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDN1,Endothelin-1,2230,249,1.98 [1.34-2.90],0.0005364740297803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDNRB,Endothelin receptor type B,2214,250,1.13 [0.83-1.53],0.4394037276935871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EEF1D,Elongation factor 1-delta,2273,252,0.99 [0.86-1.13],0.8575444845579194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,2268,253,2.07 [1.46-2.93],4.663954452908699e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFCAB2,Dynein regulatory complex protein 8,2251,250,0.94 [0.66-1.34],0.7157285970654961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,2652,309,1.75 [1.32-2.31],8.749510374690555e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFHD1,EF-hand domain-containing protein D1,2274,254,1.47 [1.10-1.98],0.0104381612268652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA1,Ephrin-A1,2659,313,2.41 [1.85-3.14],4.974355932846084e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA4,Ephrin-A4,2633,311,2.71 [2.16-3.40],7.520327615618367e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNB2,Ephrin-B2,2234,253,1.30 [1.11-1.52],0.0013624337285951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGF,Pro-epidermal growth factor,2650,306,0.97 [0.88-1.07],0.5329122020182064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGFL7,Epidermal growth factor-like protein 7,2583,300,1.21 [0.94-1.57],0.1434123843863254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGFLAM,Pikachurin,2268,253,1.11 [0.76-1.63],0.5954597093377103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGFR,Epidermal growth factor receptor,2679,313,0.98 [0.56-1.71],0.93137508982594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGLN1,Egl nine homolog 1,2646,311,0.96 [0.80-1.16],0.6962146878201312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EHBP1,EH domain-binding protein 1,2273,252,0.99 [0.83-1.17],0.9076813496575374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EHD3,EH domain-containing protein 3,2230,249,0.99 [0.89-1.10],0.8252108554951407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",2278,254,1.16 [0.96-1.41],0.126477541267558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",2254,250,0.97 [0.86-1.09],0.5815176803394773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,2202,248,0.95 [0.78-1.15],0.5757309877646054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,2230,249,1.12 [0.82-1.52],0.4684564556475284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4B,Eukaryotic translation initiation factor 4B,2634,311,0.88 [0.73-1.05],0.1506565455169015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4E,Eukaryotic translation initiation factor 4E,2214,250,1.01 [0.88-1.16],0.8672456945021083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,2648,308,1.05 [0.90-1.22],0.5616141833638072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,2674,311,1.00 [0.90-1.11],0.9795108875791884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,2274,254,0.94 [0.78-1.14],0.5348996138169819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF5,Eukaryotic translation initiation factor 5,2202,248,0.96 [0.72-1.29],0.795801279401445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF5A,Eukaryotic translation initiation factor 5A-1,2585,303,0.77 [0.54-1.10],0.1522721855972203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,2274,254,0.97 [0.84-1.13],0.6919257176606464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELAVL4,ELAV-like protein 4,2206,248,0.94 [0.81-1.10],0.4647761058790766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELN,Elastin,2273,252,1.25 [0.92-1.71],0.1512654812193792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELOA,Elongin-A,2639,307,0.84 [0.69-1.03],0.0909025669189159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELOB,Elongin-B,2202,248,1.21 [0.93-1.57],0.1570810181604272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENAH,Protein enabled homolog,2585,303,1.17 [0.95-1.43],0.1324235484772647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENDOU,Poly(U)-specific endoribonuclease,2117,239,1.08 [0.86-1.36],0.4978887422455567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENG,Endoglin,2679,313,1.40 [0.82-2.38],0.2174085610481649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO1,Alpha-enolase,2656,309,0.99 [0.86-1.13],0.8258926389129096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO2,Gamma-enolase,2673,312,1.01 [0.86-1.18],0.9045285000685862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO3,Beta-enolase,2230,249,0.83 [0.68-1.01],0.0641572046329374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENOPH1,Enolase-phosphatase E1,2267,249,0.84 [0.65-1.08],0.1822912834459435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,2202,248,0.81 [0.52-1.27],0.361021234759883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPEP,Glutamyl aminopeptidase,2202,248,1.18 [0.95-1.46],0.131608077997485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,2679,313,0.99 [0.71-1.39],0.9680027236981138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,2665,309,0.83 [0.66-1.04],0.1120079268388538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,2230,249,1.46 [1.05-2.03],0.0259979399460212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,2554,293,0.91 [0.81-1.02],0.1156021632940048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENSA,Alpha-endosulfine,2267,249,0.92 [0.72-1.18],0.503077925832456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,2583,300,1.04 [0.83-1.30],0.7481240804953264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,2603,303,0.81 [0.50-1.29],0.3709114273968562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,2603,303,1.22 [0.82-1.82],0.3321422224333952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTR1,Endosome-associated-trafficking regulator 1,2230,249,0.89 [0.73-1.09],0.274903808047987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EP300,Histone acetyltransferase p300,2214,250,1.00 [0.68-1.48],0.9931411636807754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPB41L5,Band 4.1-like protein 5,2234,253,0.92 [0.75-1.13],0.4171254017726798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPCAM,Epithelial cell adhesion molecule,2650,307,1.00 [0.89-1.11],0.9474507406455586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPGN,Epigen,2267,249,0.97 [0.71-1.32],0.8386640116922297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA1,Ephrin type-A receptor 1,2660,309,1.34 [1.01-1.79],0.0443991120363225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA10,Ephrin type-A receptor 10,2581,302,1.09 [0.94-1.26],0.2686889707578445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA2,Ephrin type-A receptor 2,2553,298,2.41 [1.93-3.01],5.183817616711641e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA4,Ephrin type-A receptor 4,2242,246,1.16 [0.77-1.75],0.4869878205456106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB4,Ephrin type-B receptor 4,2679,313,2.50 [1.83-3.40],6.5792323809697e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB6,Ephrin type-B receptor 6,2631,310,1.49 [1.14-1.97],0.0040465148865724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHX2,Bifunctional epoxide hydrolase 2,2603,303,0.97 [0.82-1.14],0.6906715237056873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPN1,Epsin-1,2251,250,1.12 [0.84-1.47],0.4433101386697073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPO,Erythropoietin,2646,311,1.30 [1.16-1.45],6.187513503280708e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPPK1,Epiplakin,2230,249,1.12 [0.95-1.32],0.1735550845385127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,2664,312,1.74 [1.33-2.28],4.863404036893833e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,2658,311,0.69 [0.47-1.01],0.0587798729079505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,2643,308,0.97 [0.58-1.60],0.894775689343156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,2658,311,1.65 [1.17-2.31],0.0039159795559523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBIN,Erbin,2639,307,0.98 [0.89-1.09],0.7206743608248098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERC2,ERC protein 2,2234,253,1.02 [0.86-1.20],0.8537933976510357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERCC1,DNA excision repair protein ERCC-1,2199,248,1.06 [0.72-1.57],0.7667096962696106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EREG,Proepiregulin,2631,310,0.96 [0.84-1.09],0.5059215749795205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERI1,3'-5' exoribonuclease 1,2251,250,0.94 [0.64-1.37],0.7468472679273617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERMAP,Erythroid membrane-associated protein,2214,250,1.46 [1.11-1.93],0.0067911772995949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,2267,249,0.76 [0.55-1.05],0.0960054915076602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERP29,Endoplasmic reticulum resident protein 29,2242,246,0.98 [0.88-1.09],0.766278506084344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERP44,Endoplasmic reticulum resident protein 44,2638,307,0.80 [0.54-1.18],0.2625662420784685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,2202,248,0.85 [0.63-1.16],0.303366223168627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESAM,Endothelial cell-selective adhesion molecule,2679,313,1.59 [1.21-2.10],0.0009364505295865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESM1,Endothelial cell-specific molecule 1,2649,308,1.01 [0.76-1.33],0.9698361377263244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESPL1,Separin,2199,248,1.13 [0.95-1.33],0.1623546305797324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESR1,Estrogen receptor,2214,250,0.84 [0.64-1.12],0.2359464451812889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESYT2,Extended synaptotagmin-2,2278,254,1.08 [0.93-1.25],0.29524334221279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EVI2B,Protein EVI2B,2199,248,1.14 [0.85-1.53],0.3949557853171335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EVI5,Ecotropic viral integration site 5 protein homolog,2214,250,1.04 [0.90-1.19],0.5948942618651492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EVPL,Envoplakin,2251,250,0.97 [0.66-1.42],0.8722692311362136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EXOSC10,Exosome component 10,2202,248,0.74 [0.56-0.97],0.0291802208942221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EXTL1,Exostosin-like 1,2202,248,1.15 [0.92-1.43],0.2187653455534087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EZR,Ezrin,2673,312,0.87 [0.57-1.32],0.5046981063750289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F10,Coagulation factor X,2287,256,0.83 [0.56-1.25],0.3772340442801488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F11,Coagulation factor XI,2250,249,1.24 [0.82-1.88],0.3054954774498021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F11R,Junctional adhesion molecule A,2661,313,1.10 [0.92-1.32],0.3010269925342507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F12,Coagulation factor XII,2278,252,0.91 [0.68-1.22],0.5309400346478916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F13B,Coagulation factor XIII B chain,2267,252,0.71 [0.45-1.12],0.1439382241491347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F2,Prothrombin,2278,252,0.64 [0.30-1.36],0.2468741996895508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F2R,Proteinase-activated receptor 1,2660,308,1.23 [1.02-1.47],0.0268135407349201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F3,Tissue factor,2653,311,1.57 [1.12-2.20],0.0083735368557369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F7,Coagulation factor VII,2650,309,0.98 [0.73-1.33],0.9035549164960264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F9,Coagulation factor IX,2653,308,0.72 [0.42-1.25],0.2405068834165908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP1,"Fatty acid-binding protein, liver",2649,308,1.24 [1.12-1.37],1.710901443028242e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP2,"Fatty acid-binding protein, intestinal",2648,308,1.20 [1.07-1.35],0.0019213307186274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP3,"Fatty acid-binding protein, heart",2273,252,1.52 [1.26-1.84],9.295598245503144e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP4,"Fatty acid-binding protein, adipocyte",2679,313,1.62 [1.39-1.89],4.6218312486660814e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP5,Fatty acid-binding protein 5,2664,309,1.26 [1.08-1.46],0.0027804085643937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP6,Gastrotropin,2600,301,1.09 [0.93-1.29],0.2938958674833245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP9,Fatty acid-binding protein 9,2646,311,0.92 [0.77-1.10],0.3567324908754907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FADD,FAS-associated death domain protein,2648,308,0.98 [0.86-1.13],0.8316344115780645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM13A,Protein FAM13A,2268,253,1.02 [0.84-1.23],0.847116211067812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM171A2,Protein FAM171A2,2274,254,1.01 [0.94-1.09],0.798029295267231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM171B,Protein FAM171B,2267,249,1.28 [0.82-2.00],0.274917077686113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM172A,Cotranscriptional regulator FAM172A,2230,249,0.93 [0.75-1.14],0.4806640294126264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM20A,Pseudokinase FAM20A,2273,252,0.79 [0.51-1.22],0.289006322396529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3B,Protein FAM3B,2639,307,2.25 [1.70-2.99],1.7996203315159542e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3C,Protein FAM3C,2647,307,2.93 [2.24-3.83],4.45788398831392e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3D,Protein FAM3D,2268,253,1.48 [1.29-1.70],1.5642765545406117e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAP,Prolyl endopeptidase FAP,2679,313,1.15 [0.82-1.62],0.4023461221144909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,2234,253,1.04 [0.87-1.24],0.6763394854449714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAS,Tumor necrosis factor receptor superfamily member 6,2671,313,1.46 [1.15-1.86],0.0020601911498893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FASLG,Tumor necrosis factor ligand superfamily member 6,2674,311,0.94 [0.72-1.24],0.6763375210221222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBLN2,Fibulin-2,2286,255,1.24 [0.89-1.73],0.2103119918616831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBN2,Fibrillin-2,2234,253,1.10 [0.88-1.37],0.3968151550771827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBP1,"Fructose-1,6-bisphosphatase 1",2648,308,0.87 [0.76-0.99],0.0359776765948901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,2273,252,1.08 [0.92-1.26],0.3631379869633142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCAR,Immunoglobulin alpha Fc receptor,2646,311,1.04 [0.85-1.27],0.7314121699882186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,2274,254,1.04 [0.63-1.69],0.8902148029866384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,2661,313,1.17 [0.98-1.40],0.0773501477081536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,2639,305,1.02 [0.86-1.21],0.8485907247715732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,2583,300,1.00 [0.84-1.20],0.9692701419133416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,2648,309,0.90 [0.74-1.09],0.2888449342566081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCN1,Ficolin-1,2285,256,1.02 [0.81-1.27],0.8834923272859145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCN2,Ficolin-2,2633,306,0.68 [0.54-0.86],0.001638384067997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL1,Fc receptor-like protein 1,2648,308,0.96 [0.77-1.19],0.7056027638237378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL2,Fc receptor-like protein 2,2666,308,1.10 [0.92-1.32],0.2928079855358679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL3,Fc receptor-like protein 3,2585,303,0.91 [0.77-1.09],0.3188555996949754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL5,Fc receptor-like protein 5,2661,313,0.98 [0.83-1.16],0.8318024207424808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL6,Fc receptor-like protein 6,2646,311,1.14 [0.98-1.31],0.0820259988095037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRLB,Fc receptor-like B,2583,300,1.21 [1.04-1.42],0.0165123264811813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FDX1,"Adrenodoxin, mitochondrial",2202,248,1.17 [0.97-1.41],0.10266580298943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FDX2,"Ferredoxin-2, mitochondrial",2202,248,1.09 [0.86-1.38],0.4953095749601529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FEN1,Flap endonuclease 1,2583,300,0.93 [0.80-1.09],0.3814892564756547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FES,Tyrosine-protein kinase Fes/Fps,2583,300,0.84 [0.68-1.05],0.1345773516907233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FETUB,Fetuin-B,2653,308,1.01 [0.78-1.33],0.9206297637761492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGA,Fibrinogen alpha chain,2216,242,0.78 [0.52-1.16],0.2143018242565311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",2274,254,0.99 [0.85-1.16],0.9414420115727066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF12,Fibroblast growth factor 12,2214,250,0.75 [0.52-1.07],0.1088166970689993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF16,Fibroblast growth factor 16,2214,250,0.82 [0.62-1.08],0.1601422575761047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF19,Fibroblast growth factor 19,2665,309,0.96 [0.85-1.09],0.5312041853576253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF2,Fibroblast growth factor 2,2646,311,1.03 [0.89-1.19],0.6718539655423486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF20,Fibroblast growth factor 20,2214,250,0.91 [0.67-1.22],0.5220671974745097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF21,Fibroblast growth factor 21,2663,312,1.02 [0.94-1.11],0.5790443346001275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF23,Fibroblast growth factor 23,2663,312,1.29 [1.12-1.50],0.0006207629138035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF3,Fibroblast growth factor 3,2214,250,1.17 [0.74-1.86],0.5059529795680907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF5,Fibroblast growth factor 5,2585,303,2.16 [1.64-2.84],3.7580288725217786e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF6,Fibroblast growth factor 6,2214,250,1.03 [0.79-1.34],0.8308402610089551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF7,Fibroblast growth factor 7,2199,248,1.06 [0.92-1.23],0.3991669613320209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF9,Fibroblast growth factor 9,2197,248,1.12 [0.82-1.52],0.4665536723110542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP1,Fibroblast growth factor-binding protein 1,2658,311,0.52 [0.39-0.69],4.612739369080167e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP2,Fibroblast growth factor-binding protein 2,2286,255,0.61 [0.48-0.77],2.842177549275936e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP3,Fibroblast growth factor-binding protein 3,2278,254,0.59 [0.43-0.82],0.0014496258036411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFR2,Fibroblast growth factor receptor 2,2658,311,1.43 [0.98-2.09],0.065646135444833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFR4,Fibroblast growth factor receptor 4,2242,246,0.95 [0.75-1.21],0.7029163830114248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGL1,Fibrinogen-like protein 1,2287,256,1.23 [1.03-1.47],0.0204785918633249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGR,Tyrosine-protein kinase Fgr,2581,302,0.91 [0.76-1.08],0.2865641945338569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FH,"Fumarate hydratase, mitochondrial",2206,248,1.05 [0.91-1.21],0.4986622723483632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,2202,248,0.81 [0.62-1.06],0.1184927638730723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FHIT,Bis(5'-adenosyl)-triphosphatase,2581,302,0.92 [0.80-1.07],0.2863127833564522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FIS1,Mitochondrial fission 1 protein,2652,309,1.00 [0.87-1.14],0.9854630338412076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,2274,254,1.01 [0.89-1.14],0.9190016896383018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,2652,304,0.98 [0.89-1.07],0.6126418040117267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,2634,311,1.19 [0.92-1.53],0.1806430051026443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,2634,311,1.03 [0.92-1.15],0.6100657249846493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,2578,301,1.15 [0.95-1.38],0.1563182059753211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBPL,FK506-binding protein-like,2268,253,0.93 [0.75-1.15],0.5114447360521097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLI1,Friend leukemia integration 1 transcription factor,2583,300,1.00 [0.91-1.10],0.9409274904613208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,2634,311,1.67 [1.22-2.28],0.001188978995741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT1,Vascular endothelial growth factor receptor 1,2635,307,1.09 [0.73-1.64],0.6712131207345342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,2583,300,1.09 [0.77-1.54],0.6400082082312262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,2674,311,1.36 [1.02-1.82],0.0364864132277643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT4,Vascular endothelial growth factor receptor 3,2658,311,0.70 [0.53-0.93],0.0140739973074975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FMNL1,Formin-like protein 1,2581,302,0.99 [0.85-1.14],0.8528098521321374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FMR1,Synaptic functional regulator FMR1,2583,300,1.01 [0.76-1.34],0.9709694296575376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FN1,Fibronectin,2278,252,0.39 [0.25-0.62],5.216609799189721e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FNDC1,Fibronectin type III domain-containing protein 1,2278,254,0.99 [0.77-1.26],0.9195480091630795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,2267,249,0.90 [0.60-1.34],0.5917251634751248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLH1,Glutamate carboxypeptidase 2,2214,250,1.01 [0.88-1.15],0.8982626193697691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR1,Folate receptor alpha,2644,310,1.60 [1.18-2.17],0.0027899697995141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR2,Folate receptor beta,2673,312,1.62 [1.18-2.24],0.0032860356083739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR3,Folate receptor gamma,2646,310,1.03 [0.98-1.08],0.1863729955505674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOS,Proto-oncogene c-Fos,2197,248,0.87 [0.61-1.24],0.4390553937702233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOSB,Protein fosB,2581,302,0.97 [0.72-1.30],0.8306614597112176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOXJ3,Forkhead box protein J3,2214,250,0.98 [0.74-1.29],0.8822646392032266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOXO1,Forkhead box protein O1,2646,311,0.97 [0.86-1.10],0.6310015492031991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOXO3,Forkhead box protein O3,2583,300,0.98 [0.87-1.10],0.7248631890201371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FRMD4B,FERM domain-containing protein 4B,2202,248,1.00 [0.84-1.21],0.9576287980669324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FRMD7,FERM domain-containing protein 7,2234,253,1.26 [0.89-1.79],0.1919156596580144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FRZB,Secreted frizzled-related protein 3,2630,311,0.85 [0.58-1.24],0.3906090640453515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSHB,Follitropin subunit beta,2230,249,1.39 [1.10-1.74],0.004738345941079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FST,Follistatin,2660,308,0.84 [0.67-1.05],0.1168005146775933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL1,Follistatin-related protein 1,2230,249,2.87 [1.74-4.74],3.591382495364448e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL3,Follistatin-related protein 3,2649,307,1.89 [1.47-2.44],7.892576372739063e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FTCD,Formimidoyltransferase-cyclodeaminase,2272,252,0.87 [0.77-0.98],0.023686235377863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUCA1,Tissue alpha-L-fucosidase,2667,312,1.03 [0.91-1.16],0.6213294176147892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUOM,Fucose mutarotase,2242,246,0.77 [0.64-0.92],0.0046355702711383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FURIN,Furin,2658,311,0.59 [0.44-0.80],0.0005657100064974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUS,RNA-binding protein FUS,2578,300,0.93 [0.70-1.23],0.5909585603925259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",2247,250,0.90 [0.73-1.10],0.3003057991238753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,2673,312,1.27 [1.03-1.55],0.0243878288643432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT8,"Alpha-(1,6)-fucosyltransferase",2634,311,0.93 [0.78-1.11],0.4201495148976524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FXN,"Frataxin, mitochondrial",2668,312,0.98 [0.85-1.13],0.7950837516334159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FXYD5,FXYD domain-containing ion transport regulator 5,2585,303,1.07 [0.92-1.24],0.4021871037128264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FYB1,FYN-binding protein 1,2656,313,0.95 [0.85-1.06],0.3827460293338544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FZD10,Frizzled-10,2234,253,1.08 [0.90-1.31],0.4080593452247036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FZD8,Frizzled-8,2206,248,0.93 [0.71-1.23],0.6293436515619409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,2267,249,0.99 [0.78-1.27],0.9415192668720084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,2251,250,1.07 [0.90-1.27],0.4476525884797481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,2206,248,1.03 [0.84-1.26],0.804580519753539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAD1,Glutamate decarboxylase 1,2199,248,1.16 [0.72-1.89],0.5366490303122854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAD2,Glutamate decarboxylase 2,2214,250,0.93 [0.69-1.25],0.6156915033327106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,2251,250,1.02 [0.78-1.31],0.9081091270677766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,2230,249,0.94 [0.74-1.19],0.6142198159905322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAGE2A,G antigen 2A,2199,248,1.03 [0.87-1.22],0.7488013828134586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAL,Galanin peptides,2665,309,0.89 [0.76-1.03],0.1252444578805975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,2639,307,1.63 [1.16-2.28],0.0049792462573554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,2668,312,0.93 [0.66-1.33],0.7057305243537253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,2585,303,1.59 [1.28-1.97],2.252791814063e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,2273,252,1.01 [0.67-1.52],0.978941722403224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT7,N-acetylgalactosaminyltransferase 7,2639,307,1.62 [1.02-2.58],0.041504759367225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAMT,Guanidinoacetate N-methyltransferase,2202,248,1.03 [0.72-1.46],0.8855342911786765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,2178,237,1.03 [0.66-1.61],0.8799544939362117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GART,Trifunctional purine biosynthetic protein adenosine-3,2274,254,0.98 [0.63-1.53],0.9365571760445668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAS2,Growth arrest-specific protein 2,2251,250,0.79 [0.60-1.03],0.0783162597071238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAS6,Growth arrest-specific protein 6,2660,310,1.40 [0.95-2.07],0.0874978570700073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GASK1A,Golgi-associated kinase 1A,2202,248,0.86 [0.65-1.14],0.3000289310153933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAST,Gastrin,2278,254,1.07 [0.99-1.15],0.0726825179560948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,2199,248,0.84 [0.52-1.34],0.4610999558023135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",2230,249,1.03 [0.87-1.21],0.7506056154149356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBA,Lysosomal acid glucosylceramidase,2234,253,1.09 [0.89-1.34],0.4018206777406522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP1,Guanylate-binding protein 1,2275,253,0.84 [0.71-0.99],0.0419902597632218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP2,Guanylate-binding protein 2,2585,303,1.02 [0.85-1.22],0.8260263068362461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP4,Guanylate-binding protein 4,2581,302,0.91 [0.73-1.13],0.378605387011394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP6,Guanylate-binding protein 6,2202,248,0.92 [0.68-1.26],0.6102406281145817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GC,Vitamin D-binding protein,2278,252,0.65 [0.40-1.04],0.0698498399833845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCC1,GRIP and coiled-coil domain-containing protein 1,2278,254,0.98 [0.87-1.10],0.7150656958222792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCG,Pro-glucagon,2583,300,1.22 [1.13-1.31],5.928669514245309e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,2181,241,1.01 [0.78-1.31],0.9361711837676828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCLM,Glutamate--cysteine ligase regulatory subunit,2202,248,1.00 [0.76-1.31],0.9888313933351056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",2639,307,1.51 [1.14-2.01],0.0042618471279604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF15,Growth/differentiation factor 15,2679,313,2.04 [1.78-2.32],4.466097791175809e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF2,Growth/differentiation factor 2,2648,308,1.34 [1.03-1.75],0.0315043685125589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDNF,Glial cell line-derived neurotrophic factor,2581,302,1.41 [1.09-1.80],0.0075508639574258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GET3,ATPase GET3,2273,252,1.07 [0.86-1.32],0.535487158836943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFAP,Glial fibrillary acidic protein,2580,300,0.83 [0.67-1.04],0.1010690509520257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFER,FAD-linked sulfhydryl oxidase ALR,2583,300,1.02 [0.86-1.21],0.8333209194734293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,2583,300,1.07 [0.99-1.16],0.0729184327707294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA1,GDNF family receptor alpha-1,2663,312,2.62 [1.97-3.48],3.916178446190296e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA2,GDNF family receptor alpha-2,2639,307,1.40 [0.87-2.23],0.1621242453029951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA3,GDNF family receptor alpha-3,2625,309,1.64 [1.18-2.28],0.0035227237744362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRAL,GDNF family receptor alpha-like,2202,249,0.92 [0.76-1.12],0.4248050817944997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGA1,ADP-ribosylation factor-binding protein GGA1,2581,302,1.10 [0.95-1.28],0.213102577019843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGACT,Gamma-glutamylaminecyclotransferase,2273,252,1.07 [0.89-1.27],0.4841881345476662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGCT,Gamma-glutamylcyclotransferase,2271,252,1.04 [0.80-1.36],0.7727255767859534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGH,Gamma-glutamyl hydrolase,2596,303,0.83 [0.61-1.13],0.2360045802076408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGT1,Glutathione hydrolase 1 proenzyme,2659,313,0.84 [0.70-1.02],0.0834132559553948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGT5,Glutathione hydrolase 5 proenzyme,2634,311,2.78 [1.94-3.98],2.430556044460888e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GH1,Somatotropin,2647,307,1.10 [1.04-1.17],0.0013655134758234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GH2,Growth hormone variant,2583,300,1.00 [0.94-1.07],0.9291138772923166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHR,Growth hormone receptor,2242,246,0.44 [0.29-0.67],0.0001146207595179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHRHR,Growth hormone-releasing hormone receptor,2581,302,1.00 [0.82-1.22],0.986222172531801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHRL,Appetite-regulating hormone,2648,308,1.05 [0.93-1.18],0.4479648064770269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GID8,Glucose-induced degradation protein 8 homolog,2274,254,1.27 [0.94-1.72],0.1213305625389827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIGYF2,GRB10-interacting GYF protein 2,2274,254,1.08 [0.92-1.27],0.3591065517453291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIMAP7,GTPase IMAP family member 7,2242,246,0.77 [0.50-1.18],0.2333634192413339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIMAP8,GTPase IMAP family member 8,2199,248,0.94 [0.73-1.22],0.6425930687902016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIP,Gastric inhibitory polypeptide,2230,249,1.35 [1.11-1.64],0.0024311235017482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPC2,PDZ domain-containing protein GIPC2,2278,254,1.63 [1.16-2.30],0.0053190929621095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPC3,PDZ domain-containing protein GIPC3,2268,253,0.97 [0.85-1.10],0.6393766121442562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPR,Gastric inhibitory polypeptide receptor,2214,250,1.19 [0.93-1.52],0.1699117914533824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIT1,ARF GTPase-activating protein GIT1,2214,250,0.96 [0.84-1.09],0.5083520397337564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GJA8,Gap junction alpha-8 protein,2199,248,1.24 [1.07-1.44],0.0048377477383825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GKN1,Gastrokine-1,2541,292,1.65 [1.17-2.33],0.0041836737805011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLA,Alpha-galactosidase A,2241,246,1.02 [0.74-1.39],0.9235152437975652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLB1,Beta-galactosidase,2634,311,1.01 [0.80-1.29],0.90873692291947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLI2,Zinc finger protein GLI2,2214,250,0.85 [0.55-1.33],0.4831408095945847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLO1,Lactoylglutathione lyase,2603,303,1.09 [0.91-1.30],0.3457774340528007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLOD4,Glyoxalase domain-containing protein 4,2647,308,0.91 [0.68-1.23],0.543984975377303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLP1R,Glucagon-like peptide 1 receptor,2206,248,1.39 [1.07-1.81],0.0147021912876171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLRX,Glutaredoxin-1,2635,306,1.04 [0.87-1.23],0.6997616282570565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",2242,246,0.92 [0.80-1.07],0.2766932361792774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,2581,302,0.98 [0.78-1.22],0.823255968996558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLYR1,Putative oxidoreductase GLYR1,2267,249,1.09 [0.88-1.36],0.4164252371818832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GM2A,Ganglioside GM2 activator,2235,251,1.60 [1.24-2.07],0.0003008070659075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMFG,Glia maturation factor gamma,2273,252,1.00 [0.84-1.20],0.9633904076116724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMPR,GMP reductase 1,2674,311,0.97 [0.79-1.18],0.7365217693751468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMPR2,GMP reductase 2,2242,246,0.97 [0.81-1.18],0.7846612825107504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNAS,Neuroendocrine secretory protein 55,2274,254,1.05 [0.92-1.20],0.4289811433808668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,2583,300,0.86 [0.73-1.01],0.07295537651358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,2234,253,0.98 [0.78-1.24],0.8881532054494713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNLY,Granulysin,2661,313,0.94 [0.78-1.13],0.5107960857328661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,2230,249,1.10 [0.79-1.54],0.5564840260527002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,2242,246,0.71 [0.50-0.99],0.0449913006479884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOLGA3,Golgin subfamily A member 3,2274,254,0.95 [0.81-1.11],0.516550767771934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOLM2,Protein GOLM2,2673,312,1.11 [0.76-1.61],0.5929197739919384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,2646,311,0.93 [0.84-1.03],0.1752693374816737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GORASP2,Golgi reassembly-stacking protein 2,2268,253,1.08 [0.83-1.41],0.5500934773314115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOT1,"Aspartate aminotransferase, cytoplasmic",2286,255,0.69 [0.53-0.91],0.0083129787204318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP1BA,Platelet glycoprotein Ib alpha chain,2637,305,0.70 [0.52-0.95],0.0204509216361528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP1BB,Platelet glycoprotein Ib beta chain,2202,248,1.02 [0.85-1.22],0.8340664120112953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,2574,300,1.11 [1.01-1.23],0.0341919312697127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP5,Platelet glycoprotein V,2242,246,0.77 [0.55-1.08],0.1240509920256038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP6,Platelet glycoprotein VI,2656,313,1.01 [0.89-1.13],0.929452127544764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPA33,Cell surface A33 antigen,2639,307,0.91 [0.84-0.98],0.0118390723312075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPC1,Glypican-1,2668,312,1.64 [1.20-2.26],0.0020954367394415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPC5,Glypican-5,2634,311,0.82 [0.69-0.98],0.030012793915069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPD1,Glycerol-3-phosphate dehydrogenase,2267,249,0.94 [0.77-1.16],0.5686082967990039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPHA2,Glycoprotein hormone alpha-2,2268,253,1.08 [0.84-1.38],0.5684598603685647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPI,Glucose-6-phosphate isomerase,2287,256,0.89 [0.69-1.17],0.4143127770696725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,2268,253,1.07 [0.91-1.27],0.4112712565786977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPKOW,G-patch domain and KOW motifs-containing protein,2581,302,1.19 [0.88-1.62],0.2581668227479297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPNMB,Transmembrane glycoprotein NMB,2588,299,2.64 [1.88-3.69],1.7477538588965243e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR101,Probable G-protein coupled receptor 101,2206,248,1.11 [0.89-1.38],0.3418059008157467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR158,Probable G-protein coupled receptor 158,2274,254,1.03 [0.73-1.45],0.8595320474926884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR15L,Protein GPR15L,2268,253,1.18 [0.98-1.43],0.0752571691803425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR37,Prosaposin receptor GPR37,2603,303,1.35 [1.17-1.56],4.856941012832428e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPRC5C,G-protein coupled receptor family C group 5 member C,2267,249,1.16 [0.96-1.41],0.1233521679729881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRAP2,GRB2-related adapter protein 2,2648,308,0.99 [0.91-1.07],0.7545098036403128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,2273,252,1.04 [0.85-1.26],0.7326110723702395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",2274,254,0.93 [0.69-1.24],0.6188953460701374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",2206,248,1.09 [0.87-1.38],0.4504666618538828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRK5,G protein-coupled receptor kinase 5,2603,303,0.82 [0.65-1.03],0.0892577342199483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRN,Progranulin,2648,313,2.45 [1.69-3.56],2.2597801312860494e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRP,Gastrin-releasing peptide,2230,249,0.93 [0.76-1.15],0.5133594773932308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",2639,307,1.05 [0.89-1.24],0.5346072055684394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRSF1,G-rich sequence factor 1,2186,246,1.06 [0.91-1.24],0.4632964167097574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSAP,Gamma-secretase-activating protein,2583,300,1.04 [0.93-1.17],0.4829302397206216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSN,Gelsolin,2281,255,0.64 [0.35-1.18],0.1540365850738906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSR,"Glutathione reductase, mitochondrial",2279,255,0.67 [0.40-1.11],0.121605889206537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTA1,Glutathione S-transferase A1,2645,308,0.86 [0.76-0.96],0.0085293957482929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTA3,Glutathione S-transferase A3,2583,300,0.91 [0.80-1.03],0.1276444913823947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTM4,Glutathione S-transferase Mu 4,2202,248,1.08 [0.93-1.26],0.2961764856113501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTP1,Glutathione S-transferase P,2564,300,1.12 [0.97-1.29],0.114350305957575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTT2B,Glutathione S-transferase theta-2B,2278,254,1.00 [0.95-1.05],0.9184173229631936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,2251,250,1.10 [0.93-1.31],0.2617865790977817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GTPBP2,GTP-binding protein 2,2234,253,0.97 [0.83-1.13],0.7158517212343934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUCA2A,Guanylin,2652,312,1.91 [1.54-2.38],6.895275568957108e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUCY2C,Heat-stable enterotoxin receptor,2251,250,0.91 [0.77-1.07],0.2652070238073726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUK1,Guanylate kinase,2202,248,1.11 [0.80-1.55],0.5272374845073863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUSB,Beta-glucuronidase,2659,312,0.87 [0.76-1.01],0.0626849452897204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GYS1,"Glycogen [starch] synthase, muscle",2603,303,0.88 [0.78-0.99],0.0353632080340754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMA,Granzyme A,2674,311,1.02 [0.76-1.37],0.8922334265200594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMB,Granzyme B,2646,311,0.83 [0.70-0.99],0.038229281054242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMH,Granzyme H,2603,303,1.01 [0.88-1.17],0.8652420855358873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,H2AP,Huntingtin-interacting protein M,2199,248,0.90 [0.68-1.21],0.4873128201166646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",2202,248,1.11 [0.96-1.29],0.1524450372922778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",2662,312,0.96 [0.84-1.10],0.5623739249095385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAO1,Hydroxyacid oxidase 1,2668,312,0.98 [0.91-1.06],0.6814964905220722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",2661,313,0.99 [0.86-1.13],0.8310520129274753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR1,Hepatitis A virus cellular receptor 1,2667,312,1.69 [1.50-1.89],4.7327557089065335e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR2,Hepatitis A virus cellular receptor 2,2661,313,1.69 [1.31-2.18],5.693327303489108e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HBEGF,Proheparin-binding EGF-like growth factor,2662,312,0.96 [0.84-1.10],0.5322782774318178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HBQ1,Hemoglobin subunit theta-1,2668,312,0.94 [0.80-1.10],0.428461779645327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HBZ,Hemoglobin subunit zeta,2273,252,0.91 [0.81-1.03],0.1288522163406937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HCG22,Protein PBMUCL2,2202,248,0.80 [0.61-1.06],0.1150471477549325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HCLS1,Hematopoietic lineage cell-specific protein,2674,311,0.93 [0.77-1.12],0.4509359977208231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDAC8,Histone deacetylase 8,2214,250,0.98 [0.77-1.24],0.8524670680446969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDAC9,Histone deacetylase 9,2206,248,0.96 [0.79-1.17],0.6985407436002999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDDC2,5'-deoxynucleotidase HDDC2,2268,253,1.02 [0.78-1.33],0.9053114230409548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDGF,Hepatoma-derived growth factor,2663,312,1.06 [0.95-1.18],0.3019286485112468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,2278,254,0.99 [0.81-1.20],0.8888316244735426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEBP1,Heme-binding protein 1,2603,303,1.11 [0.92-1.33],0.2643991640609531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEG1,Protein HEG homolog 1,2242,246,1.22 [0.80-1.86],0.3460807846529152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEPACAM2,HEPACAM family member 2,2278,254,1.03 [0.78-1.34],0.8530187338338501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEPH,Hephaestin,2273,252,3.41 [2.18-5.33],8.067711870568957e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEXIM1,Protein HEXIM1,2646,311,0.93 [0.81-1.06],0.2657421696377667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HGF,Hepatocyte growth factor,2674,311,1.10 [0.84-1.44],0.4906732215775908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HGFAC,Hepatocyte growth factor activator,2269,255,1.37 [0.88-2.16],0.1660953040383058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,2583,300,0.98 [0.86-1.13],0.820683231816031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,2278,254,1.02 [0.87-1.21],0.7909960098451396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HIF1A,Hypoxia-inducible factor 1-alpha,2214,250,0.82 [0.65-1.04],0.1078611803613331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HIP1,Huntingtin-interacting protein 1,2202,248,1.16 [0.79-1.71],0.4404723317555069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HIP1R,Huntingtin-interacting protein 1-related protein,2273,253,1.25 [1.01-1.55],0.0399699272642923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HJV,Hemojuvelin,2274,254,1.10 [0.85-1.42],0.4617152533796531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HK2,Hexokinase-2,2603,303,1.14 [0.80-1.63],0.4670628328549594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",2274,254,1.57 [1.09-2.28],0.015725134566415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",2637,309,1.24 [0.97-1.60],0.0906829792687251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",2646,311,1.94 [1.48-2.55],1.6894951497086949e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMBS,Porphobilinogen deaminase,2668,312,0.86 [0.69-1.08],0.2029200329210051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMCN2,Hemicentin-2,2238,246,1.11 [0.89-1.37],0.3576509088978042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",2230,249,1.05 [0.81-1.37],0.722919161136734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",2202,248,1.07 [0.80-1.44],0.6521307760470294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMMR,Hyaluronan mediated motility receptor,2193,246,1.08 [0.85-1.37],0.5152759449654369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMOX1,Heme oxygenase 1,2629,305,0.70 [0.57-0.86],0.0005868280594662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMOX2,Heme oxygenase 2,2581,302,1.12 [0.90-1.40],0.3065813690498479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNF1A,Hepatocyte nuclear factor 1-alpha,2234,253,1.03 [0.88-1.20],0.7293889651981538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNMT,Histamine N-methyltransferase,2628,310,1.01 [0.84-1.23],0.8827303433840404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,2598,303,0.99 [0.86-1.14],0.8818737975553277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,2274,254,1.04 [0.81-1.35],0.737680561375387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HPCAL1,Hippocalcin-like protein 1,2674,311,1.04 [0.90-1.20],0.6040020617647177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HPGDS,Hematopoietic prostaglandin D synthase,2583,300,1.14 [0.88-1.49],0.325777020837666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HPSE,Heparanase,2259,251,0.96 [0.85-1.09],0.5613330818430031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRAS,GTPase Hras,2243,249,0.96 [0.85-1.10],0.574919554336183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,2230,249,1.48 [1.16-1.87],0.0014438078783354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRG,Histidine-rich glycoprotein,2267,252,1.27 [0.88-1.84],0.1968342724074186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS1BP3,HCLS1-binding protein 3,2230,249,1.01 [0.87-1.17],0.889140481447497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,2639,307,1.11 [0.86-1.43],0.4067233767439838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,2668,312,0.88 [0.68-1.15],0.3534877150349976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,2214,250,1.25 [0.92-1.69],0.1462093090448477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSBP1,Heat shock factor-binding protein 1,2230,249,1.15 [1.01-1.31],0.0385890040707661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,2646,311,0.80 [0.63-1.02],0.0666974441297267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,2278,254,1.02 [0.85-1.22],0.8433659670102265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,2202,248,1.07 [0.85-1.34],0.5755382439212546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,2230,249,0.94 [0.72-1.23],0.6757343278311538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSP90B1,Endoplasmin,2569,300,1.00 [0.84-1.19],0.9981174826155388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPA1A,Heat shock 70 kDa protein 1A,2660,309,0.99 [0.85-1.14],0.859631754555778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPA2,Heat shock-related 70 kDa protein 2,2267,249,1.47 [1.07-2.02],0.0180613527228064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPB1,Heat shock protein beta-1,2609,302,0.93 [0.80-1.08],0.3513362893544649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPB6,Heat shock protein beta-6,2668,312,1.66 [1.34-2.07],4.77306155186846e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,2626,304,1.82 [1.36-2.44],6.041942057611679e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HTR1A,5-hydroxytryptamine receptor 1A,2206,248,1.01 [0.87-1.18],0.9151603380152112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HTR1B,5-hydroxytryptamine receptor 1B,2206,248,1.01 [0.76-1.34],0.9586869183055754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HTRA2,"Serine protease HTRA2, mitochondrial",2658,311,0.96 [0.81-1.14],0.653707755898298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYAL1,Hyaluronidase-1,2627,302,1.86 [1.27-2.72],0.0013274566895191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYOU1,Hypoxia up-regulated protein 1,2679,313,1.50 [1.01-2.22],0.0426021672475052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICA1,Islet cell autoantigen 1,2585,303,0.95 [0.83-1.08],0.4380520266804723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM1,Intercellular adhesion molecule 1,2632,306,1.00 [0.73-1.38],0.994258812907722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM2,Intercellular adhesion molecule 2,2679,313,1.37 [1.01-1.85],0.0434348172799718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM3,Intercellular adhesion molecule 3,2679,313,1.30 [0.92-1.84],0.1323184360759274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM4,Intercellular adhesion molecule 4,2646,311,0.93 [0.77-1.13],0.472925105657125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM5,Intercellular adhesion molecule 5,2648,308,1.07 [0.86-1.32],0.5618665223164125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICOSLG,ICOS ligand,2639,307,1.75 [1.06-2.88],0.0284280399202492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ID4,DNA-binding protein inhibitor ID-4,2251,250,1.00 [0.75-1.33],0.990571248157414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,2581,302,1.10 [0.91-1.33],0.3211345856856298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDO1,"Indoleamine 2,3-dioxygenase 1",2230,249,0.90 [0.74-1.10],0.2953446115623586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDS,Iduronate 2-sulfatase,2674,311,0.93 [0.31-2.81],0.9025119390000974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDUA,Alpha-L-iduronidase,2668,312,1.18 [0.95-1.46],0.1326080733020783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,2221,250,1.10 [0.80-1.51],0.5616747085627714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,2251,250,0.99 [0.77-1.26],0.9129357450729948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,2251,250,0.79 [0.56-1.10],0.1657260195265281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNAR1,Interferon alpha/beta receptor 1,2268,253,0.95 [0.58-1.53],0.8207792584752729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNG,Interferon gamma,2585,303,1.10 [1.00-1.22],0.0393347984834297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNGR1,Interferon gamma receptor 1,2665,309,1.95 [1.29-2.96],0.0017004196829086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNGR2,Interferon gamma receptor 2,2634,311,1.02 [0.85-1.22],0.8426790683920304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNL1,Interferon lambda-1,2581,302,1.24 [1.01-1.52],0.0352904819819973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNL2,Interferon lambda-2,2206,248,1.06 [0.88-1.28],0.5116972329244183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNLR1,Interferon lambda receptor 1,2646,311,0.96 [0.72-1.29],0.7895657898845935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNW1,Interferon omega-1,2202,248,1.08 [0.77-1.53],0.6497246541536714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFT20,Intraflagellar transport protein 20 homolog,2234,253,1.27 [0.95-1.69],0.1074577844909924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGBP1,Immunoglobulin-binding protein 1,2274,254,0.97 [0.79-1.19],0.7630024400580923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,2206,248,1.13 [0.89-1.44],0.3145462589669352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,2286,255,1.24 [0.80-1.90],0.3338766193587101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF1R,Insulin-like growth factor 1 receptor,2639,307,2.03 [1.38-3.01],0.0003813813349076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,2202,248,1.24 [0.96-1.61],0.1027412732935037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF2R,Cation-independent mannose-6-phosphate receptor,2661,313,1.22 [0.80-1.86],0.3466392454839192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP1,Insulin-like growth factor-binding protein 1,2677,312,1.10 [1.01-1.19],0.0300526749444168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP2,Insulin-like growth factor-binding protein 2,2674,313,1.40 [1.21-1.61],3.224446668494016e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP3,Insulin-like growth factor-binding protein 3,2655,309,0.66 [0.53-0.83],0.000400378386387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP4,Insulin-like growth factor-binding protein 4,2635,309,1.69 [1.44-1.99],8.369032210723421e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP6,Insulin-like growth factor-binding protein 6,2638,306,1.69 [1.32-2.17],2.831523169070025e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP7,Insulin-like growth factor-binding protein 7,2679,313,1.41 [1.09-1.83],0.0083328028127329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,2648,308,1.40 [1.10-1.78],0.0063762201106331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFL4,Insulin growth factor-like family member 4,2214,250,0.98 [0.83-1.16],0.817445047459972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGHMBP2,DNA-binding protein SMUBP-2,2202,248,1.44 [1.18-1.77],0.0004420486669231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGLC2,Immunoglobulin lambda constant 2,2270,249,1.28 [0.80-2.03],0.2995916083387036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGLON5,IgLON family member 5,2199,248,0.99 [0.86-1.14],0.8753368518545858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF21,Immunoglobulin superfamily member 21,2230,249,0.93 [0.68-1.26],0.6229462153032614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF3,Immunoglobulin superfamily member 3,2639,307,1.19 [0.96-1.49],0.1201624029430158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF8,Immunoglobulin superfamily member 8,2648,308,1.65 [1.27-2.15],0.0001954048222455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF9,Protein turtle homolog A,2273,252,0.88 [0.78-1.00],0.0432670900765931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IKBKG,NF-kappa-B essential modulator,2646,311,0.94 [0.83-1.05],0.2642019140326535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IKZF2,Zinc finger protein Helios,2583,300,0.99 [0.88-1.12],0.8893978731306602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10,Interleukin-10,2585,303,1.11 [0.99-1.24],0.0843678813088178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10RA,Interleukin-10 receptor subunit alpha,2585,303,0.93 [0.76-1.15],0.5237708589637976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10RB,Interleukin-10 receptor subunit beta,2665,309,1.64 [1.22-2.21],0.001174930613399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL11,Interleukin-11,2585,303,1.11 [0.96-1.29],0.1637181144805867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12A_IL12B,Interleukin-12,2639,307,1.20 [1.07-1.34],0.0019772960951536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12B,Interleukin-12 subunit beta,2674,311,1.27 [1.07-1.50],0.0058104955207107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12RB1,Interleukin-12 receptor subunit beta-1,2585,303,1.45 [1.12-1.87],0.0051248036949734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12RB2,Interleukin-12 receptor subunit beta-2,2214,250,1.29 [0.95-1.75],0.0983075292053895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL13,Interleukin-13,2585,303,0.86 [0.67-1.09],0.2181735920179437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,2620,304,0.97 [0.63-1.50],0.9036587304713954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,2206,248,1.00 [0.65-1.55],0.9893632729498892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15,Interleukin-15,2646,311,1.77 [1.34-2.36],7.453757542886562e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15RA,Interleukin-15 receptor subunit alpha,2585,303,1.47 [1.11-1.94],0.0069307797524312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL16,Pro-interleukin-16,2674,311,1.02 [0.81-1.29],0.8619514634848169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17A,Interleukin-17A,2579,302,1.20 [0.99-1.46],0.0693277970878633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17C,Interleukin-17C,2585,303,1.35 [1.22-1.50],7.302774810656445e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17D,Interleukin-17D,2585,303,1.13 [0.89-1.42],0.311039324750942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17F,Interleukin-17F,2585,303,1.15 [1.02-1.31],0.0249236368157986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17RA,Interleukin-17 receptor A,2661,313,1.20 [0.96-1.49],0.1098792113679045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17RB,Interleukin-17 receptor B,2621,308,1.31 [1.08-1.57],0.0049211953314675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18,Interleukin-18,2642,308,1.25 [1.00-1.56],0.0464282552361724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18BP,Interleukin-18-binding protein,2655,309,1.93 [1.46-2.54],3.3299500361537385e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18R1,Interleukin-18 receptor 1,2674,311,1.51 [1.14-2.00],0.0038646158206874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18RAP,Interleukin-18 receptor accessory protein,2621,309,0.98 [0.92-1.04],0.4506173520844367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL19,Interleukin-19,2597,301,1.14 [1.01-1.29],0.0371178879260103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1A,Interleukin-1 alpha,2585,303,1.18 [1.02-1.36],0.0300736549893706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1B,Interleukin-1 beta,2570,302,1.11 [0.94-1.32],0.2314900497410994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R1,Interleukin-1 receptor type 1,2659,313,3.63 [2.58-5.10],1.139675594266247e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R2,Interleukin-1 receptor type 2,2644,308,0.89 [0.57-1.40],0.620845764551991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RAP,Interleukin-1 receptor accessory protein,2661,313,1.07 [0.86-1.32],0.5509552749234674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RL1,Interleukin-1 receptor-like 1,2671,313,1.77 [1.41-2.22],6.910427451638597e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RL2,Interleukin-1 receptor-like 2,2585,303,1.02 [0.78-1.34],0.8798967080463282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RN,Interleukin-1 receptor antagonist protein,2649,309,1.12 [0.95-1.31],0.1661953125220232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2,Interleukin-2,2585,303,1.01 [0.73-1.40],0.954440301431448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL20,Interleukin-20,2585,303,0.97 [0.79-1.19],0.7838265999464423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL20RA,Interleukin-20 receptor subunit alpha,2585,303,1.09 [0.87-1.36],0.4706990034162041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL20RB,Interleukin-20 receptor subunit beta,2214,250,1.00 [0.74-1.35],0.9981889704930772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL21R,Interleukin-21 receptor,2214,250,1.09 [0.90-1.32],0.3651323429661844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL22,Interleukin-22,2267,249,1.16 [0.98-1.37],0.0924203677482482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,2585,303,1.14 [0.91-1.43],0.243821141943043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL24,Interleukin-24,2585,303,0.94 [0.77-1.15],0.5720252322048885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL25,Interleukin-25,2193,247,1.27 [0.88-1.84],0.1988124647262405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RA,Interleukin-2 receptor subunit alpha,2624,305,1.56 [1.26-1.95],6.553004472887461e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RB,Interleukin-2 receptor subunit beta,2585,303,1.16 [0.94-1.44],0.1687303853115515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RG,Cytokine receptor common subunit gamma,2267,249,1.26 [0.93-1.71],0.1383060850292656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL3,Interleukin-3,2199,248,1.14 [0.91-1.41],0.2497150738179416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL31,Interleukin-31,2214,250,1.01 [0.81-1.26],0.9165983969913808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL31RA,Interleukin-31 receptor subunit alpha,2204,249,1.01 [0.74-1.39],0.9488110903258848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL32,Interleukin-32,2646,311,0.99 [0.81-1.20],0.9094353641818562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL33,Interleukin-33,2585,303,1.02 [0.78-1.33],0.8765913454419978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL34,Interleukin-34,2577,302,0.97 [0.74-1.28],0.8267992760384175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL36A,Interleukin-36 alpha,2214,250,1.01 [0.81-1.26],0.9509135518149634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL36G,Interleukin-36 gamma,2209,250,1.12 [0.95-1.32],0.1938411113419764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL3RA,Interleukin-3 receptor subunit alpha,2585,303,1.18 [0.87-1.59],0.2808998913475002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL4,Interleukin-4,2585,303,1.08 [0.97-1.21],0.1545304741247785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL4R,Interleukin-4 receptor subunit alpha,2646,311,1.56 [1.23-1.98],0.0002212876046151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL5,Interleukin-5,2585,303,0.99 [0.91-1.07],0.7630218406003529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL5RA,Interleukin-5 receptor subunit alpha,2646,311,1.21 [1.02-1.43],0.0261035362728586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6,Interleukin-6,2639,307,0.95 [0.83-1.09],0.4741548582537854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6R,Interleukin-6 receptor subunit alpha,2630,305,1.37 [1.03-1.83],0.0314398241904087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6ST,Interleukin-6 receptor subunit beta,2648,308,2.21 [1.30-3.74],0.0032464933360306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL7,Interleukin-7,2646,311,0.92 [0.78-1.08],0.3139797764668186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL7R,Interleukin-7 receptor subunit alpha,2661,313,1.07 [0.89-1.30],0.4702149893116161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL9,Interleukin-9,2251,250,1.00 [0.81-1.23],0.99114786522004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,2575,302,1.15 [0.96-1.37],0.124376725006776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMMT,MICOS complex subunit MIC60,2267,249,1.23 [0.97-1.55],0.0822100454210818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPA1,Inositol monophosphatase 1,2634,311,0.95 [0.80-1.13],0.5486931364742363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPACT,Protein IMPACT,2278,254,0.90 [0.72-1.12],0.3506611076377743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,2206,248,1.27 [0.84-1.92],0.2599049027032105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ING1,Inhibitor of growth protein 1,2578,301,0.92 [0.74-1.15],0.4627302774795579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INHBB,Inhibin beta B chain,2242,246,1.21 [0.98-1.49],0.0718816669769682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INHBC,Inhibin beta C chain,2661,313,1.03 [0.79-1.33],0.841028275592338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP1,Inositol polyphosphate 1-phosphatase,2639,307,1.03 [0.85-1.25],0.7616311760607885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",2230,249,0.92 [0.74-1.15],0.490223857006515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",2274,254,1.19 [0.91-1.57],0.2008459000424169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",2639,307,1.00 [0.90-1.11],0.9324611442595238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL3,Insulin-like 3,2278,254,0.96 [0.83-1.10],0.5644073987797613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL4,Early placenta insulin-like peptide,2267,249,1.42 [1.14-1.76],0.0017862678377629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL5,Insulin-like peptide INSL5,2268,253,1.15 [1.02-1.29],0.0183735295753106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSR,Insulin receptor,2214,250,1.71 [0.86-3.40],0.1293260366977247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,2633,311,1.02 [0.91-1.15],0.7303516351751425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,2639,307,1.03 [0.86-1.23],0.76873657940808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",2603,303,0.98 [0.87-1.10],0.7489938405488883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IRAK1,Interleukin-1 receptor-associated kinase 1,2585,303,1.03 [0.88-1.20],0.7038752300620763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IRAK4,Interleukin-1 receptor-associated kinase 4,2646,311,0.98 [0.89-1.08],0.6642274499848393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,2549,295,1.12 [0.86-1.46],0.4083026627361664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ISM1,Isthmin-1,2646,311,0.91 [0.71-1.16],0.434088677534862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ISM2,Isthmin-2,2286,255,1.11 [0.84-1.47],0.4537204972630329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IST1,IST1 homolog,2251,251,1.01 [0.89-1.15],0.8657772410729567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA11,Integrin alpha-11,2646,311,0.86 [0.65-1.12],0.2631071458483398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA2,Integrin alpha-2,2242,246,0.87 [0.62-1.22],0.4275218839840293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA5,Integrin alpha-5,2661,313,1.01 [0.70-1.46],0.9458592388667229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA6,Integrin alpha-6,2646,311,0.79 [0.64-0.98],0.0333774281878596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAL,Integrin alpha-L,2214,250,1.07 [0.81-1.41],0.6358382515689819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAM,Integrin alpha-M,2661,313,1.31 [0.98-1.74],0.0678352977609259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAV,Integrin alpha-V,2668,312,0.95 [0.54-1.67],0.8581641336491052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAX,Integrin alpha-X,2251,250,1.13 [0.90-1.42],0.3055186411054157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB1,Integrin beta-1,2643,309,1.03 [0.66-1.59],0.9122219830064136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB1BP1,Integrin beta-1-binding protein 1,2583,300,1.08 [0.85-1.38],0.5337879836725165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB1BP2,Integrin beta-1-binding protein 2,2603,303,1.01 [0.92-1.11],0.8662159765964454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB2,Integrin beta-2,2638,309,1.40 [1.02-1.92],0.0348384716837919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB5,Integrin beta-5,2658,311,1.14 [0.90-1.45],0.2766660766084995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB6,Integrin beta-6,2585,303,2.09 [1.52-2.87],5.980267652584476e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB7,Integrin beta-7,2668,312,1.43 [1.17-1.74],0.0003913920354603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGBL1,Integrin beta-like protein 1,2286,255,1.41 [1.14-1.75],0.0016372124475283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,2278,252,0.82 [0.43-1.54],0.5312013241264624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,2655,309,1.70 [1.31-2.22],8.54402811377976e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,2278,252,0.71 [0.44-1.15],0.1588668380084693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,2267,249,1.10 [0.84-1.45],0.4879562524224375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITM2A,Integral membrane protein 2A,2646,311,1.07 [0.91-1.25],0.4448891816328407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITPA,Inosine triphosphate pyrophosphatase,2202,248,0.97 [0.81-1.17],0.7610450272575097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",2230,249,1.08 [0.91-1.29],0.3694752482728873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",2206,248,1.19 [0.90-1.56],0.2139103647297214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",2581,302,1.08 [0.89-1.31],0.4581616097314214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IZUMO1,Izumo sperm-egg fusion protein 1,2199,248,1.03 [0.79-1.33],0.8493649112714614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM2,Junctional adhesion molecule B,2673,312,2.86 [2.16-3.80],3.3098962363715337e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM3,Junctional adhesion molecule C,2242,246,1.16 [0.93-1.43],0.182457573739297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JCHAIN,Immunoglobulin J chain,2585,303,1.18 [1.00-1.39],0.0476437105015618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,2199,248,1.07 [0.85-1.33],0.5674574794471298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JPT2,Jupiter microtubule associated homolog 2,2268,253,1.00 [0.86-1.16],0.9840957755217558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JUN,Transcription factor AP-1,2585,303,1.13 [0.94-1.34],0.1918655617534884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,2639,307,1.22 [0.98-1.51],0.079348225951562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KAZN,Kazrin,2268,253,0.98 [0.86-1.10],0.6816951536419911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,2206,248,0.97 [0.77-1.23],0.811678775472998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,2234,253,1.04 [0.90-1.21],0.5808729605752685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCNIP4,Kv channel-interacting protein 4,2581,302,1.07 [0.89-1.29],0.4619860322672636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCTD5,BTB/POZ domain-containing protein KCTD5,2233,249,0.97 [0.74-1.29],0.841705349702552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KDM3A,Lysine-specific demethylase 3A,2214,250,1.06 [0.92-1.23],0.3871597030159461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KDR,Vascular endothelial growth factor receptor 2,2658,311,0.65 [0.44-0.97],0.0343391304252358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KEL,Kell blood group glycoprotein,2581,302,1.14 [0.87-1.50],0.3445169187332559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KHDC3L,KH domain-containing protein 3,2199,248,1.03 [0.86-1.22],0.7626024854500302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KHK,Ketohexokinase,2230,249,0.85 [0.70-1.03],0.1000266923169219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA0319,Dyslexia-associated protein KIAA0319,2278,254,1.20 [0.81-1.78],0.3644996760817413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA1549,UPF0606 protein KIAA1549,2251,250,1.01 [0.85-1.20],0.901324701114848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA1549L,UPF0606 protein KIAA1549L,2251,250,1.00 [0.64-1.55],0.9888914642230032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA2013,Uncharacterized protein KIAA2013,2267,249,1.05 [0.83-1.33],0.6711726503455391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF1C,Kinesin-like protein KIF1C,2202,248,1.63 [1.19-2.23],0.0024886230686265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF20B,Kinesin-like protein KIF20B,2206,248,0.99 [0.85-1.16],0.9402548393447488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF22,Kinesin-like protein KIF22,2202,248,1.01 [0.91-1.11],0.9135836852177468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIFBP,KIF-binding protein,2639,307,1.01 [0.90-1.14],0.8516006131154484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,2267,249,1.03 [0.91-1.17],0.6419361983564642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,2583,300,1.02 [0.90-1.15],0.7623024557185456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,2268,253,1.01 [0.95-1.09],0.7175111559478464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,2583,300,1.04 [0.96-1.12],0.370953136416447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,2199,248,0.96 [0.81-1.13],0.6028480394065353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIRREL1,Kin of IRRE-like protein 1,2206,248,1.20 [0.99-1.46],0.0652807558002329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIRREL2,Kin of IRRE-like protein 2,2581,302,1.09 [0.85-1.40],0.481791721251097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIT,Mast/stem cell growth factor receptor Kit,2653,308,1.23 [0.89-1.69],0.2160798018045125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KITLG,Kit ligand,2648,308,1.43 [1.12-1.83],0.0042716282098017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLB,Beta-klotho,2581,302,1.26 [1.11-1.44],0.0003220038035344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLF4,Krueppel-like factor 4,2206,248,1.10 [0.81-1.50],0.5527219840449509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLHL41,Kelch-like protein 41,2274,254,1.32 [1.07-1.64],0.0102536430014158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK1,Kallikrein-1,2625,306,0.94 [0.86-1.02],0.1228670767717492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK10,Kallikrein-10,2649,310,1.06 [0.83-1.36],0.6563536082740025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK11,Kallikrein-11,2630,309,1.78 [1.34-2.37],7.546173818263179e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK12,Kallikrein-12,2583,300,1.06 [0.99-1.15],0.0990883636582805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK13,Kallikrein-13,2593,302,0.89 [0.73-1.09],0.2539338162568626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK14,Kallikrein-14,2668,312,0.92 [0.74-1.14],0.429547772974031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK15,Kallikrein-15,2262,249,1.08 [0.84-1.37],0.5569497405173152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK3,Prostate-specific antigen,2286,255,0.92 [0.82-1.03],0.1637555151076271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK4,Kallikrein-4,2668,312,1.69 [1.50-1.91],3.226845388031793e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK6,Kallikrein-6,2653,310,1.10 [0.82-1.47],0.5301844192978039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK7,Kallikrein-7,2180,241,0.73 [0.53-1.02],0.0648818985146211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK8,Kallikrein-8,2561,300,1.16 [0.90-1.51],0.2573063032860224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLKB1,Plasma kallikrein,2234,250,0.69 [0.42-1.14],0.1499857938470125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,2674,311,2.19 [1.78-2.71],2.323886828323934e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,2206,248,0.97 [0.79-1.19],0.7535912455899094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRD1,Natural killer cells antigen CD94,2674,311,1.35 [1.10-1.66],0.0043419722199586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,2214,250,1.10 [0.89-1.35],0.3888863857537012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRK1,NKG2-D type II integral membrane protein,2278,254,1.59 [1.22-2.07],0.0005184444350023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT14,"Keratin, type I cytoskeletal 14",2510,295,1.24 [0.90-1.72],0.1928214510911925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT17,"Keratin, type I cytoskeletal 17",2202,248,1.09 [0.81-1.48],0.5664990673422717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT18,"Keratin, type I cytoskeletal 18",2639,307,1.02 [0.92-1.13],0.7089539315485738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT19,"Keratin, type I cytoskeletal 19",2641,310,1.46 [1.30-1.65],4.919703531197085e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT5,"Keratin, type II cytoskeletal 5",2581,302,1.01 [0.83-1.22],0.9331132237555464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT6C,"Keratin, type II cytoskeletal 6C",2202,248,1.24 [0.94-1.62],0.1267494441236681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT8,"Keratin, type II cytoskeletal 8",2206,248,1.06 [0.98-1.16],0.150150942672231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,2645,308,0.87 [0.73-1.05],0.1424924599068698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KYNU,Kynureninase,2674,311,0.77 [0.63-0.94],0.0103483974832516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,L1CAM,Neural cell adhesion molecule L1,2658,311,0.97 [0.71-1.34],0.8618885612361127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,2273,252,0.96 [0.84-1.11],0.6066253315366841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LACRT,Extracellular glycoprotein lacritin,2259,248,0.80 [0.59-1.08],0.1406500340743309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LACTB2,Endoribonuclease LACTB2,2648,308,0.96 [0.82-1.13],0.64008160219272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAG3,Lymphocyte activation gene 3 protein,2639,307,1.64 [1.33-2.03],4.802814702379181e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,2649,308,1.70 [1.43-2.04],4.572811524200278e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,2634,311,1.03 [0.94-1.13],0.5606951075576936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMA1,Laminin subunit alpha-1,2202,248,0.86 [0.65-1.13],0.2842974267892223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMA4,Laminin subunit alpha-4,2665,309,1.01 [0.76-1.35],0.9238899819849048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMB1,Laminin subunit beta-1,2230,249,1.57 [1.07-2.30],0.0218356126944247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMP1,Lysosome-associated membrane glycoprotein 1,2227,249,1.05 [0.66-1.69],0.8274284304303801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMP2,Lysosome-associated membrane glycoprotein 2,2587,297,0.76 [0.46-1.27],0.292640187181585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMP3,Lysosome-associated membrane glycoprotein 3,2669,311,1.16 [0.97-1.39],0.1124148389848189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMTOR5,Ragulator complex protein LAMTOR5,2267,249,0.70 [0.49-0.99],0.0443626171537006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAP3,Cytosol aminopeptidase,2585,303,0.87 [0.70-1.09],0.2383917886532274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LARP1,La-related protein 1,2267,249,1.04 [0.85-1.28],0.6719655442802289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAT,Linker for activation of T-cells family member 1,2674,311,0.99 [0.86-1.13],0.8291668838736519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAT2,Linker for activation of T-cells family member 2,2639,307,1.01 [0.93-1.10],0.7588613358696488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LATS1,Serine/threonine-protein kinase LATS1,2214,250,1.07 [0.93-1.24],0.3502101246299038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAYN,Layilin,2631,310,2.32 [1.90-2.84],1.954457051086107e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LBP,Lipopolysaccharide-binding protein,2655,309,1.08 [0.91-1.29],0.3874550827087761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LBR,Delta(14)-sterol reductase LBR,2673,312,1.09 [0.95-1.24],0.2391173319205962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCAT,Phosphatidylcholine-sterol acyltransferase,2287,256,0.79 [0.46-1.38],0.4122429235972487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN15,Lipocalin-15,2274,254,1.31 [1.13-1.52],0.000280105749321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN2,Neutrophil gelatinase-associated lipocalin,2564,302,1.35 [1.08-1.68],0.0088165234218044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCP1,Plastin-2,2286,255,0.79 [0.61-1.02],0.068239175206109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LDLR,Low-density lipoprotein receptor,2657,309,0.78 [0.64-0.95],0.0125446559915696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,2274,254,1.04 [0.92-1.18],0.565464635056263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LECT2,Leukocyte cell-derived chemotaxin-2,2273,252,0.97 [0.82-1.16],0.7474018765249291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEFTY2,Left-right determination factor 2,2663,312,1.16 [0.96-1.39],0.1318747458972415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEG1,Protein LEG1 homolog,2174,239,0.93 [0.78-1.11],0.4280781466751677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LELP1,Late cornified envelope-like proline-rich protein 1,2206,248,0.92 [0.76-1.11],0.3823413017211683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEO1,RNA polymerase-associated protein LEO1,2274,254,1.11 [0.81-1.52],0.5001960399952616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEP,Leptin,2648,308,0.88 [0.75-1.03],0.1151152679775574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEPR,Leptin receptor,2648,308,1.54 [1.13-2.10],0.0066225133041042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LETM1,Mitochondrial proton/calcium exchanger protein,2274,254,1.32 [1.05-1.65],0.0179212811897191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS1,Galectin-1,2648,308,1.49 [1.13-1.96],0.004364418908497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS3,Galectin-3,2646,308,1.73 [1.25-2.39],0.0008502913593964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS3BP,Galectin-3-binding protein,2278,252,0.99 [0.68-1.43],0.9409500182612502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS4,Galectin-4,2649,308,1.69 [1.45-1.97],1.1259584323825648e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS7_LGALS7B,Galectin-7,2638,309,1.33 [1.07-1.65],0.009108921150122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS8,Galectin-8,2673,312,1.07 [0.90-1.27],0.4529368686954399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS9,Galectin-9,2652,308,1.40 [1.04-1.90],0.0277054551139964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGMN,Legumain,2665,309,1.20 [0.92-1.58],0.1868034827540892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LHB,Lutropin subunit beta,2583,300,1.08 [0.97-1.22],0.161367326690562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,2657,309,0.91 [0.77-1.08],0.269119850812599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIF,Leukemia inhibitory factor,2581,302,1.18 [0.96-1.46],0.1143286637804828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIFR,Leukemia inhibitory factor receptor,2646,311,3.09 [2.21-4.32],4.8337116255887955e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,2661,313,0.88 [0.67-1.15],0.3542967696260249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,2286,255,1.04 [0.95-1.13],0.4452375500644553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,2202,248,1.05 [0.84-1.33],0.6518886189939991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,2647,307,1.33 [0.98-1.81],0.0661477749566572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,2273,252,1.14 [0.97-1.33],0.1138151928982866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,2679,313,1.06 [0.75-1.50],0.7424434132865431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,2666,313,1.31 [0.99-1.73],0.0595920900155429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,2585,303,1.21 [0.98-1.49],0.0827856577498774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,2679,313,1.04 [0.90-1.20],0.585962641731756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIPF,Gastric triacylglycerol lipase,2230,249,1.03 [0.86-1.22],0.755344412949163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMNB1,Lamin-B1,2266,253,0.87 [0.72-1.06],0.156094888673701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMNB2,Lamin-B2,2278,254,1.35 [0.89-2.04],0.1606963356861515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMOD1,Leiomodin-1,2274,254,2.14 [1.57-2.91],1.2343779948674397e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMOD2,Leiomodin-2,2206,248,0.90 [0.72-1.12],0.3579837899748053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LONP1,"Lon protease homolog, mitochondrial",2230,249,1.00 [0.87-1.16],0.9489841547525047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPA,Apolipoprotein(a),2222,245,1.04 [0.98-1.11],0.1992151270215563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,2639,307,1.10 [0.91-1.34],0.3269379707245261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPL,Lipoprotein lipase,2648,308,1.04 [0.84-1.29],0.6880957168711729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPO,Lactoperoxidase,2565,306,1.22 [1.04-1.41],0.0118363592728765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPP,Lipoma-preferred partner,2202,248,1.05 [0.87-1.27],0.6143626401614387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,2202,248,0.96 [0.79-1.16],0.6389961236527921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,2234,253,1.08 [0.83-1.40],0.5766224965505318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRG1,Leucine-rich alpha-2-glycoprotein,2278,252,1.14 [0.72-1.80],0.5837165319195122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,2662,312,1.41 [1.08-1.84],0.0118683696254839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,2208,248,1.34 [0.92-1.97],0.1287033831054632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,2639,307,1.11 [0.77-1.58],0.5850295263590723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP11,Low-density lipoprotein receptor-related protein 11,2648,308,1.52 [1.19-1.94],0.0008236063876118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP2,Low-density lipoprotein receptor-related protein 2,2234,253,1.26 [0.91-1.74],0.1606525942459043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP2BP,LRP2-binding protein,2234,253,1.10 [0.96-1.25],0.1682220486280461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,2673,312,0.92 [0.76-1.11],0.3823478665043266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC25,Leucine-rich repeat-containing protein 25,2639,307,1.15 [0.93-1.44],0.2049241709857235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,2268,253,0.97 [0.73-1.28],0.8159270509625857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC38,Leucine-rich repeat-containing protein 38,2234,253,1.12 [0.87-1.44],0.374566985682444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC59,Leucine-rich repeat-containing protein 59,2273,252,1.06 [0.83-1.36],0.6299089191981249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,2267,249,0.88 [0.68-1.15],0.3476195148444868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRN1,Leucine-rich repeat neuronal protein 1,2585,303,0.82 [0.65-1.05],0.1174872139674631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,2234,253,1.32 [1.05-1.67],0.0173366801590547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,2274,254,0.65 [0.40-1.06],0.083053918249636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,2583,300,0.96 [0.80-1.16],0.6983815803543756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,2251,250,1.07 [0.95-1.21],0.2559873275835538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LSP1,Lymphocyte-specific protein 1,2646,311,0.92 [0.71-1.19],0.5231896515377332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTA,Lymphotoxin-alpha,2646,311,1.01 [0.78-1.30],0.9658835462831294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTA4H,Leukotriene A-4 hydrolase,2668,312,1.03 [0.87-1.22],0.7172609763841562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTB,Lymphotoxin-beta,2267,249,1.07 [0.75-1.52],0.7030517122861732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,2679,313,1.96 [1.49-2.59],1.4722200109916226e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,2583,300,1.17 [0.99-1.39],0.066661511527074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBR,Tumor necrosis factor receptor superfamily member 3,2636,308,1.64 [1.22-2.19],0.000988665737468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTO1,Protein LTO1 homolog,2585,303,1.08 [0.84-1.39],0.544802472603876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LUZP2,Leucine zipper protein 2,2267,249,1.10 [0.87-1.38],0.4244168966592712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LXN,Latexin,2617,310,0.90 [0.78-1.05],0.1825937782344457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY6D,Lymphocyte antigen 6D,2642,307,1.52 [1.24-1.87],6.009346578397306e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY75,Lymphocyte antigen 75,2646,311,1.20 [0.94-1.54],0.150546578884832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY9,T-lymphocyte surface antigen Ly-9,2617,304,1.58 [1.16-2.15],0.0034748105463802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY96,Lymphocyte antigen 96,2634,311,1.18 [0.90-1.56],0.2336384275720338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYAR,Cell growth-regulating nucleolar protein,2583,300,0.93 [0.74-1.16],0.50385644396461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYN,Tyrosine-protein kinase Lyn,2639,307,1.00 [0.88-1.12],0.9565886778865184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD1,Ly6/PLAUR domain-containing protein 1,2581,302,0.95 [0.79-1.15],0.6080992879663568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD3,Ly6/PLAUR domain-containing protein 3,2632,310,1.17 [0.89-1.55],0.2556549367400912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD8,Ly6/PLAUR domain-containing protein 8,2583,300,1.18 [1.03-1.36],0.0178211179141475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPLA2,Acyl-protein thioesterase 2,2206,248,0.96 [0.85-1.08],0.5119388348188743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,2234,253,0.93 [0.82-1.05],0.2619198699595676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,2278,252,1.62 [0.89-2.97],0.1155746861060567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYZL2,Lysozyme-like protein 2,2199,248,1.27 [0.90-1.79],0.1807486269382775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LZTFL1,Leucine zipper transcription factor-like protein 1,2242,246,0.97 [0.81-1.17],0.7640676603346699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,M6PR,Cation-dependent mannose-6-phosphate receptor,2230,249,0.83 [0.60-1.15],0.2722095801902837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,2622,310,1.09 [0.90-1.32],0.362893427135858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAEA,E3 ubiquitin-protein transferase MAEA,2583,300,0.86 [0.65-1.14],0.2873229960535217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAG,Myelin-associated glycoprotein,2234,253,0.78 [0.61-1.01],0.0615093859490482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAGEA3,Melanoma-associated antigen 3,2251,250,1.09 [0.94-1.26],0.2496864663010433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAGED1,Melanoma-associated antigen D1,2583,300,1.00 [0.81-1.22],0.9688166481924474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAMDC2,MAM domain-containing protein 2,2273,252,1.91 [1.41-2.57],2.603704912681392e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAMDC4,Apical endosomal glycoprotein,2267,249,0.98 [0.79-1.21],0.8430090234938847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",2230,249,1.11 [0.69-1.81],0.6608662103510906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAN2B2,Epididymis-specific alpha-mannosidase,2273,252,0.86 [0.70-1.04],0.1178660104952313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",2199,248,0.94 [0.73-1.21],0.6483259667744712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,2665,309,0.98 [0.90-1.07],0.655932104335097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANSC1,MANSC domain-containing protein 1,2658,311,1.51 [1.07-2.11],0.0177929743567624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANSC4,MANSC domain-containing protein 4,2202,248,0.94 [0.79-1.11],0.4696082145083824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,2206,248,0.84 [0.56-1.25],0.3826011329772441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,2202,248,0.95 [0.78-1.16],0.6291897647326721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP2,Microtubule-associated protein 2,2278,254,1.10 [0.85-1.43],0.449155219969556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,2268,253,0.94 [0.77-1.15],0.5748105174877154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,2646,311,1.01 [0.91-1.12],0.9219745951516192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,2583,300,0.92 [0.82-1.03],0.127390303851554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,2631,310,0.99 [0.91-1.09],0.9136758499400472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPK13,Mitogen-activated protein kinase 13,2199,248,1.10 [0.85-1.43],0.4618470350117994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPK9,Mitogen-activated protein kinase 9,2646,311,0.89 [0.70-1.12],0.3045057331531652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPKAPK2,MAP kinase-activated protein kinase 2,2251,250,0.97 [0.81-1.15],0.686290996395505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,2199,248,1.07 [0.99-1.15],0.1109767981823799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPT,Microtubule-associated protein tau,2581,302,1.25 [1.03-1.52],0.022464784822847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MARCO,Macrophage receptor MARCO,2648,308,1.11 [0.76-1.60],0.596595282547379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",2241,246,0.97 [0.83-1.13],0.6768765921367215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MASP1,Mannan-binding lectin serine protease 1,2631,310,0.72 [0.48-1.10],0.1286282407519697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MATN2,Matrilin-2,2656,308,0.88 [0.63-1.22],0.4398016009065504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MATN3,Matrilin-3,2633,311,0.79 [0.58-1.07],0.1329793949130641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAVS,Mitochondrial antiviral-signaling protein,2583,300,1.00 [0.89-1.12],0.9850378176590872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAX,Protein max,2581,302,0.98 [0.89-1.08],0.7105432637997212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MB,Myoglobin,2679,313,1.17 [0.99-1.37],0.0691433691302824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MBL2,Mannose-binding protein C,2242,246,0.98 [0.88-1.10],0.7614567376749753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCAM,Cell surface glycoprotein MUC18,2655,309,1.75 [1.36-2.25],1.4130779520996269e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",2274,254,0.93 [0.69-1.26],0.6527910584002861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCEMP1,Mast cell-expressed membrane protein 1,2214,250,1.06 [0.92-1.22],0.4030942975658134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCFD2,Multiple coagulation factor deficiency protein 2,2637,305,1.17 [0.93-1.47],0.1852126696456674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCTS1,Malignant T-cell-amplified sequence 1,2268,253,1.05 [0.67-1.63],0.8379782835743188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,2634,311,1.09 [0.95-1.24],0.2337847749954425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDH1,"Malate dehydrogenase, cytoplasmic",2276,255,0.97 [0.71-1.33],0.8491740358073909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDK,Midkine,2651,310,1.42 [1.21-1.67],2.354738995830456e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDM1,Nuclear protein MDM1,2234,253,1.31 [0.87-1.97],0.1987360142963631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",2230,249,1.00 [0.87-1.14],0.9660418644981288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MED18,Mediator of RNA polymerase II transcription subunit 18,2583,300,1.02 [0.89-1.18],0.7383794412694232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MED21,Mediator of RNA polymerase II transcription subunit 21,2202,248,1.04 [0.81-1.34],0.7656835708440857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,2649,308,1.01 [0.79-1.30],0.9129729117570452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,2202,248,1.11 [0.75-1.66],0.5914187565550983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,2671,313,0.83 [0.51-1.35],0.4537077860698156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MELTF,Melanotransferrin,2273,252,1.26 [0.85-1.86],0.2433141765232864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MENT,Protein MENT,2242,246,0.75 [0.46-1.24],0.2613394529275538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEP1A,Meprin A subunit alpha,2268,253,1.04 [0.88-1.22],0.6534719162774372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEP1B,Meprin A subunit beta,2648,308,0.91 [0.84-0.99],0.0279815903157033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEPE,Matrix extracellular phosphoglycoprotein,2649,308,0.56 [0.40-0.79],0.000852738826198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MERTK,Tyrosine-protein kinase Mer,2674,311,1.52 [1.06-2.19],0.0241278599923912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MESD,LRP chaperone MESD,2661,313,0.99 [0.91-1.08],0.8247045675024534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MET,Hepatocyte growth factor receptor,2659,309,1.24 [0.78-1.98],0.3628559668895919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,METAP1,Methionine aminopeptidase 1,2581,302,1.05 [0.74-1.49],0.7741265631787926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",2646,311,0.94 [0.83-1.07],0.3406169250821148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,METAP2,Methionine aminopeptidase 2,2663,312,1.02 [0.84-1.24],0.8266550039863845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP3,Microfibril-associated glycoprotein 3,2603,303,0.92 [0.74-1.14],0.4464359875006842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP3L,Microfibrillar-associated protein 3-like,2234,253,0.88 [0.71-1.08],0.2288816012639193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP4,Microfibril-associated glycoprotein 4,2242,246,1.61 [1.13-2.30],0.0086440556530121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP5,Microfibrillar-associated protein 5,2679,313,1.16 [0.92-1.46],0.2116023569043539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFGE8,Lactadherin,2661,313,1.40 [1.15-1.71],0.0007365453132642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MGLL,Monoglyceride lipase,2660,308,0.95 [0.84-1.07],0.3754218204326924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,2646,311,0.97 [0.89-1.05],0.4317681636912794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MIA,Melanoma-derived growth regulatory protein,2658,311,0.93 [0.72-1.20],0.5753720193251977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MICALL2,MICAL-like protein 2,2234,253,1.12 [0.94-1.33],0.2172535374907338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,2646,311,1.16 [1.07-1.26],0.0002824879701194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MIF,Macrophage migration inhibitory factor,2656,312,0.93 [0.80-1.08],0.341574484924746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MILR1,Allergin-1,2585,303,1.33 [1.10-1.61],0.0029505059481056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,2267,249,0.95 [0.84-1.06],0.3530383097018419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MINK1,Misshapen-like kinase 1,2278,254,1.00 [0.87-1.15],0.9820256618891944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MITD1,MIT domain-containing protein 1,2634,311,0.99 [0.89-1.10],0.825819998716522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MKI67,Proliferation marker protein Ki-67,2214,250,0.99 [0.71-1.38],0.9597041262739404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MLLT1,Protein ENL,2199,248,0.98 [0.80-1.18],0.7998505510478615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MLN,Promotilin,2646,311,1.07 [0.96-1.20],0.2365161095269611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MME,Neprilysin,2639,307,1.00 [0.89-1.12],0.9800716908101772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP1,Interstitial collagenase,2551,302,1.22 [1.08-1.37],0.0008687481802609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP10,Stromelysin-2,2648,308,1.26 [1.07-1.49],0.0051446388237716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP12,Macrophage metalloelastase,2652,311,1.44 [1.22-1.71],2.5116683380495064e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP13,Collagenase 3,2581,302,1.51 [1.12-2.03],0.0069060631779805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP15,Matrix metalloproteinase-15,2273,252,1.24 [1.03-1.50],0.0254694064038647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP3,Stromelysin-1,2661,313,1.33 [1.12-1.59],0.0015516489314301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP7,Matrilysin,2599,303,1.67 [1.36-2.04],8.311092314577692e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP8,Neutrophil collagenase,2670,312,1.07 [0.94-1.22],0.3250924617746776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP9,Matrix metalloproteinase-9,2659,313,1.05 [0.89-1.24],0.5561851248937527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",2202,248,1.00 [0.77-1.30],0.9943418363823868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MN1,Transcriptional activator MN1,2234,253,0.89 [0.71-1.11],0.2990025736746499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MNAT1,CDK-activating kinase assembly factor MAT1,2251,250,1.00 [0.75-1.33],0.9903336965643204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MNDA,Myeloid cell nuclear differentiation antigen,2645,308,0.92 [0.83-1.03],0.1416035194078115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MOCS2,Molybdopterin synthase catalytic subunit,2242,246,0.95 [0.78-1.15],0.613579961930784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MOG,Myelin-oligodendrocyte glycoprotein,2668,312,1.11 [0.85-1.44],0.4562055158580813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORC3,MORC family CW-type zinc finger protein 3,2278,254,1.22 [0.81-1.82],0.3372930062288344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORF4L1,Mortality factor 4-like protein 1,2251,250,0.66 [0.46-0.95],0.0265081982235515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORF4L2,Mortality factor 4-like protein 2,2199,248,1.26 [0.92-1.72],0.150324349097477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORN4,MORN repeat-containing protein 4,2199,248,0.94 [0.80-1.09],0.4014307018276724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPHOSPH8,M-phase phosphoprotein 8,2603,303,1.02 [0.88-1.17],0.8297282269639049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPI,Mannose-6-phosphate isomerase,2639,307,1.04 [0.92-1.18],0.5060890259039663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,2660,308,0.95 [0.83-1.09],0.4648239391251297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPO,Myeloperoxidase,2661,313,0.91 [0.73-1.13],0.3920445342675356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPRIP,Myosin phosphatase Rho-interacting protein,2263,249,0.71 [0.53-0.95],0.0216454674488659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRC1,Macrophage mannose receptor 1,2287,256,2.07 [1.41-3.02],0.0001774410754161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRI1,Methylthioribose-1-phosphate isomerase,2234,253,0.97 [0.82-1.15],0.7307377927830452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL24,"39S ribosomal protein L24, mitochondrial",2202,248,0.80 [0.56-1.14],0.2074916238230262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL28,"39S ribosomal protein L28, mitochondrial",2274,254,1.19 [0.88-1.63],0.2637367496013527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL46,"39S ribosomal protein L46, mitochondrial",2581,302,0.85 [0.58-1.23],0.3832194561373013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL52,"39S ribosomal protein L52, mitochondrial",2193,246,1.00 [0.63-1.58],0.9959987986892116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",2274,254,0.93 [0.78-1.12],0.4549540325616451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPS16,"28S ribosomal protein S16, mitochondrial",2214,250,0.87 [0.54-1.39],0.5537377182904908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSLN,Mesothelin,2629,304,1.13 [0.97-1.32],0.1197553454420505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSLNL,Mesothelin-like protein,2234,253,1.06 [0.76-1.49],0.7286269830851908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSMB,Beta-microseminoprotein,2642,305,1.11 [0.97-1.27],0.1301804910017314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSR1,Macrophage scavenger receptor types I and II,2673,312,1.61 [1.30-2.00],1.2561939686813212e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,2658,311,0.98 [0.85-1.14],0.8295220402448222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MST1,Hepatocyte growth factor-like protein,2254,255,1.13 [0.92-1.39],0.2326014547776152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSTN,Growth/differentiation factor 8,2603,303,1.07 [0.88-1.29],0.4930502110817785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTDH,Protein LYRIC,2214,250,1.10 [0.97-1.25],0.145162239896941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",2278,254,1.35 [0.89-2.03],0.1539199932222171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,2251,250,1.00 [0.90-1.12],0.9535581836844363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",2268,253,1.02 [0.89-1.17],0.8157642193241321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTPN,Myotrophin,2603,303,0.78 [0.54-1.12],0.1774699520430642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTR,Methionine synthase,2202,248,0.92 [0.75-1.12],0.4006599358597223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTSS1,Protein MTSS 1,2268,253,0.95 [0.85-1.07],0.4103515534719275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTSS2,Protein MTSS 2,2267,249,1.03 [0.91-1.17],0.6258437940934575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTUS1,Microtubule-associated tumor suppressor 1,2251,250,0.89 [0.71-1.10],0.2744606831733675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC13,Mucin-13,2581,302,1.77 [1.55-2.03],1.3947662626614018e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC16,Mucin-16,2639,307,1.02 [0.96-1.08],0.546455629372335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC2,Mucin-2,2286,255,1.05 [0.92-1.18],0.4863265664837048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUCL3,Mucin-like protein 3,2199,248,1.05 [0.81-1.38],0.6951083564591556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MVK,Mevalonate kinase,2585,303,1.01 [0.90-1.13],0.9272666814841956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MXRA8,Matrix remodeling-associated protein 8,2242,246,0.80 [0.54-1.18],0.2674643561807758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYBPC1,"Myosin-binding protein C, slow-type",2273,252,1.21 [1.04-1.40],0.0145799479909773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYBPC2,"Myosin-binding protein C, fast-type",2230,249,1.12 [0.99-1.28],0.0668345880368252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,2274,254,0.88 [0.73-1.07],0.1974319111212271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYDGF,Myeloid-derived growth factor,2273,252,0.98 [0.86-1.12],0.8131706590862304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYH4,Myosin-4,2202,248,0.95 [0.72-1.26],0.7436826268765651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYH7B,Myosin-7B,2199,248,1.20 [0.92-1.56],0.1805128044890998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYH9,Myosin-9,2286,255,0.98 [0.88-1.09],0.7131885361715314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",2202,248,1.09 [0.87-1.38],0.4529581989676835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL3,Myosin light chain 3,2230,249,1.23 [1.05-1.45],0.0114682422345868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL4,Myosin light chain 4,2230,249,1.36 [1.12-1.66],0.0022050916856909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL6B,Myosin light chain 6B,2234,253,0.99 [0.86-1.14],0.8600571660028582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",2234,253,1.29 [1.07-1.55],0.0064984679597179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYO6,Unconventional myosin-VI,2274,254,1.02 [0.72-1.44],0.9290995077776862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYO9B,Unconventional myosin-IXb,2585,303,1.03 [0.88-1.20],0.7450280312792659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOC,Myocilin,2661,313,1.21 [0.97-1.50],0.0918610297531033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM1,Myomesin-1,2206,248,0.73 [0.53-1.01],0.0606869494186525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM2,Myomesin-2,2202,248,1.26 [1.01-1.57],0.0408741770303069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM3,Myomesin-3,2242,246,1.14 [1.00-1.30],0.0480081132111654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MZB1,Marginal zone B- and B1-cell-specific protein,2661,309,1.14 [0.94-1.37],0.1853293208881049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MZT1,Mitotic-spindle organizing protein 1,2583,300,0.88 [0.71-1.09],0.2371663779070006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAA10,N-alpha-acetyltransferase 10,2202,248,1.16 [0.92-1.46],0.2186278067182759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAA80,N-alpha-acetyltransferase 80,2234,253,1.01 [0.91-1.12],0.8966167970765035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,2621,311,1.11 [0.94-1.32],0.2099127810915312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NACC1,Nucleus accumbens-associated protein 1,2267,249,0.92 [0.73-1.16],0.4894952834918993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NADK,NAD kinase,2648,308,1.03 [0.86-1.23],0.7517788785197207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGA,Alpha-N-acetylgalactosaminidase,2208,249,0.98 [0.76-1.26],0.8814599364287606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGK,N-acetyl-D-glucosamine kinase,2223,249,0.72 [0.57-0.90],0.0043224946050806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,2242,246,1.40 [0.82-2.37],0.2132447217459536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAMPT,Nicotinamide phosphoribosyltransferase,2583,300,0.94 [0.78-1.13],0.5060522320574928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAP1L4,Nucleosome assembly protein 1-like 4,2262,251,1.03 [0.76-1.38],0.8697705803221678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAPRT,Nicotinate phosphoribosyltransferase,2278,254,1.25 [0.90-1.74],0.1818400872642661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",2274,254,1.06 [0.82-1.37],0.6728264899374905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,2658,311,2.17 [1.59-2.96],8.837983882724444e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NBN,Nibrin,2585,303,0.84 [0.67-1.06],0.1394474239805598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAM1,Neural cell adhesion molecule 1,2655,309,1.09 [0.81-1.46],0.5819490910785646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAM2,Neural cell adhesion molecule 2,2661,313,0.81 [0.57-1.15],0.2354833007075043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAN,Neurocan core protein,2673,312,0.53 [0.42-0.67],1.724277078618948e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCF2,Neutrophil cytosol factor 2,2642,311,0.92 [0.82-1.04],0.1951393850401555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCK2,Cytoplasmic protein NCK2,2665,309,1.00 [0.90-1.10],0.9212230539017184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCLN,Nicalin,2585,303,1.07 [0.88-1.30],0.5177024342464851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR1,Natural cytotoxicity triggering receptor 1,2642,310,1.80 [1.42-2.28],9.460068982463376e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,2268,253,2.06 [1.50-2.83],8.036705995141524e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCS1,Neuronal calcium sensor 1,2668,312,2.85 [2.07-3.92],1.079153017447126e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDRG1,Protein NDRG1,2581,302,1.05 [0.90-1.21],0.5341884483153245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,2267,249,1.07 [0.89-1.30],0.4527169135709048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,2210,250,1.23 [0.87-1.75],0.2443704981797518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,2268,253,1.00 [0.87-1.15],0.959910163135936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",2583,300,1.17 [1.05-1.31],0.0050524198232456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEB,Nebulin,2202,248,1.15 [0.84-1.57],0.3995686187272577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECAP2,Adaptin ear-binding coat-associated protein 2,2202,248,1.21 [1.01-1.44],0.0361870799869575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN1,Nectin-1,2214,250,0.92 [0.62-1.35],0.6569978534234737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN2,Nectin-2,2647,307,2.20 [1.69-2.85],3.173484487668514e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN4,Nectin-4,2658,311,1.87 [1.53-2.29],1.1121890890088316e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,2214,250,0.98 [0.76-1.26],0.888719496111217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEDD9,Enhancer of filamentation 1,2214,250,1.22 [0.87-1.72],0.2453425632183372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEFL,Neurofilament light polypeptide,2574,301,1.90 [1.60-2.26],2.332443536296199e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEK7,Serine/threonine-protein kinase Nek7,2251,250,1.00 [0.85-1.18],0.9829093884650918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NELL1,Protein kinase C-binding protein NELL1,2658,311,0.59 [0.48-0.72],4.513709687778077e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NELL2,Protein kinase C-binding protein NELL2,2665,309,1.06 [0.76-1.47],0.7443553102206004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NENF,Neudesin,2267,249,1.02 [0.92-1.15],0.662736788433014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEO1,Neogenin,2274,254,1.19 [0.74-1.91],0.4824431544069666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEXN,Nexilin,2287,256,0.95 [0.80-1.14],0.5907084666451261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFASC,Neurofascin,2674,311,2.54 [1.90-3.40],4.1350042301095e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFAT5,Nuclear factor of activated T-cells 5,2214,250,0.96 [0.83-1.11],0.5795649440841188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",2646,311,0.93 [0.83-1.03],0.1558971840016105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",2585,303,0.99 [0.85-1.17],0.936085813152036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFE2,Transcription factor NF-E2 45 kDa subunit,2230,249,1.00 [0.84-1.19],0.9766453855361532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFIC,Nuclear factor 1 C-type,2274,254,1.10 [0.86-1.40],0.434625367178117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,2202,248,0.92 [0.77-1.10],0.3730014338774964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,2251,250,0.94 [0.72-1.23],0.6588016146154401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFKBIE,NF-kappa-B inhibitor epsilon,2583,300,0.93 [0.75-1.16],0.5212938757500025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",2268,253,1.00 [0.88-1.13],0.981125611201296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFX1,Transcriptional repressor NF-X1,2202,248,0.96 [0.81-1.15],0.6767042382841397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFYA,Nuclear transcription factor Y subunit alpha,2202,248,1.17 [0.86-1.60],0.3232879198464157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGF,Beta-nerve growth factor,2634,311,2.19 [1.00-4.81],0.0507343205649233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGFR,Tumor necrosis factor receptor superfamily member 16,2273,252,0.99 [0.67-1.46],0.941820155548303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGRN,Neugrin,2278,254,1.05 [0.59-1.87],0.8631249227661375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NHLRC3,NHL repeat-containing protein 3,2183,239,1.25 [0.84-1.87],0.269229717594733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NID1,Nidogen-1,2651,307,1.01 [0.77-1.32],0.9607986023613184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NID2,Nidogen-2,2661,313,0.95 [0.83-1.09],0.4646131201674129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NINJ1,Ninjurin-1,2583,300,1.08 [0.90-1.29],0.3964664382295934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NIT1,Deaminated glutathione amidase,2230,249,0.77 [0.59-1.00],0.0510618397789263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NIT2,Omega-amidase NIT2,2258,252,0.97 [0.81-1.16],0.7329336938453667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NLGN1,Neuroligin-1,2234,253,1.04 [0.87-1.24],0.6847218156826729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NLGN2,Neuroligin-2,2206,248,1.09 [0.84-1.41],0.5285629731830166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NME1,Nucleoside diphosphate kinase A,2214,250,0.79 [0.43-1.47],0.4536756778639258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NME3,Nucleoside diphosphate kinase 3,2656,308,0.83 [0.55-1.26],0.3871620684897106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMI,N-myc-interactor,2261,249,1.00 [0.84-1.20],0.9830025133407878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,2634,311,0.93 [0.82-1.07],0.309496369636731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMRK2,Nicotinamide riboside kinase 2,2199,248,0.93 [0.67-1.28],0.6443483144915451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,2274,254,1.16 [0.98-1.36],0.0847452812850856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOMO1,Nodal modulator 1,2661,313,0.72 [0.48-1.09],0.1208744992145621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOP56,Nucleolar protein 56,2202,248,1.11 [1.01-1.23],0.0379492387903724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS1,"Nitric oxide synthase, brain",2581,302,1.26 [1.07-1.49],0.0068707502873003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS2,"Nitric oxide synthase, inducible",2202,248,0.89 [0.64-1.23],0.4806770593778717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS3,"Nitric oxide synthase, endothelial",2581,302,1.23 [1.05-1.43],0.0103137602737491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH1,Neurogenic locus notch homolog protein 1,2679,313,2.37 [1.33-4.20],0.0032868957307579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH2,Neurogenic locus notch homolog protein 2,2286,255,1.54 [0.94-2.54],0.0896067331306031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH3,Neurogenic locus notch homolog protein 3,2679,313,1.21 [0.92-1.59],0.1749252850175449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPC2,NPC intracellular cholesterol transporter 2,2251,253,2.15 [1.55-3.00],5.728263825369419e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPDC1,Neural proliferation differentiation and control protein 1,2648,308,1.72 [1.36-2.16],5.090552040374057e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPHS1,Nephrin,2214,250,0.77 [0.53-1.12],0.1705492764640701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPHS2,Podocin,2214,250,1.01 [0.90-1.13],0.9237878820290468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPL,N-acetylneuraminate lyase,2273,252,0.93 [0.73-1.20],0.5928874175061429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPPB,Natriuretic peptides B,2603,303,1.06 [0.99-1.14],0.075358156892837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPPC,C-type natriuretic peptide,2646,311,0.96 [0.81-1.15],0.6708157561487585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPR1,Atrial natriuretic peptide receptor 1,2202,248,1.04 [0.76-1.42],0.7918893919173249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTN,Neuroplastin,2583,300,0.92 [0.80-1.08],0.3101661122387814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTX1,Neuronal pentraxin-1,2661,313,1.14 [0.90-1.44],0.2638950661119535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTX2,Neuronal pentraxin-2,2286,255,1.28 [0.90-1.82],0.1626792238036591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTXR,Neuronal pentraxin receptor,2648,308,0.84 [0.64-1.10],0.2106183065472906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPY,Pro-neuropeptide Y,2668,312,1.34 [1.15-1.56],0.0001719164298508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRCAM,Neuronal cell adhesion molecule,2648,308,1.71 [1.27-2.30],0.0003530327582432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRGN,Neurogranin,2287,256,0.99 [0.86-1.13],0.8806209802811762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRN1,Neuritin,2274,254,0.94 [0.62-1.42],0.7720476311880138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRP1,Neuropilin-1,2655,309,2.13 [1.51-2.99],1.4333963528779903e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRP2,Neuropilin-2,2661,313,1.03 [0.74-1.44],0.856486263323252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRTN,Neurturin,2585,303,0.96 [0.77-1.18],0.6937893094081349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRXN3,Neurexin-3,2234,253,1.01 [0.69-1.46],0.9741828332576664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NSFL1C,NSFL1 cofactor p47,2673,312,1.02 [0.88-1.20],0.7630557563212069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",2273,252,1.07 [0.90-1.28],0.4176465684959256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,2278,254,1.47 [1.08-1.99],0.0130782317930139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,2642,310,0.94 [0.84-1.06],0.3397267231549664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5E,5'-nucleotidase,2658,311,0.96 [0.79-1.15],0.6270573265760482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTF3,Neurotrophin-3,2646,311,1.20 [0.94-1.54],0.1522513780503346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTF4,Neurotrophin-4,2583,300,0.98 [0.74-1.29],0.8632275385761363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTRK2,BDNF/NT-3 growth factors receptor,2648,308,1.30 [0.90-1.88],0.1634167601508084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTRK3,NT-3 growth factor receptor,2673,312,1.26 [0.81-1.96],0.2971252355211943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,2648,308,1.14 [1.06-1.23],0.0004786898103792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUB1,NEDD8 ultimate buster 1,2646,311,0.96 [0.84-1.09],0.5273033731143635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,2267,249,1.04 [0.91-1.18],0.5711156568686305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUCB2,Nucleobindin-2,2666,312,1.22 [0.94-1.60],0.138262320370899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDC,Nuclear migration protein nudC,2674,311,1.04 [0.88-1.23],0.6225967626771055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,2230,249,1.11 [0.69-1.78],0.6737697604768764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,2202,248,0.96 [0.77-1.21],0.7498741400672005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT16,U8 snoRNA-decapping enzyme,2266,253,1.07 [0.93-1.23],0.3460363084519764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],2639,307,1.00 [0.82-1.20],0.9667693805383436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT5,ADP-sugar pyrophosphatase,2661,313,1.08 [0.88-1.33],0.4518800076531966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUMB,Protein numb homolog,2214,250,0.97 [0.83-1.13],0.7089134744225796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUP50,Nuclear pore complex protein Nup50,2202,248,1.24 [0.82-1.86],0.3065276809060124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NXPE4,NXPE family member 4,2202,248,1.24 [0.92-1.67],0.1605531166369415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NXPH1,Neurexophilin-1,2581,302,0.85 [0.65-1.12],0.2470077722450106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NXPH3,Neurexophilin-3,2214,250,1.41 [0.94-2.12],0.09226283204757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OBP2B,Odorant-binding protein 2b,2629,310,0.97 [0.83-1.13],0.6874297591604683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OCLN,Occludin,2274,254,1.38 [1.07-1.78],0.0128058628481738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ODAM,Odontogenic ameloblast-associated protein,2577,302,1.17 [0.98-1.39],0.0865404221924686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OFD1,Oral-facial-digital syndrome 1 protein,2251,250,1.00 [0.83-1.20],0.990906632740302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGA,Protein O-GlcNAcase,2268,253,1.00 [0.83-1.20],0.9937132975573972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGFR,Opioid growth factor receptor,2639,307,1.12 [0.82-1.54],0.4858604142635662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGN,Mimecan,2661,313,1.61 [1.32-1.95],2.2257148686923942e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,2251,250,1.01 [0.82-1.24],0.9133100403900724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OLFM4,Olfactomedin-4,2159,235,1.09 [0.99-1.21],0.0920461054432186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OLR1,Oxidized low-density lipoprotein receptor 1,2625,307,1.06 [0.89-1.25],0.5199049904014397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMD,Osteomodulin,2665,309,0.71 [0.58-0.88],0.001774070242383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMG,Oligodendrocyte-myelin glycoprotein,2639,307,0.76 [0.66-0.88],0.0001532266393586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMP,Olfactory marker protein,2206,248,1.12 [0.89-1.42],0.3391470750364198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OPHN1,Oligophrenin-1,2278,254,0.96 [0.86-1.08],0.5304732912097758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OPLAH,5-oxoprolinase,2230,249,1.06 [0.88-1.27],0.5713425843279911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OPTC,Opticin,2639,307,1.06 [0.84-1.33],0.6376669142790243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ORM1,Alpha-1-acid glycoprotein 1,2272,251,0.73 [0.40-1.33],0.2975936365363701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSBPL2,Oxysterol-binding protein-related protein 2,2278,254,0.93 [0.67-1.27],0.6340431757692497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,2656,308,1.22 [0.92-1.62],0.1768012676855622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSM,Oncostatin-M,2635,311,1.02 [0.89-1.18],0.746457534272614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSMR,Oncostatin-M-specific receptor subunit beta,2655,309,1.84 [1.17-2.89],0.0083424661138694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSTN,Osteocrin,2234,253,1.09 [0.86-1.40],0.4734529661658916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OTOA,Otoancorin,2206,248,0.95 [0.76-1.18],0.6486383372701248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OTUD6B,Deubiquitinase OTUD6B,2268,253,1.00 [0.81-1.24],0.999158692772375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OTUD7B,OTU domain-containing protein 7B,2274,254,1.11 [0.91-1.36],0.3185401429991666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",2230,249,0.95 [0.80-1.14],0.5800089872341441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OXT,Oxytocin-neurophysin 1,2673,312,0.98 [0.91-1.05],0.4940939359752708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,P4HB,Protein disulfide-isomerase,2634,309,1.18 [0.91-1.53],0.2151678589691731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PACS2,Phosphofurin acidic cluster sorting protein 2,2202,248,1.02 [0.84-1.25],0.8188061428397378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PADI2,Protein-arginine deiminase type-2,2585,303,1.09 [0.93-1.29],0.2870212296074513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PADI4,Protein-arginine deiminase type-4,2577,302,0.82 [0.71-0.96],0.0104550601273975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAEP,Glycodelin,2634,311,1.00 [0.90-1.11],0.9749065195103548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,2274,254,1.05 [0.95-1.17],0.3250565173353711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",2251,250,0.99 [0.77-1.28],0.9332429844225087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,2603,303,1.10 [0.92-1.33],0.2882621304803452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,2230,249,0.95 [0.71-1.28],0.7318321959313876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,2197,248,0.99 [0.78-1.25],0.9129579894993632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAK4,Serine/threonine-protein kinase PAK 4,2581,302,1.06 [0.90-1.25],0.5018679607992268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALLD,Palladin,2214,250,0.87 [0.62-1.23],0.4427465722509389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM,Paralemmin-1,2256,250,1.73 [1.24-2.41],0.0012057634062655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM2,Paralemmin-2,2278,254,1.72 [1.30-2.28],0.0001291554254202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM3,Paralemmin-3,2202,248,1.15 [0.98-1.35],0.0821486646807141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,2666,309,1.03 [0.73-1.43],0.882718161086317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAMR1,Inactive serine protease PAMR1,2661,313,0.70 [0.49-1.01],0.0548259044813463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAPPA,Pappalysin-1,2585,303,0.80 [0.65-0.99],0.0428534989311999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PARD3,Partitioning defective 3 homolog,2251,250,0.87 [0.72-1.05],0.1539268748626729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PARK7,Parkinson disease protein 7,2661,313,1.00 [0.82-1.22],0.9961903716589632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PARP1,Poly [ADP-ribose] polymerase 1,2646,311,0.93 [0.76-1.13],0.4424399954769537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAXX,Protein PAXX,2242,246,1.01 [0.76-1.33],0.965567550524451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,2199,248,0.98 [0.66-1.46],0.9210544641409012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBLD,Phenazine biosynthesis-like domain-containing protein,2581,302,0.86 [0.71-1.04],0.1171475543086034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,2268,253,1.57 [1.08-2.28],0.0181912098200552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCARE,Photoreceptor cilium actin regulator,2206,248,0.99 [0.84-1.15],0.8546238694575351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,2239,245,0.77 [0.61-0.98],0.0323031624396291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCBP2,Poly(rC)-binding protein 2,2274,254,1.02 [0.86-1.22],0.7801701413728584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH1,Protocadherin-1,2662,311,1.63 [1.10-2.41],0.0149238152306072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH12,Protocadherin-12,2274,254,2.22 [1.39-3.54],0.0008157696189095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH17,Protocadherin-17,2648,308,1.34 [1.06-1.69],0.0137667898183867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH7,Protocadherin-7,2268,253,1.87 [1.45-2.41],1.7131705479808997e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH9,Protocadherin-9,2268,253,0.71 [0.51-0.98],0.0367587729726427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDHB15,Protocadherin beta-15,2267,249,1.20 [0.90-1.58],0.2121002675129851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCNA,Proliferating cell nuclear antigen,2199,248,1.05 [0.88-1.26],0.5841882275443806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,2267,249,0.83 [0.63-1.09],0.176091691725304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,2679,313,1.11 [0.86-1.42],0.4164348479572983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,2268,253,1.06 [0.89-1.26],0.5237228003530152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,2273,252,1.03 [0.90-1.17],0.6676033654897404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1,Programmed cell death protein 1,2664,310,1.31 [1.07-1.60],0.0091454960341242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1LG2,Programmed cell death 1 ligand 2,2639,307,2.32 [1.77-3.02],6.265575242201985e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD5,Programmed cell death protein 5,2673,312,1.10 [0.92-1.31],0.3186019888693693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD6,Programmed cell death protein 6,2648,308,1.26 [1.06-1.50],0.0096799686453031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCL2,Phosducin-like protein 2,2199,248,0.96 [0.74-1.24],0.7445576899855622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",2199,248,1.18 [0.95-1.46],0.1404672634912021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",2202,248,0.98 [0.80-1.20],0.8468719323262858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",2242,246,0.96 [0.85-1.08],0.5191475952089024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFA,Platelet-derived growth factor subunit A,2679,313,0.90 [0.78-1.03],0.1125883811781063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFB,Platelet-derived growth factor subunit B,2665,309,0.95 [0.84-1.06],0.366353013180503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFC,Platelet-derived growth factor C,2583,300,1.04 [0.73-1.47],0.8350480352404674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFRA,Platelet-derived growth factor receptor alpha,2648,308,1.98 [1.45-2.71],2.005927873902093e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFRB,Platelet-derived growth factor receptor beta,2679,313,1.22 [0.92-1.62],0.1763436096311123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA2,Protein disulfide-isomerase A2,2199,248,0.99 [0.70-1.39],0.9450838562822924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA3,Protein disulfide-isomerase A3,2242,246,1.15 [0.71-1.85],0.5784928036017258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA4,Protein disulfide-isomerase A4,2286,255,0.95 [0.78-1.17],0.6493237811965157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA5,Protein disulfide-isomerase A5,2199,248,1.01 [0.83-1.22],0.9301135312462472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDLIM5,PDZ and LIM domain protein 5,2274,254,1.01 [0.91-1.12],0.8392974543886775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDLIM7,PDZ and LIM domain protein 7,2665,309,1.02 [0.94-1.11],0.6714304708450803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",2583,300,1.11 [0.92-1.34],0.2685441834450426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDRG1,p53 and DNA damage-regulated protein 1,2234,253,1.00 [0.78-1.28],0.9851642560516288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,2199,248,1.04 [0.87-1.25],0.657439656140262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDZD2,PDZ domain-containing protein 2,2202,248,1.03 [0.84-1.27],0.7509409219518239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,2214,250,1.03 [0.81-1.31],0.8073129504359381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEAR1,Platelet endothelial aggregation receptor 1,2679,313,1.42 [0.93-2.16],0.104254999658128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEBP1,Phosphatidylethanolamine-binding protein 1,2661,313,1.07 [0.90-1.28],0.4197087414181558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PECAM1,Platelet endothelial cell adhesion molecule,2661,313,0.88 [0.64-1.21],0.429190655833648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,2230,249,0.96 [0.59-1.56],0.8734731130193274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PENK,Proenkephalin-A,2242,246,1.28 [0.90-1.81],0.1635667770863625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEPD,Xaa-Pro dipeptidase,2287,256,0.85 [0.55-1.31],0.4640111387962287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PER3,Period circadian protein homolog 3,2214,250,0.94 [0.85-1.04],0.230967499920426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PF4,Platelet factor 4,2262,252,0.94 [0.83-1.07],0.3649813610691717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFDN2,Prefoldin subunit 2,2581,302,1.16 [0.96-1.41],0.1195187069960109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFDN4,Prefoldin subunit 4,2199,248,1.14 [0.91-1.43],0.2413120333805226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFDN6,Prefoldin subunit 6,2234,253,0.94 [0.77-1.15],0.5507019426096748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",2638,307,0.98 [0.86-1.12],0.8176693890219129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGA4,Pepsin A-4,2287,256,1.08 [0.95-1.23],0.2292878786978634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",2273,252,1.07 [0.85-1.34],0.5636751882773297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGF,Placenta growth factor,2674,311,2.17 [1.58-2.99],1.6631491743514728e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGLYRP1,Peptidoglycan recognition protein 1,2666,313,1.13 [0.91-1.41],0.2798597275518629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,2253,249,1.41 [0.92-2.17],0.1132568426840008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGLYRP4,Peptidoglycan recognition protein 4,2202,248,1.02 [0.82-1.27],0.8659681967829898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGM2,Phosphoglucomutase-2,2234,253,1.03 [0.83-1.29],0.7614821859690817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGR,Progesterone receptor,2214,250,1.05 [0.93-1.18],0.467337876548579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHACTR2,Phosphatase and actin regulator 2,2274,254,1.00 [0.90-1.12],0.9831068018991654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHLDB1,Pleckstrin homology-like domain family B member 1,2268,253,1.51 [1.19-1.90],0.000554785623186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHLDB2,Pleckstrin homology-like domain family B member 2,2199,248,1.07 [0.96-1.20],0.234739740323958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,2634,311,1.51 [1.10-2.08],0.0113221799221478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,2242,246,0.88 [0.66-1.16],0.3630830053897977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PI16,Peptidase inhibitor 16,2287,256,1.28 [0.80-2.06],0.3055138937324708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PI3,Elafin,2613,307,1.21 [1.05-1.41],0.0112715710040359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",2274,254,0.99 [0.84-1.16],0.8841459506866595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIGR,Polymeric immunoglobulin receptor,2624,307,2.00 [1.57-2.56],2.1790216040446705e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,2646,311,0.87 [0.73-1.02],0.0876357816218605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,2661,313,2.62 [2.03-3.38],1.460546646312374e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,2214,250,0.93 [0.73-1.19],0.5695101929945618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,2661,313,1.59 [1.26-2.01],9.894900665907764e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,2648,308,1.35 [1.12-1.61],0.0013220417877254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,2242,246,0.76 [0.64-0.90],0.0011514179540755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PITHD1,PITH domain-containing protein 1,2197,248,0.97 [0.84-1.12],0.6766137671279575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKD1,Polycystin-1,2273,252,2.28 [1.49-3.49],0.000139099763311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKD2,Polycystin-2,2202,248,1.01 [0.80-1.26],0.9584056522646398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKLR,Pyruvate kinase PKLR,2655,308,0.94 [0.81-1.10],0.4676091311424305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKN3,Serine/threonine-protein kinase N3,2251,250,1.01 [0.86-1.19],0.9012100269055938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G10,Group 10 secretory phospholipase A2,2634,311,1.43 [1.21-1.69],2.5086462848354604e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G15,Phospholipase A2 group XV,2658,311,1.20 [0.86-1.68],0.2910065424307508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G1B,Phospholipase A2,2678,313,0.97 [0.81-1.16],0.7316700980752888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G2A,"Phospholipase A2, membrane associated",2637,306,0.98 [0.82-1.17],0.8149368322799314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G4A,Cytosolic phospholipase A2,2665,309,0.97 [0.86-1.09],0.6145421256643823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G7,Platelet-activating factor acetylhydrolase,2661,313,0.41 [0.32-0.53],8.512510421456428e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAT,Tissue-type plasminogen activator,2671,313,0.65 [0.55-0.78],3.848614552510548e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAU,Urokinase-type plasminogen activator,2661,313,0.84 [0.60-1.17],0.3003667413256565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAUR,Urokinase plasminogen activator surface receptor,2636,308,2.27 [1.64-3.16],8.987520941148955e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLB1,"Phospholipase B1, membrane-associated",2278,254,0.78 [0.64-0.96],0.0177902290711868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",2214,250,1.00 [0.73-1.37],0.986776184904926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",2278,254,0.98 [0.87-1.12],0.8158968631168959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,2278,254,1.04 [0.87-1.23],0.6848468585206366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLG,Plasminogen,2212,243,1.10 [0.61-1.99],0.7600242253480283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLIN1,Perilipin-1,2581,302,1.27 [0.99-1.63],0.0622785306893829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLIN3,Perilipin-3,2648,308,1.38 [1.10-1.74],0.0054881935439721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLPBP,Pyridoxal phosphate homeostasis protein,2648,308,0.98 [0.84-1.14],0.7900839928811407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLSCR3,Phospholipid scramblase 3,2271,252,1.18 [0.94-1.47],0.1515815647953248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLTP,Phospholipid transfer protein,2671,312,1.18 [0.92-1.52],0.1987330499872586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXDC1,Plexin domain-containing protein 1,2583,300,1.23 [0.92-1.65],0.1687444973711583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXDC2,Plexin domain-containing protein 2,2278,254,1.34 [0.93-1.94],0.1189239134725636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNA4,Plexin-A4,2646,311,0.95 [0.84-1.08],0.4408208757820723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB2,Plexin-B2,2665,312,2.85 [2.11-3.84],8.161369579507324e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB3,Plexin-B3,2638,308,0.93 [0.74-1.16],0.5216936440395478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,2638,306,1.02 [0.96-1.07],0.577327697568204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMCH,Pro-MCH,2202,248,0.90 [0.76-1.08],0.2616055654370111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMM2,Phosphomannomutase 2,2202,248,1.05 [0.85-1.30],0.6564836812816182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMS1,PMS1 protein homolog 1,2234,253,1.07 [0.86-1.33],0.5363178242254063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMVK,Phosphomevalonate kinase,2578,301,0.98 [0.89-1.07],0.6393589544862518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNLIP,Pancreatic triacylglycerol lipase,2287,256,1.03 [0.88-1.21],0.6852150542992226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,2278,254,1.10 [0.97-1.25],0.1257705665556213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNLIPRP2,Pancreatic lipase-related protein 2,2649,308,1.00 [0.97-1.03],0.9628704794941528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNMA1,Paraneoplastic antigen Ma1,2230,249,1.02 [0.82-1.27],0.8733057656451622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNMA2,Paraneoplastic antigen Ma2,2206,248,1.02 [0.78-1.32],0.8911837737525719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",2585,303,1.08 [0.99-1.17],0.0815952916107014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PODXL,Podocalyxin,2639,307,0.87 [0.46-1.65],0.6801928820618374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PODXL2,Podocalyxin-like protein 2,2658,311,1.15 [0.82-1.60],0.4214609886462456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POF1B,Protein POF1B,2214,250,1.71 [1.38-2.12],8.954686614789751e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,2214,250,1.12 [0.75-1.68],0.5773863486220414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",2639,307,1.42 [1.12-1.81],0.0041550961290938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POMC,Pro-opiomelanocortin,2230,249,0.88 [0.74-1.05],0.153529153594375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON1,Serum paraoxonase/arylesterase 1,2287,256,0.51 [0.34-0.76],0.0011021204879142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON2,Serum paraoxonase/arylesterase 2,2603,303,0.89 [0.67-1.17],0.3985436678664104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON3,Serum paraoxonase/lactonase 3,2665,309,0.68 [0.51-0.91],0.008607478985156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POSTN,Periostin,2286,255,0.83 [0.61-1.14],0.2552531954499057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPBP,Platelet basic protein,2261,252,0.93 [0.80-1.07],0.3070463487928445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,2673,312,0.90 [0.73-1.12],0.3668125538277144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,2646,309,0.99 [0.88-1.10],0.7894922820242528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,2251,250,1.06 [0.87-1.29],0.5588789314510487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",2286,255,0.88 [0.72-1.08],0.2168162718139525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPL,Periplakin,2214,250,1.12 [0.79-1.60],0.522968755696777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPM1A,Protein phosphatase 1A,2583,300,1.16 [0.87-1.55],0.3115070914777732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPM1B,Protein phosphatase 1B,2214,250,0.95 [0.76-1.20],0.6794746677425623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPM1F,Protein phosphatase 1F,2273,252,0.99 [0.78-1.26],0.9571500266695712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPME1,Protein phosphatase methylesterase 1,2639,307,0.93 [0.79-1.10],0.3994275213401218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,2267,249,0.96 [0.83-1.12],0.6287516550842109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,2658,311,0.99 [0.89-1.10],0.8944263310076548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,2251,250,1.01 [0.85-1.20],0.8709327150347739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,2274,254,1.08 [0.93-1.26],0.2883190056778419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,2274,254,1.66 [1.32-2.08],1.2253562103426882e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R2,Protein phosphatase inhibitor 2,2648,308,1.00 [0.88-1.14],0.971817797093982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R9B,Neurabin-2,2674,311,1.01 [0.91-1.13],0.7998026612897132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,2268,253,1.01 [0.91-1.12],0.8727158267472525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP3R1,Calcineurin subunit B type 1,2634,311,1.07 [0.83-1.37],0.5946506543228431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPT1,Palmitoyl-protein thioesterase 1,2234,253,0.93 [0.78-1.10],0.3902272454751843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPY,Pancreatic prohormone,2644,307,1.16 [1.06-1.27],0.0010547489383111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PQBP1,Polyglutamine-binding protein 1,2583,300,1.06 [0.89-1.26],0.5354598799747967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRAME,Melanoma antigen preferentially expressed in tumors,2199,248,1.05 [0.65-1.70],0.8372907229386224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRAP1,Proline-rich acidic protein 1,2286,255,1.92 [1.41-2.61],3.442022286141977e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRC1,Protein regulator of cytokinesis 1,2267,249,1.02 [0.80-1.31],0.8677160708578474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRCP,Lysosomal Pro-X carboxypeptidase,2666,312,1.50 [1.15-1.96],0.0030023956587236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX1,Peroxiredoxin-1,2572,305,0.94 [0.83-1.06],0.3166527912336256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX2,Peroxiredoxin-2,2249,254,1.00 [0.83-1.21],0.9850298391762738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",2585,303,1.09 [0.95-1.26],0.2274273468215163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX5,"Peroxiredoxin-5, mitochondrial",2674,311,0.93 [0.79-1.08],0.3465116422314499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX6,Peroxiredoxin-6,2668,312,0.88 [0.74-1.03],0.1201780512773662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PREB,Prolactin regulatory element-binding protein,2585,303,1.37 [1.01-1.85],0.040281335517438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRELP,Prolargin,2649,308,1.80 [1.22-2.67],0.0031234503028461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRG2,Bone marrow proteoglycan,2286,255,1.31 [1.06-1.62],0.0107973380502097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRG3,Proteoglycan 3,2286,255,1.02 [0.81-1.30],0.8574454919245718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,2585,303,1.09 [0.90-1.31],0.4020376868349248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,2234,253,1.21 [0.87-1.68],0.2565073125906102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,2648,308,0.96 [0.85-1.09],0.5597993540736843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,2273,251,1.00 [0.85-1.17],0.994162138974816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKCQ,Protein kinase C theta type,2585,303,0.96 [0.75-1.22],0.7151001796223454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKD2,Serine/threonine-protein kinase D2,2202,248,1.12 [0.82-1.53],0.4926514248887782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKG1,cGMP-dependent protein kinase 1,2242,246,0.97 [0.88-1.07],0.5722995376094349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,2583,300,0.99 [0.84-1.15],0.8745324181328328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRL,Prolactin,2673,312,1.11 [0.98-1.26],0.0933640008633006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRND,Prion-like protein doppel,2278,254,1.07 [0.86-1.34],0.5393298005198142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROC,Vitamin K-dependent protein C,2653,308,0.82 [0.56-1.20],0.3144463475574117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROCR,Endothelial protein C receptor,2202,248,1.17 [0.85-1.61],0.3345237886406959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROK1,Prokineticin-1,2646,311,1.01 [0.84-1.20],0.9518387796840868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROS1,Vitamin K-dependent protein S,2278,252,0.86 [0.54-1.37],0.5145815600823103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRR4,Proline-rich protein 4,2216,242,0.96 [0.80-1.14],0.6385536273445147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRR5,Proline-rich protein 5,2214,250,1.21 [0.98-1.50],0.079887328016938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRRT3,Proline-rich transmembrane protein 3,2230,249,1.22 [0.93-1.62],0.1565500372354351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS2,Trypsin-2,2655,309,1.08 [0.93-1.25],0.3042156283976677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS22,Brain-specific serine protease 4,2214,250,1.42 [1.07-1.88],0.0148579335340152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS27,Serine protease 27,2641,308,1.39 [1.09-1.76],0.0069360546209703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS53,Serine protease 53,2278,254,0.60 [0.45-0.81],0.0007071647122884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS8,Prostasin,2647,309,1.76 [1.40-2.21],9.001148415347526e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,2581,302,0.95 [0.87-1.04],0.2768036007080589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRTG,Protogenin,2668,312,1.28 [0.88-1.86],0.2047230754069443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRTN3,Myeloblastin,2582,304,1.00 [0.81-1.23],0.9798169062251194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRUNE2,Protein prune homolog 2,2251,250,0.81 [0.53-1.24],0.3276323554136306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSAP,Prosaposin,2267,254,1.97 [1.31-2.97],0.001243043316881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSAPL1,Proactivator polypeptide-like 1,2268,253,1.00 [0.80-1.26],0.9820859087750372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSCA,Prostate stem cell antigen,2268,253,1.02 [0.98-1.07],0.3725379799087283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,2634,311,1.25 [1.14-1.37],2.226968948633658e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSIP1,PC4 and SFRS1-interacting protein,2646,311,0.96 [0.82-1.13],0.635015740989636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMA1,Proteasome subunit alpha type-1,2583,300,0.97 [0.76-1.24],0.8148820021166285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMC3,26S proteasome regulatory subunit 6A,2199,248,0.98 [0.66-1.44],0.9035113420898728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,2274,254,1.03 [0.81-1.30],0.8097828795925254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,2234,253,1.01 [0.80-1.27],0.95094852773909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,2639,307,0.99 [0.83-1.17],0.8724571905159406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSME1,Proteasome activator complex subunit 1,2632,311,0.92 [0.69-1.21],0.5487715895615999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSME2,Proteasome activator complex subunit 2,2621,308,1.08 [0.81-1.44],0.589779258502314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMG3,Proteasome assembly chaperone 3,2646,311,0.98 [0.81-1.19],0.867233495864697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMG4,Proteasome assembly chaperone 4,2214,250,1.01 [0.82-1.25],0.9363121177682684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSPN,Persephin,2646,311,1.06 [0.95-1.17],0.2927139726581873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSRC1,Proline/serine-rich coiled-coil protein 1,2583,300,1.14 [0.98-1.33],0.1009873697619253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,2161,233,0.97 [0.86-1.09],0.5883437582170958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",2581,302,1.14 [0.82-1.58],0.420890788292443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGDS,Prostaglandin-H2 D-isomerase,2622,305,1.89 [1.49-2.41],1.7619912424870137e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGES2,Prostaglandin E synthase 2,2198,249,1.07 [0.85-1.35],0.5648928571737442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGR1,Prostaglandin reductase 1,2273,252,0.96 [0.84-1.09],0.512016105757096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTH,Parathyroid hormone,2234,253,0.93 [0.81-1.07],0.3344570767178493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,2646,311,1.34 [1.09-1.66],0.0052681507497754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTK7,Inactive tyrosine-protein kinase 7,2581,302,1.76 [1.36-2.28],2.1086602830174628e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTN,Pleiotrophin,2603,303,0.94 [0.77-1.15],0.5451911743095268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,2214,250,0.84 [0.65-1.08],0.1743333770592424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,2634,311,1.00 [0.88-1.15],0.9720261683415988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,2660,308,0.97 [0.86-1.09],0.6147026365998238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,2213,250,1.09 [0.79-1.50],0.6017339683464107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,2273,252,1.64 [1.12-2.40],0.0109679683046741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,2286,255,1.02 [0.60-1.71],0.9536874958504662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,2679,313,1.30 [0.94-1.80],0.1185899669486853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,2268,253,1.39 [1.10-1.75],0.0052428416909577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,2268,253,1.03 [0.61-1.74],0.9238321395696528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,2641,310,0.91 [0.61-1.34],0.6212829318574224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,2627,309,1.52 [1.17-1.97],0.0016948271471205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,2278,254,0.87 [0.65-1.18],0.3825621709855829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,2679,313,1.41 [0.98-2.03],0.0613783224457437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,2273,252,0.85 [0.58-1.24],0.3997175504527717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,2242,246,0.92 [0.74-1.14],0.4271399681986474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,2567,301,0.93 [0.79-1.09],0.3564010623130766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTTG1,Securin,2251,250,0.83 [0.61-1.14],0.2479719167422819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTX3,Pentraxin-related protein PTX3,2646,311,1.41 [1.11-1.77],0.0039893187989541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PVALB,Parvalbumin alpha,2657,312,1.04 [0.95-1.14],0.3830059693897804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PVR,Poliovirus receptor,2673,312,1.15 [0.89-1.48],0.2793260922911948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PXDNL,Peroxidasin-like protein,2267,249,1.11 [0.91-1.36],0.2842537930910213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PXN,Paxillin,2581,302,1.06 [0.87-1.30],0.5493151461113746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PYDC1,Pyrin domain-containing protein 1,2230,249,1.26 [0.96-1.66],0.0944685886015956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PYY,Peptide YY,2202,248,1.26 [1.14-1.38],3.213816108321448e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PZP,Pregnancy zone protein,2278,252,0.88 [0.68-1.14],0.3227321565330084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QDPR,Dihydropteridine reductase,2638,307,0.93 [0.72-1.18],0.5383840487018074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QPCT,Glutaminyl-peptide cyclotransferase,2652,312,1.78 [1.24-2.55],0.0018735563268182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QSOX1,Sulfhydryl oxidase 1,2229,244,1.16 [0.86-1.56],0.323339177979432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB10,Ras-related protein Rab-10,2273,252,0.92 [0.73-1.16],0.4973396422931129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB11FIP3,Rab11 family-interacting protein 3,2273,252,0.96 [0.86-1.08],0.5249403662228187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB27B,Ras-related protein Rab-27B,2273,252,0.93 [0.80-1.08],0.3439910004453089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB2B,Ras-related protein Rab-2B,2267,249,0.94 [0.76-1.16],0.5692029557274478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB33A,Ras-related protein Rab-33A,2202,248,1.00 [0.82-1.21],0.9716124283752794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB37,Ras-related protein Rab-37,2585,303,1.07 [0.95-1.20],0.2772806681560792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB39B,Ras-related protein Rab-39B,2202,248,0.91 [0.79-1.06],0.2258437247754072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,2206,248,1.01 [0.80-1.27],0.9499249532661956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB44,Ras-related protein Rab-44,2267,249,0.96 [0.74-1.25],0.761050616022591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB6A,Ras-related protein Rab-6A,2646,311,0.62 [0.51-0.77],6.664232480193914e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB6B,Ras-related protein Rab-6B,2581,302,1.01 [0.82-1.25],0.902547730316794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABEP1,Rab GTPase-binding effector protein 1,2242,246,0.94 [0.80-1.11],0.4830986578854584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABEPK,Rab9 effector protein with kelch motifs,2583,300,1.10 [0.94-1.29],0.226832288732454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABGAP1L,Rab GTPase-activating protein 1-like,2585,303,1.03 [0.87-1.21],0.7645060471502909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAC3,Ras-related C3 botulinum toxin substrate 3,2234,253,1.12 [0.97-1.31],0.1302944810427913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAD23B,UV excision repair protein RAD23 homolog B,2583,300,1.11 [0.89-1.39],0.3377162808814128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAD51,DNA repair protein RAD51 homolog 1,2251,250,1.14 [0.88-1.48],0.3250046601405092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RALB,Ras-related protein Ral-B,2214,250,1.06 [0.70-1.60],0.7997455209389853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RALY,RNA-binding protein Raly,2267,249,1.07 [0.84-1.37],0.5769628790927295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RANBP1,Ran-specific GTPase-activating protein,2230,249,0.92 [0.72-1.16],0.4666377129545589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RANBP2,E3 SUMO-protein ligase RanBP2,2206,248,1.04 [0.71-1.52],0.8597721153981912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RANGAP1,Ran GTPase-activating protein 1,2583,300,1.05 [0.85-1.29],0.645270223421488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAP1A,Ras-related protein Rap-1A,2214,250,1.04 [0.87-1.25],0.6570955853861512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,2251,250,1.01 [0.79-1.29],0.9424951128362742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RARRES1,Retinoic acid receptor responder protein 1,2583,300,1.69 [1.28-2.23],0.0002462021992071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RARRES2,Retinoic acid receptor responder protein 2,2655,309,1.21 [0.99-1.48],0.0615990909508378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RASA1,Ras GTPase-activating protein 1,2581,302,1.14 [0.84-1.53],0.4084392451817923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,2199,248,1.19 [0.94-1.51],0.1510973304614762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RASSF2,Ras association domain-containing protein 2,2583,300,1.05 [0.88-1.24],0.6006782682901042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBFOX3,RNA binding protein fox-1 homolog 3,2274,254,1.51 [1.22-1.88],0.0001811668232791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBKS,Ribokinase,2600,308,0.75 [0.65-0.87],0.0001606730194736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBM17,Splicing factor 45,2274,254,1.02 [0.86-1.20],0.8557623944064596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBM19,Probable RNA-binding protein 19,2202,248,0.93 [0.68-1.27],0.6346712117634108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBM25,RNA-binding protein 25,2199,248,1.16 [0.90-1.50],0.2435626926078211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP1,Retinol-binding protein 1,2234,253,1.17 [1.00-1.37],0.0551598308644915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP2,Retinol-binding protein 2,2639,307,1.28 [1.14-1.43],4.1556594519258e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP5,Retinol-binding protein 5,2639,307,1.08 [0.92-1.26],0.3428263151633484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP7,Retinoid-binding protein 7,2268,253,1.25 [1.05-1.47],0.0097033977641704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBPMS,RNA-binding protein with multiple splicing,2214,250,1.15 [0.96-1.38],0.1345346605067753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBPMS2,RNA-binding protein with multiple splicing 2,2230,249,1.00 [0.89-1.13],0.9647280324595514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RCC1,Regulator of chromosome condensation,2267,249,1.12 [0.90-1.39],0.3273873452465222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RCOR1,REST corepressor 1,2603,303,0.94 [0.73-1.21],0.6228034124607857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,2230,249,0.77 [0.43-1.37],0.3701022217390327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REEP4,Receptor expression-enhancing protein 4,2274,254,1.06 [0.87-1.30],0.5683380602392956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1A,Lithostathine-1-alpha,2628,304,1.95 [1.69-2.24],2.598649005806196e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1B,Lithostathine-1-beta,2679,313,1.61 [1.41-1.85],3.9763212737424695e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3A,Regenerating islet-derived protein 3-alpha,2679,313,1.48 [1.30-1.68],1.3074339410860855e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3G,Regenerating islet-derived protein 3-gamma,2267,249,1.38 [1.03-1.84],0.0286910742339824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG4,Regenerating islet-derived protein 4,2656,308,1.97 [1.70-2.27],1.3636851553771708e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RELB,Transcription factor RelB,2214,250,1.13 [0.90-1.42],0.2802334694415032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RELT,Tumor necrosis factor receptor superfamily member 19L,2661,313,1.68 [1.26-2.24],0.0004258759970736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REN,Renin,2648,308,1.43 [1.30-1.56],5.922554956097987e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REPS1,RalBP1-associated Eps domain-containing protein 1,2214,250,0.88 [0.63-1.25],0.4846967038830737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REST,RE1-silencing transcription factor,2199,248,1.02 [0.71-1.45],0.924049939194468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,2639,307,1.03 [0.80-1.32],0.8228040110715749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RETN,Resistin,2648,312,1.22 [0.99-1.51],0.0589687537179679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REXO2,"Oligoribonuclease, mitochondrial",2202,248,0.87 [0.65-1.16],0.3295540256228843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RFC4,Replication factor C subunit 4,2267,249,0.96 [0.54-1.71],0.8907603580635743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGCC,Regulator of cell cycle RGCC,2274,254,0.94 [0.79-1.10],0.4307527916040339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,2251,250,1.25 [1.09-1.45],0.0021642154858511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMA,Repulsive guidance molecule A,2673,312,1.67 [1.24-2.23],0.0005944555607647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMB,RGM domain family member B,2673,312,1.72 [1.27-2.35],0.0005230818095818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGS10,Regulator of G-protein signaling 10,2274,254,1.03 [0.83-1.27],0.8095363963631232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGS8,Regulator of G-protein signaling 8,2585,303,1.03 [0.89-1.20],0.6971076083005123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RHOC,Rho-related GTP-binding protein RhoC,2623,310,1.01 [0.92-1.10],0.830790135272814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RICTOR,Rapamycin-insensitive companion of mTOR,2214,250,0.98 [0.77-1.24],0.8597898852013424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,2242,246,0.93 [0.75-1.17],0.5482454859810237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RILP,Rab-interacting lysosomal protein,2662,312,0.94 [0.80-1.12],0.5056020811239093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RILPL2,RILP-like protein 2,2273,252,0.99 [0.87-1.12],0.8615061411391721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,2202,248,0.97 [0.81-1.17],0.7589040468134097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RLN1,Prorelaxin H1,2274,254,1.32 [1.11-1.56],0.0015434193057813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RLN2,Prorelaxin H2,2234,246,1.04 [0.82-1.32],0.7361695960457071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE1,Ribonuclease pancreatic,2287,256,2.21 [1.50-3.27],6.462472782803605e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE10,Inactive ribonuclease-like protein 10,2230,249,1.21 [0.94-1.55],0.1410477391626917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE3,Eosinophil cationic protein,2638,308,0.98 [0.89-1.07],0.6352877248090834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE4,Ribonuclease 4,2207,250,1.68 [1.13-2.50],0.0096265157175916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE6,Ribonuclease K6,2273,255,1.68 [1.35-2.09],3.67963974894225e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASEH2A,Ribonuclease H2 subunit A,2274,254,1.09 [0.84-1.41],0.5390591950170025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASET2,Ribonuclease T2,2671,313,2.14 [1.68-2.72],5.462878446229526e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF149,E3 ubiquitin-protein ligase RNF149,2230,249,2.06 [1.46-2.91],3.93977840123552e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF168,E3 ubiquitin-protein ligase RNF168,2214,250,0.88 [0.63-1.24],0.4723708985595701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF31,E3 ubiquitin-protein ligase RNF31,2214,250,1.09 [0.83-1.44],0.5281812212016554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF4,E3 ubiquitin-protein ligase RNF4,2251,250,1.09 [0.91-1.30],0.3444836110013404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF41,E3 ubiquitin-protein ligase NRDP1,2583,300,0.97 [0.83-1.14],0.752198133249016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF43,E3 ubiquitin-protein ligase RNF43,2251,250,0.99 [0.80-1.24],0.9576050412377176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF5,E3 ubiquitin-protein ligase RNF5,2230,249,0.89 [0.75-1.06],0.1950378069641766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO1,Roundabout homolog 1,2656,308,1.47 [1.05-2.07],0.0267965479133639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO2,Roundabout homolog 2,2673,312,1.14 [0.76-1.70],0.5388292117347483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO4,Roundabout homolog 4,2230,249,1.23 [0.62-2.43],0.5515982387381899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,2648,308,1.65 [1.24-2.19],0.0005963230078703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RP2,Protein XRP2,2639,307,1.00 [0.79-1.27],0.9701589313310436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPA2,Replication protein A 32 kDa subunit,2214,250,1.09 [0.74-1.61],0.6732521295332965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPE,Ribulose-phosphate 3-epimerase,2251,250,0.96 [0.80-1.16],0.6886260136752808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,2234,253,1.15 [0.91-1.45],0.2572758898342626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPL14,60S ribosomal protein L14,2230,249,1.14 [0.81-1.59],0.4602149028590817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPS10,40S ribosomal protein S10,2202,248,0.83 [0.58-1.18],0.2923418515939794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRAS,Ras-related protein R-Ras,2234,253,1.02 [0.92-1.12],0.7322356966005152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,2583,300,1.07 [0.89-1.28],0.4884556813148732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,2583,300,0.97 [0.83-1.13],0.6647335639004439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRP15,RRP15-like protein,2206,248,0.91 [0.80-1.03],0.143910039546753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RSPO1,R-spondin-1,2634,311,1.22 [0.91-1.65],0.1818138074420225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RSPO3,R-spondin-3,2668,312,1.74 [1.29-2.34],0.0002787800222372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTBDN,Retbindin,2639,307,1.28 [0.92-1.77],0.1414981335065165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTKN2,Rhotekin-2,2202,248,1.05 [0.85-1.31],0.6405417288929434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",2274,254,0.99 [0.86-1.13],0.8631318330582399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTN4R,Reticulon-4 receptor,2668,312,2.02 [1.52-2.67],1.079889929452773e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RUVBL1,RuvB-like 1,2583,300,1.01 [0.91-1.11],0.9061968085061636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RWDD1,RWD domain-containing protein 1,2673,312,1.02 [0.87-1.21],0.7773527907109836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RYR1,Ryanodine receptor 1,2202,248,1.13 [0.82-1.56],0.4644353254221323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A11,Protein S100-A11,2625,306,1.08 [0.88-1.33],0.448912234187436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A12,Protein S100-A12,2613,303,0.94 [0.82-1.08],0.3685036023781762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A13,Protein S100-A13,2214,250,1.04 [0.75-1.46],0.810682785504005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A14,Protein S100-A14,2274,254,0.92 [0.74-1.14],0.4328415804627925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A16,Protein S100-A16,2577,302,0.95 [0.80-1.13],0.5463697291976153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A3,Protein S100-A3,2267,249,1.00 [0.78-1.28],0.9996458182737704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A4,Protein S100-A4,2658,311,0.97 [0.81-1.16],0.7348197643774048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100G,Protein S100-G,2274,254,0.81 [0.63-1.04],0.0987359787141488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100P,Protein S100-P,2603,303,1.27 [1.10-1.47],0.0009094440843762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAA4,Serum amyloid A-4 protein,2278,252,0.33 [0.16-0.66],0.0017591610584498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAFB2,Scaffold attachment factor B2,2274,254,1.07 [0.67-1.70],0.7747295270100791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAG,S-arrestin,2206,248,1.06 [0.85-1.33],0.607847292483944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,2646,311,0.97 [0.83-1.12],0.6402827525955395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAP18,Histone deacetylase complex subunit SAP18,2251,250,0.90 [0.76-1.08],0.2602334504303212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SARG,Specifically androgen-regulated gene protein,2267,252,1.01 [0.90-1.13],0.8801447124097816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,2202,248,1.22 [0.90-1.65],0.2027101083009094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAT1,Diamine acetyltransferase 1,2202,248,1.14 [0.90-1.44],0.2877621592423769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAT2,Thialysine N-epsilon-acetyltransferase,2251,250,0.90 [0.75-1.10],0.302177464122657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SATB1,DNA-binding protein SATB1,2274,254,1.01 [0.66-1.55],0.9532090619305406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SBSN,Suprabasin,2279,255,1.19 [0.87-1.62],0.2728116958947413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCAMP3,Secretory carrier-associated membrane protein 3,2639,307,1.02 [0.91-1.16],0.6983587063545669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARA5,Scavenger receptor class A member 5,2673,312,2.90 [2.23-3.79],4.382291045670533e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB1,Scavenger receptor class B member 1,2581,302,1.13 [0.96-1.32],0.1456023168875792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB2,Lysosome membrane protein 2,2576,305,2.08 [1.66-2.60],1.8901957697245927e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF1,Scavenger receptor class F member 1,2679,313,1.27 [1.00-1.60],0.0477182164433718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF2,Scavenger receptor class F member 2,2673,312,2.24 [1.69-2.97],1.7113554736412572e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG2,Secretogranin-2,2660,312,2.16 [1.69-2.77],1.1935681638120403e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG3,Secretogranin-3,2656,308,1.09 [0.82-1.45],0.5523267539608931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB1A1,Uteroglobin,2657,309,1.31 [1.09-1.57],0.0038085799761327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB2A2,Mammaglobin-A,2202,248,0.92 [0.60-1.42],0.7092324640253114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB3A1,Secretoglobin family 3A member 1,2242,246,1.01 [0.64-1.60],0.9719223940402782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB3A2,Secretoglobin family 3A member 2,2660,308,1.03 [0.94-1.14],0.5138110902013195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGN,Secretagogin,2585,303,1.80 [1.52-2.13],9.461743385226372e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCIN,Adseverin,2206,248,1.05 [0.89-1.25],0.5540736842278593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCLY,Selenocysteine lyase,2662,312,0.82 [0.67-1.00],0.0500567359622239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN2A,Sodium channel protein type 2 subunit alpha,2206,248,1.16 [0.92-1.46],0.2090211849452703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN2B,Sodium channel subunit beta-2,2234,253,1.29 [0.88-1.89],0.1946624180318262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN3A,Sodium channel protein type 3 subunit alpha,2234,253,0.96 [0.68-1.36],0.8266264197213432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN3B,Sodium channel subunit beta-3,2206,248,1.03 [0.80-1.33],0.8096043555181147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN4B,Sodium channel subunit beta-4,2230,249,1.26 [0.98-1.63],0.0729418823684266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCP2,Non-specific lipid-transfer protein,2583,300,1.02 [0.89-1.17],0.7909940422579659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,2222,249,1.01 [0.79-1.30],0.9351310538142976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCRG1,Scrapie-responsive protein 1,2273,252,1.15 [0.77-1.71],0.4904117871199519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCRIB,Protein scribble homolog,2230,249,1.03 [0.90-1.17],0.7095664919541746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCRN1,Secernin-1,2646,311,0.91 [0.75-1.10],0.3184325103277121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCT,Secretin,2234,253,1.52 [1.22-1.90],0.0002043396040739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDC1,Syndecan-1,2648,308,1.09 [0.86-1.39],0.4616362921324752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDC4,Syndecan-4,2648,308,0.70 [0.57-0.86],0.0007839082042267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDCCAG8,Serologically defined colon cancer antigen 8,2267,249,0.97 [0.87-1.09],0.6356659439822276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDHB,Succinate dehydrogenase,2268,253,0.89 [0.72-1.09],0.2616574791963603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDK2,Protein sidekick-2,2242,246,0.86 [0.63-1.17],0.335368453966438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEC31A,Protein transport protein Sec31A,2230,249,0.99 [0.84-1.17],0.941877366653499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEL1L,Protein sel-1 homolog 1,2230,249,1.80 [1.45-2.25],1.9000664003692254e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELE,E-selectin,2679,313,1.11 [0.93-1.33],0.2515367400920112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELENOP,Selenoprotein P,2278,252,0.97 [0.59-1.58],0.8964616495398565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELL,L-selectin,2278,252,0.43 [0.25-0.74],0.0022870373644521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELP,P-selectin,2655,309,0.95 [0.80-1.14],0.5952143043724207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELPLG,P-selectin glycoprotein ligand 1,2646,311,1.30 [0.92-1.82],0.1343900206062648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA3F,Semaphorin-3F,2648,308,1.48 [1.04-2.10],0.0285477081491402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA3G,Semaphorin-3G,2242,246,1.23 [0.96-1.57],0.0958076164982093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA4C,Semaphorin-4C,2639,307,1.06 [0.79-1.44],0.6839054259210721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA4D,Semaphorin-4D,2673,312,1.03 [0.74-1.45],0.8500568560259131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA6C,Semaphorin-6C,2214,250,1.33 [0.91-1.94],0.1377811872985735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA7A,Semaphorin-7A,2671,313,1.67 [1.25-2.23],0.0004618284967183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN3,Neuronal-specific septin-3,2274,254,0.94 [0.80-1.10],0.4433202140646354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN7,Septin-7,2251,250,1.07 [0.87-1.31],0.5317636803118541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN8,Septin-8,2275,254,2.02 [1.45-2.82],2.962392340637479e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN9,Septin-9,2639,307,0.93 [0.66-1.30],0.6652993160241203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA1,Alpha-1-antitrypsin,2242,249,0.65 [0.13-3.16],0.5911160784973459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA11,Serpin A11,2679,313,0.95 [0.75-1.19],0.6387308244689306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA12,Serpin A12,2582,300,0.90 [0.82-1.00],0.0504887767699501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA3,Alpha-1-antichymotrypsin,2268,249,0.84 [0.38-1.87],0.6749960904996023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA4,Kallistatin,2228,244,0.95 [0.57-1.56],0.8276081056571997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA5,Plasma serine protease inhibitor,2245,248,0.70 [0.46-1.07],0.0985914035243945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA6,Corticosteroid-binding globulin,2278,252,1.27 [0.61-2.67],0.5223139166310609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA7,Thyroxine-binding globulin,2278,252,0.76 [0.39-1.48],0.4250806021183998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA9,Serpin A9,2631,307,1.09 [0.96-1.25],0.1932545868623715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB1,Leukocyte elastase inhibitor,2654,312,0.99 [0.88-1.11],0.8761928638144847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB5,Serpin B5,2603,303,1.03 [0.84-1.28],0.7630432851805466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB6,Serpin B6,2666,311,1.11 [0.93-1.33],0.2314366178750717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB8,Serpin B8,2674,311,1.01 [0.86-1.19],0.876325418719943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB9,Serpin B9,2634,311,0.88 [0.65-1.21],0.4459194584116667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINC1,Antithrombin-III,2274,252,1.54 [0.71-3.35],0.2735424715781465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPIND1,Heparin cofactor 2,2274,252,0.97 [0.65-1.47],0.9012446333482164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINE1,Plasminogen activator inhibitor 1,2679,313,0.85 [0.73-0.99],0.0384982513938803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINE2,Glia-derived nexin,2273,252,0.91 [0.75-1.10],0.3109012483185064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINF1,Pigment epithelium-derived factor,2243,250,1.18 [0.77-1.81],0.4568320803461736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINF2,Alpha-2-antiplasmin,2236,249,0.85 [0.35-2.06],0.7255373806666249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPING1,Plasma protease C1 inhibitor,2274,252,0.99 [0.53-1.87],0.9866355585662248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINH1,Serpin H1,2251,250,1.08 [0.98-1.19],0.1241729490973741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINI1,Neuroserpin,2241,246,0.60 [0.39-0.92],0.0184511566836948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINI2,Serpin I2,2268,253,1.07 [0.87-1.31],0.5175270512964749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,2581,302,1.05 [0.90-1.23],0.5274948735944425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,2626,310,0.60 [0.42-0.85],0.0047327075083404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6,Seizure protein 6 homolog,2234,253,1.14 [0.81-1.62],0.4526953639464083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6L,Seizure 6-like protein,2658,311,1.65 [1.19-2.29],0.0025437361918745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6L2,Seizure 6-like protein 2,2639,307,1.41 [0.93-2.12],0.1036752450348745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SF3B4,Splicing factor 3B subunit 4,2639,307,0.98 [0.85-1.13],0.7761510350998817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFRP1,Secreted frizzled-related protein 1,2629,310,1.31 [1.06-1.61],0.0109189506881728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFRP4,Secreted frizzled-related protein 4,2242,246,1.09 [0.82-1.46],0.5614329421087687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFTPA1,Pulmonary surfactant-associated protein A1,2583,300,1.12 [0.95-1.33],0.1813867234472324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFTPA2,Pulmonary surfactant-associated protein A2,2583,300,1.01 [0.83-1.23],0.9339837712627168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFTPD,Pulmonary surfactant-associated protein D,2648,308,1.09 [0.94-1.26],0.253139953777612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SGSH,N-sulphoglucosamine sulphohydrolase,2238,249,0.87 [0.70-1.08],0.2151184112564659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH2B3,SH2B adapter protein 3,2583,300,0.99 [0.89-1.10],0.802818765644193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH2D1A,SH2 domain-containing protein 1A,2646,311,0.91 [0.76-1.11],0.3568036927954907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,2206,248,1.00 [0.81-1.22],0.9662314969910636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3BP1,SH3 domain-binding protein 1,2268,253,1.05 [0.83-1.33],0.6668513013121982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3GL3,Endophilin-A3,2239,249,1.17 [1.00-1.36],0.0433851126266345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3GLB2,Endophilin-B2,2278,254,1.03 [0.86-1.23],0.7402852357041136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHBG,Sex hormone-binding globulin,2287,256,1.06 [0.84-1.33],0.6223926306998735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHC1,SHC-transforming protein 1,2199,248,1.07 [0.96-1.18],0.2191588289735453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHD,SH2 domain-containing adapter protein D,2196,247,0.98 [0.85-1.14],0.8248548127741919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHH,Sonic hedgehog protein,2214,250,1.11 [0.84-1.47],0.461242180708428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHISA5,Protein shisa-5,2286,255,2.04 [1.46-2.87],3.4112801930594366e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",2660,308,0.89 [0.79-1.01],0.0754095146747176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHPK,Sedoheptulokinase,2251,250,0.99 [0.73-1.35],0.9672997063911798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIAE,Sialate O-acetylesterase,2657,311,1.16 [0.94-1.44],0.1709803262633828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC1,Sialoadhesin,2665,309,1.36 [1.08-1.72],0.0085613262860339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,2646,311,1.52 [1.17-1.97],0.0017522645547127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,2581,302,1.04 [0.92-1.17],0.5730375751970107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,2661,313,1.00 [0.92-1.09],0.9575865258746792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,2668,312,1.91 [1.44-2.54],8.487000253824685e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,2648,308,1.30 [0.91-1.85],0.1441609361333015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,2230,249,1.17 [0.91-1.50],0.2226433803734768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,2667,312,1.07 [0.77-1.49],0.6950135036826053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIL1,Nucleotide exchange factor SIL1,2230,249,0.97 [0.67-1.41],0.8681198070227444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,2649,310,1.34 [1.11-1.62],0.0025001557113713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPB1,Signal-regulatory protein beta-1,2644,308,1.54 [1.27-1.88],1.5958481787486383e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,2214,250,1.01 [0.86-1.19],0.8763154060614411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,2639,307,0.96 [0.85-1.09],0.5494213463303826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",2581,302,0.92 [0.76-1.11],0.3702167781830267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,2585,303,1.16 [0.97-1.39],0.0994490981489968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SKAP1,Src kinase-associated phosphoprotein 1,2631,310,0.91 [0.79-1.04],0.1724383244387973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SKAP2,Src kinase-associated phosphoprotein 2,2665,309,0.97 [0.88-1.08],0.6031216296650461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SKIV2L,Helicase SKI2W,2202,248,1.17 [0.85-1.60],0.3370701330605327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLA2,Src-like-adapter 2,2274,254,1.01 [0.90-1.14],0.8651275100266665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF1,Signaling lymphocytic activation molecule,2585,303,1.45 [1.22-1.72],1.9199978383566733e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF6,SLAM family member 6,2583,300,1.15 [0.89-1.49],0.2855619069412437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF7,SLAM family member 7,2646,311,1.27 [1.08-1.49],0.0044739994647204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF8,SLAM family member 8,2583,300,1.31 [1.09-1.58],0.003918375202619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC12A2,Solute carrier family 12 member 2,2202,248,1.18 [0.73-1.92],0.5051377937985253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC13A1,Solute carrier family 13 member 1,2267,249,1.02 [0.81-1.27],0.8929439549756554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC16A1,Monocarboxylate transporter 1,2581,302,1.23 [1.05-1.45],0.0117242429256344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC1A4,Neutral amino acid transporter A,2234,253,1.24 [1.00-1.54],0.049068125124971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC27A4,Long-chain fatty acid transport protein 4,2581,302,0.94 [0.79-1.12],0.5130853124309975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC28A1,Sodium/nucleoside cotransporter 1,2199,248,0.95 [0.76-1.18],0.6418693849126673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,2199,248,0.99 [0.75-1.30],0.932316561393374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC39A14,Zinc transporter ZIP14,2581,302,1.34 [1.07-1.67],0.0108545674572748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC39A5,Zinc transporter ZIP5,2646,311,1.17 [0.96-1.42],0.1204747478385133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC44A4,Choline transporter-like protein 4,2234,253,0.97 [0.81-1.16],0.750004341564349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC4A1,Band 3 anion transport protein,2286,255,1.17 [0.91-1.51],0.231281059134913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC51B,Organic solute transporter subunit beta,2202,248,0.89 [0.74-1.06],0.1851993681281188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,2242,246,1.02 [0.88-1.18],0.8243698978516601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,2268,253,1.13 [0.92-1.39],0.260177209528084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",2199,248,1.26 [1.04-1.52],0.0161037848427968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLIT2,Slit homolog 2 protein,2581,302,1.11 [0.92-1.35],0.2738963184606389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK1,SLIT and NTRK-like protein 1,2214,250,0.80 [0.55-1.16],0.2458120229392188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK2,SLIT and NTRK-like protein 2,2668,312,1.61 [1.26-2.04],0.0001200301220929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK6,SLIT and NTRK-like protein 6,2603,303,1.82 [1.40-2.36],6.188765864597277e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLK,STE20-like serine/threonine-protein kinase,2251,250,1.02 [0.87-1.21],0.7812830960162749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLMAP,Sarcolemmal membrane-associated protein,2268,253,1.06 [0.92-1.23],0.4060130043636497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,2265,252,1.40 [1.04-1.89],0.0259173137762334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD1,Mothers against decapentaplegic homolog 1,2583,300,0.99 [0.88-1.13],0.930823841605744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD2,Mothers against decapentaplegic homolog 2,2267,249,0.96 [0.80-1.15],0.6692006631216809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD3,Mothers against decapentaplegic homolog 3,2267,249,1.02 [0.80-1.30],0.8715663303054457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD5,Mothers against decapentaplegic homolog 5,2639,307,0.35 [0.21-0.58],5.384193239867689e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMARCA2,Probable global transcription activator SNF2L2,2581,302,1.17 [1.02-1.34],0.0245738097940064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMC3,Structural maintenance of chromosomes protein 3,2199,248,0.95 [0.74-1.21],0.6720402127958844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,2268,253,0.89 [0.72-1.10],0.2724682386538628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMOC1,SPARC-related modular calcium-binding protein 1,2668,312,1.37 [1.02-1.83],0.0356219697214378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMOC2,SPARC-related modular calcium-binding protein 2,2665,309,1.47 [1.17-1.85],0.0008865657881133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPD1,Sphingomyelin phosphodiesterase,2666,309,1.21 [1.00-1.46],0.049013061375255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPD3,Sphingomyelin phosphodiesterase 3,2214,250,1.08 [0.86-1.35],0.508123646734161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,2660,309,0.95 [0.82-1.10],0.4857948446539089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,2267,249,0.81 [0.66-0.99],0.0382764699076323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMS,Spermine synthase,2206,248,1.11 [0.92-1.34],0.2878291212881668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMTN,Smoothelin,2274,254,1.03 [0.90-1.18],0.6461366453346021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAP23,Synaptosomal-associated protein 23,2648,308,0.97 [0.86-1.09],0.6418879476816234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAP25,Synaptosomal-associated protein 25,2206,248,0.98 [0.76-1.27],0.9028288203629404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAP29,Synaptosomal-associated protein 29,2658,311,0.96 [0.86-1.08],0.5093764170118769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAPIN,SNARE-associated protein Snapin,2274,254,0.78 [0.63-0.97],0.0251033138275448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNCA,Alpha-synuclein,2242,246,0.99 [0.89-1.10],0.7851704738010389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNCG,Gamma-synuclein,2634,311,1.44 [1.25-1.66],6.921169826743301e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",2230,249,1.61 [1.17-2.22],0.0037127507671938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',2278,254,1.10 [0.88-1.38],0.4102223972829611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNU13,NHP2-like protein 1,2202,248,1.19 [0.98-1.46],0.0791614678934888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX15,Sorting nexin-15,2242,246,0.93 [0.74-1.17],0.5491296492692446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX18,Sorting nexin-18,2268,253,1.19 [0.92-1.55],0.185774849643621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX2,Sorting nexin-2,2267,249,1.11 [0.97-1.27],0.1302691210288847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX5,Sorting nexin-5,2230,249,1.20 [0.78-1.84],0.4001883687664995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX9,Sorting nexin-9,2648,308,1.04 [0.90-1.22],0.5846170372945774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD1,Superoxide dismutase [Cu-Zn],2592,299,0.98 [0.79-1.21],0.8554285832752955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",2661,313,0.91 [0.72-1.14],0.3949787650769119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD3,Extracellular superoxide dismutase,2287,256,1.03 [0.87-1.22],0.7166877163468537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORBS1,Sorbin and SH3 domain-containing protein 1,2274,254,1.18 [0.94-1.49],0.1563937586696952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORCS2,VPS10 domain-containing receptor SorCS2,2583,300,1.75 [1.38-2.23],4.666857185817351e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORD,Sorbitol dehydrogenase,2657,311,0.88 [0.77-1.00],0.0521186980059286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORT1,Sortilin,2647,307,0.92 [0.71-1.20],0.5468292169561534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOST,Sclerostin,2647,307,1.22 [0.95-1.56],0.1258304935957548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,2234,253,0.98 [0.78-1.23],0.8479543190070055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOX2,Transcription factor SOX-2,2268,252,0.75 [0.45-1.25],0.2672320424643527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOX9,Transcription factor SOX-9,2234,253,1.50 [0.95-2.34],0.0793656792723619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,2274,254,1.25 [0.85-1.83],0.2566970063754406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPAG1,Sperm-associated antigen 1,2274,254,1.19 [0.96-1.48],0.1181867045555163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPARC,SPARC,2658,311,0.95 [0.83-1.10],0.5125739726511168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPARCL1,SPARC-like protein 1,2644,308,0.89 [0.62-1.28],0.533155685191524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPART,Spartin,2242,246,0.95 [0.80-1.13],0.5704570580559662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPESP1,Sperm equatorial segment protein 1,2273,252,1.16 [0.81-1.66],0.417980167332034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK1,Serine protease inhibitor Kazal-type 1,2661,313,1.99 [1.70-2.32],5.0624327194552864e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK2,Serine protease inhibitor Kazal-type 2,2242,246,1.35 [1.00-1.81],0.0501377028098577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK4,Serine protease inhibitor Kazal-type 4,2646,311,1.64 [1.45-1.84],4.179514016612783e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK5,Serine protease inhibitor Kazal-type 5,2661,313,1.24 [0.94-1.65],0.1250369796808515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK6,Serine protease inhibitor Kazal-type 6,2668,312,1.04 [0.86-1.25],0.7123368946621416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK8,Serine protease inhibitor Kazal-type 8,2202,248,1.12 [0.77-1.62],0.5590146523051238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT1,Kunitz-type protease inhibitor 1,2654,312,1.50 [1.07-2.10],0.0184033180144952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT2,Kunitz-type protease inhibitor 2,2665,309,1.58 [1.24-2.02],0.0002104991308595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT3,Kunitz-type protease inhibitor 3,2268,253,0.98 [0.90-1.06],0.5438558068136488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPOCK1,Testican-1,2634,311,0.42 [0.29-0.60],1.788421109804152e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON1,Spondin-1,2656,308,1.89 [1.44-2.46],3.445289275571496e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON2,Spondin-2,2640,307,1.73 [1.34-2.24],2.579291993448406e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPP1,Osteopontin,2674,313,0.98 [0.79-1.20],0.8328014296167912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",2214,250,1.01 [0.75-1.36],0.9482175392238656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRING1,SREBP regulating gene protein,2199,248,1.08 [0.87-1.33],0.5062435974301749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRR1B,Cornifin-B,2251,250,1.14 [1.00-1.28],0.0437245512368994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRR3,Small proline-rich protein 3,2278,254,1.13 [0.96-1.34],0.1377327024745588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRY2,Protein sprouty homolog 2,2585,303,1.01 [0.90-1.13],0.8665334426557204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",2206,248,1.08 [0.76-1.54],0.6717958318628212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPTLC1,Serine palmitoyltransferase 1,2278,254,1.11 [0.83-1.47],0.4834540560562179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRC,Proto-oncogene tyrosine-protein kinase Src,2654,310,0.99 [0.91-1.08],0.7975970085092351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRP14,Signal recognition particle 14 kDa protein,2639,307,1.01 [0.84-1.20],0.9278766417845484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRPK2,SRSF protein kinase 2,2646,311,0.94 [0.83-1.07],0.3542425209126204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRPX,Sushi repeat-containing protein SRPX,2273,252,1.29 [0.94-1.75],0.1094680060278841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSB,Lupus La protein,2581,302,1.06 [0.93-1.22],0.3779431657647724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",2214,250,0.97 [0.68-1.37],0.849111214262614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,2647,307,0.93 [0.86-1.00],0.0641994015744604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,2655,309,1.00 [0.79-1.26],0.9998274923849808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSH3,Protein phosphatase Slingshot homolog 3,2199,248,0.98 [0.63-1.52],0.9158799291681272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,2268,253,1.07 [0.85-1.36],0.553155595259655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST13,Hsc70-interacting protein,2242,246,0.91 [0.73-1.13],0.3812469191963171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",2639,307,1.46 [1.21-1.75],7.472999138067475e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",2679,313,1.01 [0.72-1.41],0.9509183280494098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",2214,250,0.86 [0.63-1.17],0.336681535354312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAB2,Stabilin-2,2286,255,0.78 [0.51-1.20],0.2585274895363159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAM,Signal transducing adapter molecule 1,2267,249,0.88 [0.61-1.28],0.5102540841720176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAMBP,STAM-binding protein,2631,310,1.00 [0.85-1.18],0.9898790294340266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAT2,Signal transducer and activator of transcription 2,2214,250,1.03 [0.87-1.22],0.7236856792485855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAT5B,Signal transducer and activator of transcription 5B,2639,307,0.98 [0.91-1.06],0.5848823792176084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,2199,248,1.07 [0.90-1.27],0.4654350735973325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STC1,Stanniocalcin-1,2673,312,1.20 [0.98-1.48],0.0767343568598362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STC2,Stanniocalcin-2,2656,312,1.30 [0.87-1.96],0.2036330913301892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STEAP4,Metalloreductase STEAP4,2206,248,0.98 [0.82-1.18],0.8487229279806547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STIP1,Stress-induced-phosphoprotein 1,2656,312,0.98 [0.83-1.14],0.7625658079242355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STK11,Serine/threonine-protein kinase STK11,2603,303,1.00 [0.87-1.15],0.9967992530014892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STK24,Serine/threonine-protein kinase 24,2581,302,1.09 [0.92-1.29],0.3102259698207568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STK4,Serine/threonine-protein kinase 4,2648,308,0.94 [0.83-1.06],0.3070800580468881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STOML2,"Stomatin-like protein 2, mitochondrial",2199,248,1.00 [0.87-1.14],0.9762467299680836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX16,Syntaxin-16,2583,300,1.00 [0.83-1.19],0.9708445865442972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX1B,Syntaxin-1B,2234,253,1.11 [0.84-1.46],0.4827880899383652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX3,Syntaxin-3,2278,254,0.95 [0.69-1.32],0.7650456210698156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX4,Syntaxin-4,2639,307,1.12 [0.95-1.32],0.1759710033787764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX5,Syntaxin-5,2214,250,1.27 [0.97-1.67],0.082991543853845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX6,Syntaxin-6,2583,300,1.03 [0.88-1.21],0.69954054394114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX7,Syntaxin-7,2214,250,1.20 [0.93-1.54],0.1674955331625249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX8,Syntaxin-8,2646,311,1.05 [0.85-1.30],0.6458346681462004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STXBP1,Syntaxin-binding protein 1,2274,254,0.96 [0.82-1.13],0.6148593531156821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STXBP3,Syntaxin-binding protein 3,2583,300,1.11 [0.86-1.43],0.4192245864009718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUGP1,SURP and G-patch domain-containing protein 1,2268,253,0.96 [0.70-1.32],0.8224561210710751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUGT1,Protein SGT1 homolog,2583,300,1.01 [0.88-1.15],0.9291098912037408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SULT1A1,Sulfotransferase 1A1,2673,312,0.99 [0.91-1.07],0.8019889196872164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SULT2A1,Bile salt sulfotransferase,2646,311,0.93 [0.79-1.08],0.3433255786155033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUMF1,Formylglycine-generating enzyme,2214,250,1.07 [0.90-1.28],0.4255211098032138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,2673,312,0.96 [0.79-1.16],0.6662774641429243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUOX,"Sulfite oxidase, mitochondrial",2274,254,0.95 [0.80-1.14],0.6071781390119801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD1,Sushi domain-containing protein 1,2603,303,0.87 [0.70-1.06],0.1709376821001397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD2,Sushi domain-containing protein 2,2661,313,1.70 [1.24-2.34],0.0010230438422259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD4,Sushi domain-containing protein 4,2267,249,1.07 [0.81-1.40],0.6426807910923145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD5,Sushi domain-containing protein 5,2232,245,1.22 [0.87-1.70],0.2513834626643854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SV2A,Synaptic vesicle glycoprotein 2A,2234,253,1.09 [0.90-1.32],0.3611870617386452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SWAP70,Switch-associated protein 70,2268,253,0.96 [0.66-1.38],0.8076497714004417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYAP1,Synapse-associated protein 1,2242,246,0.90 [0.72-1.13],0.3565803945170553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,2206,248,1.02 [0.83-1.25],0.8633329709631786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYT1,Synaptotagmin-1,2278,254,0.86 [0.62-1.20],0.3889387828301911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYTL4,Synaptotagmin-like protein 4,2273,252,1.02 [0.86-1.20],0.8249751117305153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,2251,250,0.99 [0.88-1.12],0.932585240516422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TACC3,Transforming acidic coiled-coil-containing protein 3,2639,307,1.00 [0.91-1.09],0.9602778413120786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TACSTD2,Tumor-associated calcium signal transducer 2,2342,273,1.80 [1.27-2.56],0.0010114890934783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TADA3,Transcriptional adapter 3,2267,249,0.90 [0.66-1.23],0.5242874728785789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAFA5,Chemokine-like protein TAFA-5,2639,307,1.64 [1.31-2.05],1.538527375435539e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAGLN3,Transgelin-3,2199,248,0.99 [0.80-1.22],0.8913675319057023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TALDO1,Transaldolase,2282,255,0.98 [0.74-1.31],0.9149800095912228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TANK,TRAF family member-associated NF-kappa-B activator,2585,303,0.88 [0.75-1.02],0.0981832870899439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAP1,Antigen peptide transporter 1,2251,250,1.04 [0.87-1.23],0.698318893941785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TARBP2,RISC-loading complex subunit TARBP2,2581,302,1.02 [0.89-1.18],0.7388187051089443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",2234,253,0.97 [0.81-1.17],0.7716194513694297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",2267,249,0.92 [0.67-1.28],0.6276432888706712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAX1BP1,Tax1-binding protein 1,2278,254,0.93 [0.76-1.13],0.466673805269244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBC1D17,TBC1 domain family member 17,2581,302,1.17 [0.96-1.42],0.1225153370424691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBC1D23,TBC1 domain family member 23,2639,307,0.98 [0.88-1.10],0.7535501766312537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBC1D5,TBC1 domain family member 5,2646,311,0.97 [0.85-1.10],0.5994579288597347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBCA,Tubulin-specific chaperone A,2242,246,0.99 [0.85-1.16],0.924167483665717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBCB,Tubulin-folding cofactor B,2634,311,1.00 [0.90-1.11],0.97341677948448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBCC,Tubulin-specific chaperone C,2634,311,1.03 [0.90-1.17],0.7092334759206945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,2583,300,1.01 [0.90-1.15],0.8277359694141727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBR1,T-box brain protein 1,2234,253,0.97 [0.76-1.24],0.8378031027931432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCL1A,T-cell leukemia/lymphoma protein 1A,2632,310,0.85 [0.77-0.93],0.0007309393503604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCL1B,T-cell leukemia/lymphoma protein 1B,2603,303,1.06 [0.94-1.19],0.3746343544012802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCN1,Transcobalamin-1,2234,251,0.71 [0.49-1.01],0.0586761302619277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCN2,Transcobalamin-2,2674,313,2.10 [1.56-2.83],1.1201646605103958e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCOF1,Treacle protein,2273,252,1.20 [0.82-1.76],0.3513115245860553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCP11,T-complex protein 11 homolog,2251,250,1.07 [0.88-1.31],0.4947876802269288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCTN3,Tectonic-3,2273,252,0.83 [0.57-1.20],0.3168566963302514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDGF1,Teratocarcinoma-derived growth factor 1,2581,302,1.03 [0.96-1.10],0.3746151177320924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDO2,"Tryptophan 2,3-dioxygenase",2234,253,0.77 [0.54-1.09],0.1369636559217744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,2267,249,1.04 [0.88-1.24],0.6234765334737318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDRKH,Tudor and KH domain-containing protein,2581,302,1.01 [0.89-1.14],0.9101698573507464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEF,Thyrotroph embryonic factor,2202,248,0.94 [0.69-1.29],0.714871066141053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEK,Angiopoietin-1 receptor,2658,311,1.40 [0.91-2.15],0.1241169585677695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TERF1,Telomeric repeat-binding factor 1,2214,250,0.95 [0.61-1.47],0.8160975073205304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TET2,Methylcytosine dioxygenase TET2,2243,249,0.96 [0.84-1.08],0.4830601291825642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEX101,Testis-expressed protein 101,2234,253,1.04 [0.84-1.29],0.6987729203726205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEX33,Testis-expressed protein 33,2251,250,0.85 [0.60-1.21],0.3683154350631098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TF,Serotransferrin,2278,252,1.71 [0.99-2.96],0.0559396400906299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFAP2A,Transcription factor AP-2-alpha,2206,248,1.01 [0.82-1.23],0.9491289000205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF1,Trefoil factor 1,2650,313,1.37 [1.24-1.51],8.647922040203211e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF2,Trefoil factor 2,2660,308,1.55 [1.35-1.78],4.821322150971031e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF3,Trefoil factor 3,2632,308,1.74 [1.50-2.02],3.101784365838856e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFPI,Tissue factor pathway inhibitor,2643,307,0.80 [0.58-1.10],0.1662145308719025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFPI2,Tissue factor pathway inhibitor 2,2651,310,1.00 [0.77-1.31],0.9739691537918836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFRC,Transferrin receptor protein 1,2651,307,1.30 [1.02-1.65],0.0314050848459006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TG,Thyroglobulin,2267,249,1.04 [0.93-1.15],0.4962586735296735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFA,Protransforming growth factor alpha,2646,311,1.42 [1.18-1.72],0.0002782961642558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFB1,Transforming growth factor beta-1 proprotein,2669,311,1.08 [0.84-1.40],0.5350199940291132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFB2,Transforming growth factor beta-2 proprotein,2267,249,1.17 [0.92-1.50],0.2084575919566067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,2630,305,0.57 [0.40-0.80],0.0015291970008298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR1,TGF-beta receptor type-1,2214,250,1.52 [0.88-2.60],0.1304874438241072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR2,TGF-beta receptor type-2,2658,311,1.84 [1.49-2.27],1.0220821072206932e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR3,Transforming growth factor beta receptor type 3,2679,313,1.37 [1.01-1.87],0.044058400991291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,2642,308,0.98 [0.86-1.12],0.7746229473332921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGOLN2,Trans-Golgi network integral membrane protein 2,2287,256,1.87 [1.25-2.79],0.0021738881774659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,2197,248,0.84 [0.71-0.99],0.0334267979269591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBD,Thrombomodulin,2648,308,1.64 [1.23-2.19],0.0008444528387825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBS2,Thrombospondin-2,2661,313,1.27 [1.04-1.54],0.0187358808154203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBS4,Thrombospondin-4,2651,307,0.90 [0.73-1.10],0.3137411327447175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THOP1,Thimet oligopeptidase,2641,307,0.76 [0.56-1.03],0.0812504585432429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THPO,Thrombopoietin,2603,303,1.01 [0.79-1.30],0.91483561251804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THRAP3,Thyroid hormone receptor-associated protein 3,2202,248,0.92 [0.81-1.04],0.1778338933318726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THSD1,Thrombospondin type-1 domain-containing protein 1,2196,247,1.08 [0.78-1.51],0.6275398264746683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THTPA,Thiamine-triphosphatase,2263,249,1.00 [0.87-1.16],0.9628164738621924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THY1,Thy-1 membrane glycoprotein,2673,312,1.67 [1.23-2.26],0.0010299238689935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIA1,Nucleolysin TIA-1 isoform p40,2579,300,1.00 [0.92-1.09],0.9406141699869768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIE1,Tyrosine-protein kinase receptor Tie-1,2679,313,1.16 [0.90-1.50],0.2585407643612389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",2578,301,1.06 [0.85-1.33],0.5949192391851514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,2251,250,1.22 [1.00-1.48],0.0450990738867827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,2655,309,0.77 [0.62-0.96],0.0218195899497466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,2273,252,1.09 [0.81-1.47],0.5796504417601107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,2278,254,0.95 [0.82-1.10],0.5142506908263906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP1,Metalloproteinase inhibitor 1,2612,306,1.39 [1.02-1.90],0.0372175172971984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP2,Metalloproteinase inhibitor 2,2273,252,1.43 [1.02-2.00],0.0384759068009179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP3,Metalloproteinase inhibitor 3,2665,309,1.00 [0.92-1.07],0.9016415793956584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP4,Metalloproteinase inhibitor 4,2661,313,1.17 [0.92-1.48],0.1921628072114663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TINAGL1,Tubulointerstitial nephritis antigen-like,2644,307,1.87 [1.22-2.86],0.0037915661323137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TJAP1,Tight junction-associated protein 1,2658,311,0.97 [0.86-1.10],0.6871679587452948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TJP3,Tight junction protein ZO-3,2206,248,1.18 [0.91-1.54],0.2137862411743932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TK1,"Thymidine kinase, cytosolic",2251,250,0.87 [0.64-1.17],0.3470378363452945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR1,Toll-like receptor 1,2214,250,1.32 [0.85-2.04],0.2162173008195034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR2,Toll-like receptor 2,2251,250,0.94 [0.55-1.59],0.8194031064763119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR3,Toll-like receptor 3,2674,311,1.09 [0.93-1.28],0.2699224174509703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR4,Toll-like receptor 4,2214,250,0.87 [0.56-1.34],0.523106317162616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,2234,253,0.99 [0.79-1.24],0.93690906435148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED1,Transmembrane emp24 domain-containing protein 1,2251,250,1.08 [0.86-1.36],0.4993470651315226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED10,Transmembrane emp24 domain-containing protein 10,2202,248,1.08 [0.84-1.38],0.5669468831349248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED4,Transmembrane emp24 domain-containing protein 4,2202,248,0.83 [0.65-1.07],0.1481758314713366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED8,Protein TMED8,2268,253,0.98 [0.87-1.11],0.7394100162892767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMEM106A,Transmembrane protein 106A,2267,249,0.99 [0.83-1.18],0.8790070268650245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMEM132A,Transmembrane protein 132A,2230,249,1.17 [0.97-1.41],0.0957980906324865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMEM25,Transmembrane protein 25,2274,254,1.22 [0.94-1.58],0.1426364367663067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMOD4,Tropomodulin-4,2199,248,1.06 [0.79-1.42],0.7133463029305673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS11B,Transmembrane protease serine 11B,2206,248,0.96 [0.81-1.14],0.6528449236871596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS11D,Transmembrane protease serine 11D,2275,254,1.20 [0.91-1.59],0.1992883649247795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS15,Enteropeptidase,2639,307,1.32 [1.19-1.47],4.0817566389577364e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS5,Transmembrane protease serine 5,2627,310,1.04 [0.80-1.36],0.7440995589769488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMSB10,Thymosin beta-10,2661,313,1.17 [1.02-1.34],0.0299162434748036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNC,Tenascin,2655,309,1.12 [0.92-1.37],0.2638914196894061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNF,Tumor necrosis factor,2601,302,1.28 [1.01-1.62],0.04005271635047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,2268,253,1.03 [0.80-1.31],0.8312223969525234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,2585,303,0.99 [0.75-1.29],0.9164551889832202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,2242,246,1.03 [0.84-1.26],0.7809912531489567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,2634,311,1.90 [1.54-2.35],2.471106990419941e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,2634,311,1.37 [1.22-1.54],1.3333443429431304e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,2653,308,1.05 [0.85-1.30],0.6306500264422092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,2674,311,2.11 [1.74-2.56],5.16828542457453e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,2649,308,1.65 [1.23-2.22],0.0009328539882728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,2658,311,2.02 [1.60-2.54],2.4001932665051822e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,2656,308,1.50 [1.17-1.92],0.0014482463886392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,2585,303,1.29 [1.02-1.62],0.0304363669516853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,2656,308,2.19 [1.72-2.79],2.819606631727101e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,2242,246,1.35 [1.02-1.78],0.0370398462719994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,2668,312,1.88 [1.50-2.36],4.734062458043446e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,2661,313,2.56 [2.00-3.28],1.0241745591037945e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,2661,313,1.53 [1.29-1.80],5.848173129446804e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,2673,312,1.89 [1.37-2.61],0.0001167108032813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,2669,311,1.97 [1.59-2.43],4.866319554447944e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,2634,311,1.26 [1.07-1.49],0.0059892608677801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,2673,312,1.43 [1.17-1.76],0.0006127913339184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,2634,311,1.58 [1.31-1.89],8.511497355030282e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,2674,311,0.58 [0.40-0.84],0.00393835266267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,2646,311,0.77 [0.65-0.91],0.0020098355449557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,2674,311,0.60 [0.42-0.86],0.0046463154663964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,2665,309,2.31 [1.64-3.24],1.6517073054993426e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,2676,313,1.13 [0.81-1.58],0.4789257673066256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,2634,311,0.91 [0.76-1.09],0.3006188410794697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,2286,255,1.45 [1.07-1.95],0.0154037926811198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNIP1,TNFAIP3-interacting protein 1,2278,254,0.95 [0.83-1.10],0.4968036536819646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNN,Tenascin-N,2286,255,0.86 [0.66-1.14],0.3019260232731024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNNI3,"Troponin I, cardiac muscle",2603,303,0.96 [0.86-1.08],0.4926359101182209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNPO1,Transportin-1,2251,250,1.22 [0.84-1.76],0.2881221052567551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNR,Tenascin-R,2634,311,1.12 [0.88-1.41],0.3587274690848021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNXB,Tenascin-X,2661,313,0.65 [0.45-0.94],0.0235438940657976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,2273,252,1.06 [0.91-1.24],0.4325534417765855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOP1,DNA topoisomerase 1,2268,253,1.02 [0.92-1.13],0.6858881931584544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOP1MT,"DNA topoisomerase I, mitochondrial",2199,248,0.97 [0.75-1.26],0.8387261584875647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOP2B,DNA topoisomerase 2-beta,2214,250,0.96 [0.82-1.13],0.6561573600600947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOR1AIP1,Torsin-1A-interacting protein 1,2230,249,1.13 [0.91-1.39],0.273774512119516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53,Cellular tumor antigen p53,2583,300,1.06 [0.84-1.34],0.6251747934576346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53BP1,TP53-binding protein 1,2214,250,1.10 [0.95-1.27],0.1960368180496514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53I3,Quinone oxidoreductase PIG3,2186,240,0.98 [0.76-1.25],0.8426173734701158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,2603,303,1.29 [0.97-1.71],0.0759281393032718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP73,Tumor protein p73,2234,253,0.93 [0.65-1.32],0.6676173830236264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPBGL,Trophoblast glycoprotein-like,2234,253,1.04 [0.78-1.40],0.7760421383029907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPD52L2,Tumor protein D54,2242,246,0.98 [0.87-1.10],0.7324317287340725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPK1,Thiamin pyrophosphokinase 1,2273,252,0.67 [0.44-1.04],0.0766275431295409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPM3,Tropomyosin alpha-3 chain,2202,248,1.07 [0.83-1.37],0.6258909912515219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPMT,Thiopurine S-methyltransferase,2583,300,0.91 [0.79-1.05],0.1966598041829417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPP1,Tripeptidyl-peptidase 1,2635,307,1.15 [0.93-1.40],0.1902342416561212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPPP2,Tubulin polymerization-promoting protein family member 2,2251,250,1.03 [0.88-1.20],0.7231547451505671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPPP3,Tubulin polymerization-promoting protein family member 3,2581,302,0.86 [0.64-1.16],0.3142136880906233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPR,Nucleoprotein TPR,2202,248,0.99 [0.77-1.27],0.933642264737144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPRKB,EKC/KEOPS complex subunit TPRKB,2199,248,1.06 [0.89-1.27],0.4829108090741044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPSAB1,Tryptase alpha/beta-1,2672,311,1.18 [0.97-1.45],0.1018252583322284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPSD1,Tryptase delta,2274,254,1.22 [0.90-1.66],0.209097205893682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPSG1,Tryptase gamma,2214,250,1.17 [0.78-1.77],0.4441827939438606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPT1,Translationally-controlled tumor protein,2585,303,1.02 [0.86-1.20],0.8247068754366516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRAF2,TNF receptor-associated factor 2,2646,311,0.95 [0.82-1.10],0.5124309539379794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",2214,250,0.99 [0.72-1.36],0.9465337233960194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,2202,248,0.91 [0.70-1.18],0.4691329846020313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,2251,250,0.92 [0.79-1.06],0.2474008978146535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREH,Trehalase,2286,255,1.03 [0.88-1.21],0.7393555283215667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREM2,Triggering receptor expressed on myeloid cells 2,2649,308,1.09 [0.91-1.29],0.3412925031705593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREML1,Trem-like transcript 1 protein,2287,256,1.00 [0.79-1.26],0.9840758974954216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREML2,Trem-like transcript 2 protein,2661,313,0.94 [0.71-1.25],0.6792141008380924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,2668,312,1.12 [0.94-1.32],0.1991582380493438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,2646,311,0.94 [0.82-1.07],0.3505762298425714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM24,Transcription intermediary factor 1-alpha,2249,250,0.87 [0.72-1.06],0.179786849973296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,2268,253,0.97 [0.87-1.09],0.6525209167056882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM26,Tripartite motif-containing protein 26,2199,248,0.94 [0.76-1.16],0.5873606589944704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM40,E3 ubiquitin ligase TRIM40,2234,253,0.99 [0.84-1.16],0.8571256280393699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM5,Tripartite motif-containing protein 5,2646,311,0.92 [0.82-1.04],0.2006471024763972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,2267,249,1.00 [0.87-1.15],0.9888766377989524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,2202,248,0.98 [0.76-1.27],0.898433810448935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSC1,Hamartin,2214,250,0.91 [0.74-1.11],0.3355400651609936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSC22D1,TSC22 domain family protein 1,2274,254,1.05 [0.87-1.26],0.606817923072587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSHB,Thyrotropin subunit beta,2648,308,0.85 [0.75-0.97],0.0133495743507629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSLP,Thymic stromal lymphopoietin,2603,303,1.10 [0.95-1.27],0.2097156408211609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSNAX,Translin-associated protein X,2202,248,1.10 [0.80-1.52],0.5659771471787407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN1,Tetraspanin-1,2603,303,1.08 [0.96-1.22],0.1969127962655952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN15,Tetraspanin-15,2202,248,1.10 [0.87-1.38],0.4299267682957591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN7,Tetraspanin-7,2206,248,0.96 [0.84-1.11],0.5998039241425237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN8,Tetraspanin-8,2268,253,0.97 [0.87-1.09],0.6128681588420474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPYL1,Testis-specific Y-encoded-like protein 1,2214,250,1.08 [0.80-1.46],0.6310130041462019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TST,Thiosulfate sulfurtransferase,2580,302,1.05 [0.91-1.21],0.5357667099416408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTF2,Transcription termination factor 2,2234,253,1.19 [0.93-1.53],0.1670955237023301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTN,Titin,2202,248,1.32 [1.12-1.55],0.0006892746624545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTR,Transthyretin,2256,250,1.08 [0.67-1.72],0.7598674341464241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TUBB3,Tubulin beta-3 chain,2206,248,1.16 [0.73-1.82],0.5305735724578491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TWF2,Twinfilin-2,2286,255,1.01 [0.87-1.17],0.8960685510196063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXK,Tyrosine-protein kinase TXK,2251,250,1.03 [0.89-1.21],0.6673140489386271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXLNA,Alpha-taxilin,2634,311,0.97 [0.86-1.09],0.6060184457422728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXN,Thioredoxin,2252,254,1.06 [0.81-1.40],0.6602996121696074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC15,Thioredoxin domain-containing protein 15,2658,311,0.75 [0.52-1.07],0.1094206470286434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC5,Thioredoxin domain-containing protein 5,2673,312,1.17 [1.01-1.36],0.0355552171404474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC9,Thioredoxin domain-containing protein 9,2278,254,1.03 [0.81-1.31],0.8114497513794199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNL1,Thioredoxin-like protein 1,2202,247,1.05 [0.93-1.19],0.3949136985531922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",2661,313,0.90 [0.72-1.12],0.3619196694258487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYMP,Thymidine phosphorylase,2630,306,0.99 [0.84-1.16],0.8701658053894838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,2648,308,1.35 [0.95-1.90],0.0897773446703879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",2214,250,1.35 [1.11-1.64],0.00305551593054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBAC1,Ubiquitin-associated domain-containing protein 1,2639,307,1.14 [0.85-1.51],0.3815917655553216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,2267,249,1.18 [0.77-1.81],0.4398346982651622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,2273,252,0.99 [0.81-1.23],0.9609613398905476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,2214,250,1.09 [0.89-1.35],0.408661058904383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBQLN3,Ubiquilin-3,2202,248,0.95 [0.78-1.16],0.6442837948877935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBXN1,UBX domain-containing protein 1,2242,246,0.97 [0.80-1.16],0.7301587224839715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,2268,253,1.01 [0.93-1.11],0.7803735135356158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UGDH,UDP-glucose 6-dehydrogenase,2202,248,1.15 [1.02-1.29],0.0237613441448418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,2202,248,1.39 [0.98-1.96],0.0647988305023062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ULBP2,UL16-binding protein 2,2634,311,1.81 [1.44-2.28],5.040122982823288e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UMOD,Uromodulin,2666,310,0.72 [0.61-0.85],0.0001120419452145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UNC5D,Netrin receptor UNC5D,2214,250,1.15 [0.73-1.81],0.5362153531607814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UNC79,Protein unc-79 homolog,2199,248,1.11 [0.89-1.39],0.3544338171580556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UNG,Uracil-DNA glycosylase,2267,249,1.10 [0.76-1.59],0.6301341849395767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPB1,Beta-ureidopropionase,2273,252,0.87 [0.77-0.99],0.0321324503924961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPK3A,Uroplakin-3a,2206,248,1.02 [0.80-1.30],0.8649803696188708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPK3BL1,Uroplakin-3b-like protein 1,2245,248,0.89 [0.68-1.16],0.3847461673355273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UROD,Uroporphyrinogen decarboxylase,2242,246,1.01 [0.84-1.21],0.9435103039025096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UROS,Uroporphyrinogen-III synthase,2234,253,1.07 [0.88-1.29],0.4987220260490499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USO1,General vesicular transport factor p115,2639,307,1.05 [0.93-1.18],0.4260381729914685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,2267,249,1.03 [0.87-1.23],0.7163163275163418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,2278,254,1.43 [1.08-1.89],0.0115381544789792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,2202,248,1.12 [0.98-1.27],0.0941382759930539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,2603,303,1.01 [0.91-1.13],0.8119662528224201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UXS1,UDP-glucuronic acid decarboxylase 1,2583,300,1.02 [0.85-1.23],0.8099692909294718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAMP5,Vesicle-associated membrane protein 5,2603,303,1.02 [0.84-1.23],0.8683171395066435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAMP8,Vesicle-associated membrane protein 8,2214,250,1.00 [0.87-1.16],0.9566621158349298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,2646,311,0.96 [0.85-1.09],0.5640676077745104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASN,Vasorin,2602,300,2.02 [1.45-2.81],3.516150300968681e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASP,Vasodilator-stimulated phosphoprotein,2287,256,0.99 [0.84-1.17],0.9240076681465684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,2639,307,1.13 [0.69-1.84],0.6330109891009272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAV3,Guanine nucleotide exchange factor VAV3,2206,248,1.01 [0.89-1.15],0.8711602821053759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCAM1,Vascular cell adhesion protein 1,2653,308,1.85 [1.34-2.55],0.0001756491062257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCAN,Versican core protein,2673,312,1.28 [0.93-1.77],0.1343233866328165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCPKMT,Protein-lysine methyltransferase METTL21D,2199,248,1.04 [0.90-1.20],0.6016818408654716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFA,Vascular endothelial growth factor A,2665,310,1.13 [0.96-1.34],0.1477092235266446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFB,Vascular endothelial growth factor B,2214,250,0.94 [0.62-1.41],0.7587297191173501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFC,Vascular endothelial growth factor C,2658,311,0.93 [0.78-1.10],0.3890549067993756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFD,Vascular endothelial growth factor D,2670,310,1.93 [1.51-2.46],1.4958383540622306e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VGF,Neurosecretory protein VGF,2274,254,1.03 [0.72-1.47],0.8782582251891148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VIM,Vimentin,2603,303,0.96 [0.88-1.05],0.3893069776206231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,2230,249,1.23 [0.71-2.10],0.4611236380262292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VIT,Vitrin,2273,252,0.91 [0.67-1.22],0.5146275000145125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VMO1,Vitelline membrane outer layer protein 1 homolog,2639,307,1.15 [0.98-1.34],0.0797020930339712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VNN1,Pantetheinase,2287,256,0.84 [0.72-0.98],0.0249430727388104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VNN2,Vascular non-inflammatory molecule 2,2639,307,1.07 [0.86-1.33],0.5172686784080193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,2251,250,0.95 [0.79-1.15],0.6164786245354432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS37A,Vacuolar protein sorting-associated protein 37A,2639,307,1.04 [0.91-1.18],0.5616428012089871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS4B,Vacuolar protein sorting-associated protein 4B,2267,249,1.02 [0.89-1.16],0.7905425462895473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,2639,307,0.99 [0.87-1.13],0.8673747164793948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,2267,249,0.74 [0.49-1.11],0.1463074276064588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,2202,248,1.31 [0.93-1.86],0.1272884051563926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,2267,249,1.36 [1.18-1.57],1.86324120991261e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,2656,312,1.84 [1.50-2.24],2.8812814756954673e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,2645,308,1.15 [0.99-1.34],0.076935160985055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSNL1,Visinin-like protein 1,2278,254,0.68 [0.51-0.92],0.0123138143437642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM1,V-set and transmembrane domain-containing protein 1,2581,302,1.25 [1.03-1.52],0.0245141017398667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,2251,250,0.93 [0.67-1.28],0.6528207027902715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,2603,303,1.22 [1.06-1.41],0.0058186113098138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,2673,312,1.03 [0.89-1.19],0.6855603167200154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,2583,300,1.45 [1.10-1.91],0.0080991521271132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,2242,246,1.02 [0.82-1.26],0.868472428178365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWA1,von Willebrand factor A domain-containing protein 1,2663,312,1.06 [0.83-1.35],0.6601567110780433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWA5A,von Willebrand factor A domain-containing protein 5A,2199,248,1.06 [0.91-1.23],0.4431599347728842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWC2,Brorin,2630,310,1.41 [1.12-1.78],0.0033389394374992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,2274,254,1.30 [1.05-1.60],0.015586618119584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWF,von Willebrand factor,2679,313,1.03 [0.90-1.18],0.6200426374986195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",2661,313,0.91 [0.70-1.18],0.4656680192821796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WAS,Wiskott-Aldrich syndrome protein,2585,303,0.99 [0.85-1.15],0.86729717852552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,2603,303,0.98 [0.88-1.10],0.7631842903355263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,2581,302,0.96 [0.85-1.09],0.5427260907676598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASHC3,WASH complex subunit 3,2278,254,0.98 [0.83-1.16],0.852427441465436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASL,Neural Wiskott-Aldrich syndrome protein,2214,250,1.12 [0.92-1.37],0.240971752468378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WDR46,WD repeat-containing protein 46,2267,249,0.64 [0.44-0.94],0.0232401221302483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC1,WAP four-disulfide core domain protein 1,2223,244,1.13 [0.93-1.39],0.2237543222972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC12,WAP four-disulfide core domain protein 12,2665,312,1.17 [1.01-1.35],0.0346935924934349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC2,WAP four-disulfide core domain protein 2,2518,287,1.79 [1.48-2.16],1.924239117386593e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",2626,310,0.74 [0.59-0.93],0.0084023176276169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",2656,308,1.01 [0.76-1.34],0.9561008135479646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WIF1,Wnt inhibitory factor 1,2668,312,0.57 [0.42-0.76],0.0001597718822971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WNT9A,Protein Wnt-9a,2585,303,1.86 [1.49-2.32],4.3467136613476766e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,2634,311,0.89 [0.73-1.09],0.2514520661293583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XCL1,Lymphotactin,2668,312,1.32 [1.12-1.56],0.001072664738535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XG,Glycoprotein Xg,2667,312,1.82 [1.42-2.34],2.979337828336863e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XIAP,E3 ubiquitin-protein ligase XIAP,2214,250,1.06 [0.85-1.33],0.5854615498950031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XPNPEP2,Xaa-Pro aminopeptidase 2,2658,311,0.89 [0.81-0.97],0.0111763429139467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XRCC4,DNA repair protein XRCC4,2581,302,0.97 [0.74-1.29],0.8535717627683036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YAP1,Transcriptional coactivator YAP1,2278,254,2.57 [1.79-3.69],2.830214581564467e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",2268,253,1.01 [0.93-1.10],0.7676158794484512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YES1,Tyrosine-protein kinase Yes,2639,307,1.01 [0.93-1.11],0.75812601791424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YJU2,Splicing factor YJU2,2267,249,1.03 [0.69-1.54],0.8772001565020008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YOD1,Ubiquitin thioesterase OTU1,2202,248,0.92 [0.76-1.12],0.4185900606610335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YTHDF3,YTH domain-containing family protein 3,2585,303,0.98 [0.87-1.11],0.7260844928297884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YWHAQ,14-3-3 protein theta,2242,246,0.97 [0.81-1.15],0.6909537936259651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YY1,Transcriptional repressor protein YY1,2214,250,1.01 [0.64-1.60],0.9609389460717542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZBP1,Z-DNA-binding protein 1,2214,250,0.85 [0.59-1.23],0.3912351266520101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,2583,300,0.94 [0.81-1.09],0.4092105079823525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,2603,303,1.07 [0.84-1.37],0.5792389708348902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,2202,248,1.06 [0.88-1.28],0.5086283304380976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZFYVE19,Abscission/NoCut checkpoint regulator,2268,253,1.00 [0.87-1.15],0.9874164422735552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZHX2,Zinc fingers and homeoboxes protein 2,2278,254,1.02 [0.71-1.46],0.9155918504024524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNF174,Zinc finger protein 174,2214,250,1.04 [0.74-1.45],0.8368284201366281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNF75D,Zinc finger protein 75D,2251,250,0.98 [0.81-1.19],0.8638061861547658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNF830,Zinc finger protein 830,2267,249,1.11 [0.95-1.30],0.1795167804712064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNRD2,Protein ZNRD2,2268,253,1.03 [0.87-1.21],0.7491507926905702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,2267,249,0.93 [0.74-1.17],0.5312843614497019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZP3,Zona pellucida sperm-binding protein 3,2230,249,1.01 [0.96-1.05],0.7312870245376233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZP4,Zona pellucida sperm-binding protein 4,2199,248,1.19 [0.89-1.59],0.2516805458763551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZPR1,Zinc finger protein ZPR1,2206,248,0.99 [0.88-1.13],0.9264426191129818
